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SUMMARY 
 
The recent rise of bio-succinic acid as industrial platform chemical has brought the 
rumen bacterium Basfia succiniciproducens, a natural producer of this organic acid, 
into the focus of research. In order to upgrade this industrial producer into a cell factory 
of broader use, the potential of B. succiniproducens to produce carbon-three 
compounds was explored. A new genome engineering approach and the identification 
of suitable promoters for gene expression was targeted. For production of the C3 
chemical alanine from glucose and xylose, a bioprocess was developed. Genetic 
engineering for β-alanine and 3-hydroxypropionate (3-HP) production was examined. 
A blue-white selection screening system for genome engineering was established, 
using a lacZ deficient strain. Suitable promoters for heterologous expression of 
different genes of interest were identified. Using B. succiniciproducens ALA-1, hosting 
a genomic copy of an alanine dehydrogenase from Geobacillus stearothermophilus, 
alanine production was improved to 29 g L-1 by establishing a fed-batch strategy under 
anaerobic conditions. Via equipment of B. succiniciproducens with an episomal copy 
of an aspartate 1-decarboxylase from Corynebacterium glutamicum or Vibrio 
natriegens, β-alanine synthesis was realized (450 mg L-1). The expression of a β-
alanine pyruvate transaminase from Pseudomonas putida and a malonate 
semialdehyde reductase from Escherichia coli enabled production of 3-HP 
(100 mg L- 1) from glucose. 
 
 
 
 
 
 
 
 
 
 
 
  
IX 
ZUSAMMENFASSUNG 
 
Die Nutzung von Bio-Bernsteinsäure als industrielle Plattformchemikalie hat das 
Pansen-Bakterium Basfia succiniciproducens, einen natürlichen Produzenten dieser 
organischen Säure, in den Fokus der Forschung gebracht. Um diesen 
Produzentenstamm für weitere Anwendungen auszubauen, wurde das Potential von 
B. succiniciproducens zur Produktion von C3 Chemikalien erforscht. Eine neue genom-
basierte Methode zur genetischen Modifikation sowie geeignete Promotoren für die 
Genexpression wurden angestrebt. Für die Produktion der C3 Chemikalie Alanin aus 
Glucose und Xylose wurde ein Bioprozess entwickelt. Genetische Arbeiten zur 
Produktion von β-Alanin und 3-Hydroxypropionat (3-HP) wurden durchgeführt. 
Ein blau-weiß Screening System für genomische Modifikationen wurde zunächst in 
einem lacZ defizienten Stamm etabliert. Auch geeignete Promotoren für die heterologe 
Expression verschiedenster Ziel-Gene wurden identifiziert. Der Stamm 
B. succiniciproducens ALA-1, der eine genomische Kopie einer Alanin Dehydrogenase 
aus Geobacillus stearothermophilus besitzt, produzierte 29 g L-1 Alanin in einem 
anaeroben Fed-Batch Prozess. Durch Einbringen von episomalen Kopien einer 
Aspartat 1-Decarboxylase aus Corynebacterium glutamicum oder Vibrio natriegens 
wurde die β-Alanin (450 mg L-1) Synthese realisiert. Die Expression einer β-Alanin 
Pyruvat Transaminase aus Pseudomonas putida und einer Malonate semialdehyd 
Reduktase aus Escherichia coli ermöglichte die Produktion von 3-HP (100 mg L-1) aus 
Glucose. 
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1 INTRODUCTION AND OBJECTIVES 
 
1.1 Introduction 
 
Our industrialized world is driven by using fossil resources like petroleum. Mankind’s 
elevated and thriving demand of these non-renewable resources depletes their 
availability and can lead to shortages with incalculable consequences for our 
communities and life. Furthermore, the use of fossil resources in our daily life yields a 
carbon dioxide fingerprint in every single production process of commercial goods or 
means of transportation (Becker and Wittmann, 2015). This led to elevated carbon 
dioxide concentrations in our atmosphere (Crutzen, 2002; Dlugokencky and Tans, 
2017). Carbon dioxide, as a greenhouse gas, can influence our climate significantly, 
leading to deviations from its natural behavior (Crutzen, 2002; UNEP, 2017). 
To face these challenges and reduce the dependence on fossil resources as well as 
greenhouse gas emissions, the recent years have seen a tremendous increase in the 
sustainable production of chemicals and commercial goods through biotechnology 
processes (Becker et al., 2015; Werpy et al., 2004). Particularly, the production of 
amino acids (Becker and Wittmann, 2012b) and organic acids (Becker et al., 2015) 
plays a key role in the development of a bio-based community. 
To broaden this further, the US Department of Energy published a candidate list of 
12 top value chemicals, which can be derived through biotechnology processes 
(Werpy et al., 2004). This list comprises carbon-three to carbon-six chemicals, which 
are grouped into organic acids, amino acids, (sugar) alcohols and lactones. Organic 
acids are depicted as the bulk fraction of these platform chemicals (Table 1.1). 
In detail, 3-hydroxypropionate (C3), the 1,4-diacids succinate, fumarate, malate (C4), 
itaconate, levulinate (C5), 2,5-furandicarboxylate and glucarate (C6) are mentioned. 
In particular, amino acids like aspartate (C4) and glutamate (C5) are also identified for 
application in chemical industry. Furthermore, (sugar) alcohols, like the commonly 
known glycerol (C3), a side product of biodiesel industry (Yang et al., 2012), and xylitol 
(xylose, C5), arabitol (arabinose, C5) and sorbitol (sorbit, C6) are listed (Werpy et al., 
2004).  
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Table 1.1. List of top value chemicals comprising compound details and potential applications. 
Applications are divided in nine categories e.g. industrial. All categories name specific applications 
e.g. transportation (fuels, anti-freeze, …). Detailed information is listed in Werpy et al., 2004. 
Compound Compound class 
Number of 
carbon atoms Derivatives of interest Application 
3-Hydroxypropionate Organic acid 3 
Acrylates, Acrylamides, 
Esters, 1,3-
Propanediol, Malonate 
 
Safe Food Supply, 
Industrial, Environment, 
Housing 
Glycerol Sugar alcohol 3 
Propylene glycol, 
Malonate, 1,3-
Propanediol, Diacids, 
Propylalcohol, 
Dialdehyde, Epoxides 
Housing, Industrial, 
Transportation, Safe 
Food Supply 
Succinate Organic acid 4 
Tetrahydrofuran, 1,4-
Butanediol, γ-
Butyrolactone, 
Pyrrolidones, Esters, 
Diamines, 
4,4-Bionelle, 
Hydroxybutyricacid 
Industrial, Textiles, 
Environment, 
Transportation, Safe 
Food Supply, 
Communication 
Aspartate Amino acid 4 
Amino succinate 
derivatives, 
Polypyrrolidones 
Industrial, Environment, 
Health and Hygiene 
Fumarate Organic acid 4 
Unsaturated succinate 
derivatives 
Transportation, Safe 
Food Supply, 
Communication, 
Housing 
Malate Organic acid 4 
Hydroxysuccinate 
derivatives, 
Hydroxybutyrolactone 
Industrial, Textiles, 
Environment 
Itaconate Organic acid 5 
Methyl succinate 
derivatives, 
Unsaturated esters 
Transportation, 
Housing, Textiles, 
Recreation 
Levulinate Organic acid 5 
δ-Aminolevulinate, 2-
Methyl 
Tetrahydrofuran, 1,4-
Diols, Esters, Succinate 
Industrial, Environment, 
Health and Hygiene, 
Textiles,  Recreation, 
Housing 
Glutamate Amino acid 5 
Amino diols, Glutarate, 
Pyrrolidones 
Industrial, Textiles, 
Environment, Safe 
Food Supply, Health 
and Hygiene 
Xylitol Sugar alcohol 5 
Ethylene glycol, 
Propylene glycol, 
Glycerol, Lactate, 
Hydroxyfurans, Sugar 
acids 
Industrial, 
Transportation, Safe 
Food Supply Arabitol Sugar alcohol 5 
2,5-Furandicarboxylate Organic acid 6 
Succinate, 2,5-Furan 
derivatives containing 
hydroxyl or amino 
groups 
Safe Food Supply, 
Industrial, Textiles 
Glucarate Organic acid 6 
Dilactones, 
Monolactones, Other 
products 
Industrial, Environment, 
Health and Hygiene, 
Housing, Recreation 
Sorbitol Sugar alcohol 6 
Ethylene glycol, 
Propylene glycol, 
Glycerol, Lactate, 
Isosorbide 
Transportation, 
Housing, Safe Food 
Supply, 
Communication, 
Recreation, 
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The potential to convert these platform chemicals into industrial applicable chemicals 
is huge. A brief overview over the latter comprises: acrylates, acrylamides, 
1,3-propanediol, 1,4-butanediol, tetrahydrofuran, γ-butyrolactone (GBL) and polymers 
like polyhydroxypolyamides. A demonstrative valuable application is the 
polymerization of acrylate and acrylamides, which can be produced via 
3-hydroxypropionate (Figure 1.1 A). These compounds can be crosslinked to 
copolymers which have a very high water absorbency (Liu and Rempel, 1997). This 
technique is nowadays used in diapers and soft contact lenses. 
Furthermore, succinate, a metabolite of the tricarboxylic acid cycle in all organisms 
(Fernie et al., 2004), can be converted to commodity chemicals like tetrahydrofuran or 
γ-butyrolactone (GBL) (Figure 1.1 B). Notably, the latter has a broad application, in 
industry as plasticizer (McKinlay et al., 2007), as a valuable precursor for 
pharmaceuticals (Choi et al., 2013) or as a commonly known anaesthetic agent (Lenz 
et al., 2008). 
 
Figure 1.1. Overview of industrial important products derived from platform chemicals. The 
carbon-three compound 3-hydroxypropionate is used for the production of e.g. acrylates, which are 
processed to superabsorbent polymers among others (A). The carbon-four diacid succinate is 
processed into solvents, e.g. 1,4-butanediol or tetrahydrofuran (B). 
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1.2 Objectives 
 
The objective of the present work was to broaden the use of B. succiniciproducens and 
derive carbon-three compounds. In particular, the heterologous production of 
L-alanine, β-alanine, and 3-hydroxypropionate from β-alanine, should be evaluated. Up 
to date, little is known about the ability of B. succiniciproducens to express 
heterologous genes, in particular suitable promoters, which can be deployed for 
achieving high expression levels. At first, enhancing the genetic toolbox was targeted. 
Therefore, set-up of a blue-white screening system in a lacZ deficient strain was done. 
Furthermore, suitable promoters for heterologous expression of various genes should 
be identified. The second step aimed at the utilization of appropriate genes and gene 
clusters for heterologous synthesis of the target products. Producing strains should 
then be developed and improved step-wise, using systems metabolic engineering. 
Finally, suitable process conditions for overproduction should be identified and applied. 
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2 THEORETICAL BACKGROUND 
 
2.1 Basfia succiniciproducens – a novel industrial workhorse 
 
The identification of succinate as a top value added chemical by the US DoE, initialized 
a rapid and parallelized run for commercialization of bio-based succinate. This led to 
the discovery of B. succiniciproducens DD1 (Kuhnert et al., 2010; Scholten and 
Dägele, 2008), isolated from the rumen of a Holstein cow (Kuhnert et al., 2010). 
Subsequent investigation generated succinate overproducers during the last decade 
(Becker et al., 2013; Lange et al., 2017; Scholten and Dägele, 2008; Scholten et al., 
2009; Stellmacher et al., 2010). The microbe can utilize a variety of feed stocks 
(Kuhnert et al., 2010), including glycerol (Scholten and Dägele, 2008). Glycerol depicts 
a bulk by-product in biodiesel industry (Yang et al., 2012), make it a cheap and 
common used substrate. 
Alongside, transcriptomics and fluxomics were used to elucidate its unexplored 
metabolism and identify targets for metabolic engineering (Becker et al., 2013; 
Scholten et al., 2009; Stellmacher et al., 2010). In particular, gene knockouts (Becker 
et al., 2013) or homologous gene expression (Lange et al., 2017) were investigated for 
succinate overproduction. Taken together, this provides a solid start point for further 
metabolic engineering of B. succiniciproducens. 
 
2.1.1 The distinct metabolism and physiology of Basfia succiniciproducens 
 
The first isolate of B. succiniciproducens, named DD1, was enriched from the bovine 
rumen of a Holstein cow, while screening for native succinate producers (Scholten and 
Dägele, 2008). Seven strains were isolated (Kuhnert et al., 2010) and taxonomically 
assigned to the family Pasteurellaceae by assessing the 16S rRNA, rpoB, infB and the 
recN gene sequences. Distinct phenotypical aspects of the Pasteurellaceae family 
include a capnophilic, facultative anaerobic, non-spore-forming, and non-motile 
lifestyle. The cells are gram-negative and coccoid to rod-shaped (Kuhnert et al., 2010). 
The Pasteurellaceae family comprises primary or opportunistic pathogens of the 
respiratory and genital tract of vertebrates (Dousse et al., 2008; Guettler et al., 1999). 
However, the isolated strain DD1 is neither toxic nor pathogenic against bovine, human 
or fish cell lines (Kuhnert et al., 2010). This is beneficial for development of industrial 
relevant processes, by reducing costs and handling risks. Additionally, only a few 
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vitamins are essential for the strain (Hong et al., 2004), allowing minimal medium 
cultivation and consequently exact investigations of phenotypic aspects. 
 
The genome sequence of B. succiniciproducens DD1 comprises 2.34 Mbp with 2363 
open reading frames (ORFs) (Kuhnert et al., 2010). It is related (95 % on DNA and 
amino acid sequence level) to Mannheimia succiniciproducens MBEL55E, another 
prominent succinate producer (Lee et al., 2002). Of the 2380 ORFs found in the 
M. succiniciproducens genome, 2006 ORFs are homologous to B. succiniciproducens 
and might be regarded as a core genome (Kuhnert et al., 2010).  
The central carbon metabolism of B. succiniciproducens DD1 (Figure 2.1) is 
composed by the Embden-Meyerhof-Parnas (EMP) pathway, and fueling the pentose 
phosphate (PP) pathway. Furthermore, the gluconeogenesis is found, which uses 
malic enzyme (sfcA), malate dehydrogenase (mdh), phosphoenolpyruvate 
carboxykinase (pckA) and fructose-1,6-bisphosphatase (fbp, glpX) to bypass the 
irreversible reactions of EMP pathway. The Entner-Doudoroff (ED) pathway, 
connected to gluconate metabolism, is found inactive (Becker et al., 2013). Several 
(carbohydrate) transporters, comprising phosphotransferase systems and ABC 
transporters, are annotated, which obviously mediated succinate production from 
different substrates (glycerol, sucrose, glucose, fructose, xylose, arabinose, galactose 
and mannose) (Scholten and Dägele, 2008). Due to its niche lifestyle in the bovine 
rumen, the observed efficient succinate formation from different feedstocks evolved by 
natural selection. The role of B. succiniciproducens in the bovine rumen is specialized 
as a part of the hosts microbial digestion, in a symbiotic manner. Its broad substrate 
spectrum enables conversion of plant carbohydrates from the bovine feed into 
succinate. Succinate is subsequently decarboxylated into propionate by the microbial 
rumen flora. The latter is then utilized by the host, underlining the importance of 
B. succiniciproducens as a member of the rumen flora (Guettler et al., 1999). Due to 
the specialized function of the rumen, the phenotypical succinate production is 
furthermore found in other rumen bacteria, e.g. M. succiniciproducens (Lee et al., 
2002) and Actinobacillus succinogenes (Guettler et al., 1999). Additionally, acetate, 
formate and lactate and ethanol are the major and minor by-products of the 
metabolism, respectively (Becker et al., 2013). 
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Recently, metabolic flux analysis (Becker et al., 2013) allowed first insights into the 
specialized metabolism of B. succiniciproducens. High yield succinate production is 
mainly achieved through the reductive branch of the TCA cycle, whereas the 
contribution of the oxidative branch is negligible (Figure 2.1). The latter is a 
consequence of the beneficial incorporation of CO2, while ATP is formed. This step is 
conducted by the anaplerotic ATP-dependent phosphoenolpyruvate carboxykinase 
(Figure 2.1), fueling the reductive branch of the TCA cycle (Becker et al., 2013). 
The enzyme links CO2 incorporation to energy generation and cell growth. This was 
demonstrated by pckA knockout studies in M. succiniciproducens (Lee et al., 2006). 
As suggested for M. succiniciproducens, it appears likely that fumarate functions as an 
electron acceptor (Hong et al., 2004). 
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Figure 2.1. Central carbon metabolism of B. succiniciproducens DD1. Substrate carbon is taken 
up and channeled through the core metabolism by the EMP (glycolysis) and pentose phosphate (PP) 
pathway. Specific reactions at the pyruvate node and in the TCA cycle act reversible. The genes, 
encoding enzymes which catalyze the interconversions, are given in italics. Reactions corresponding to 
energy conversion are depicted in red, while redox reactions are indicated in orange. Gray arrows 
indicate reactions, which are eliminated in the used strain of the present study: B. succiniciproducens 
∆ldhA ∆pflD (DD3). Question marks (?) denote unidentified genes. Abbreviations are: G6P, glucose 6-
phosphate; 6PG, 6-phosphogluconate; P5P, pentose 5-phosphate; Sh7P, sedoheptulose 7-phosphate; 
E4P, erythrose 4-phosphate; F6P, fructose 6-phosphate; F16BP, fructose 1,6-bisphosphate; DHAP, 
dihydroxyacetone phosphate; GAP, glyceraldehyde 3-phosphate; 3PG, 3-phospho glycerate; PEP, 
phosphoenolpyruvate; PYR, pyruvate; OAA, oxaloacetate; AcCoA, acetyl-CoA; CIT, citrate; 2OG; 2-
oxoglutarate; SUC, succinate; FUM, fumarate; MAL, malate; MQH2, menaquinol; ATP, adenosine 
triphosphate; NADH, nicotineamide adenine dinucleotide, reduced; NADPH, nicotineamide adenine 
dinucleotide phosphate, reduced. 
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2.2 The C4 platform chemical succinate – an industrial production 
accessible using Basfia succiniciproducens 
 
Since biotechnological production of acetate and citrate, back in 1823 (Raspor and 
Goranovič, 2008) and 1913 (Zahorski, 1913), organic acids belong to the veterans of 
bio-based goods (Alonso et al., 2014; Becker et al., 2015). Beyond traditional uses in 
feed and food, particularly the renaissance of bio-plastics has pushed bio-production 
of organic acids as bi-functional monomers. Acids with additional keto- or 
hydroxyl-groups are desirable building blocks for polyesters, and di-carboxylic acids 
are used for the production of polyamides with advanced material properties (Becker 
and Wittmann, 2015). Recently, succinate, an intermediate of the tricarboxylic acid 
(TCA) cycle, evoked a strong research interest for its bio-based production. 
This carbon-four 1,4-diacid provides a basic chemistry, similar to the petrochemically 
derived maleic acid/anhydride, which is beneficial for manufacturing biopolymers or 
solvents like butanediol, maleic anhydride and nylon-type polymers (Beauprez et al., 
2010; Becker et al., 2015; Werpy et al., 2004). 
 
Beside the biotechnology workhorses Escherichia coli and Corynebacterium 
glutamicum, members of the Pasteurellaceae family appeared promising for succinate 
production (Guettler et al., 1999; Lee et al., 2002; Scholten and Dägele, 2008). 
A. succinogenes (Pateraki et al., 2016), M. succiniciproducens (Kim et al., 2017) and 
B. succiniciproducens (Becker et al., 2013; Cimini et al., 2016) revealed their potential 
in bio-based succinate production. These bacteria are to date well-established 
industrial bio-succinate producers with a broader substrate spectrum (Dousse et al., 
2008; Guettler et al., 1999; Kim et al., 2004; Scholten and Dägele, 2008). 
 
The intensive research in this field contributed to our current understanding of microbial 
succinate fermentation and its optimization (Becker et al., 2015). In brief, reviewed 
rational strategies exploited the elimination of by-product formation (Becker et al., 
2013; Cheng et al., 2013; Litsanov et al., 2012) and amplification of the anaplerotic flux 
toward the reductive TCA cycle branch (Cheng et al., 2013; Litsanov et al., 2012). 
Additionally, renewable substrates like lignocellulosic derived xylose (Salvachúa et al., 
2016) and sucrose (Lange et al., 2017) were considered, recently. 
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As example, Lange et al. (2017) demonstrated the powerful use of 13C metabolic flux 
analysis for metabolic engineering of B. succiniciproducens for efficient sucrose 
utilization. The overexpression of a newly discovered fructokinase (rbsK), the deletion 
of the competing fructose PTS and the combination of both strategies led to synergistic 
improvements in succinate production from sucrose. It was demonstrated, that 
B. succiniciproducens DD1 ∆fruA, lacking the fructose PTS, produced 71 g L-1 
succinate at a yield of 2.5 mol mol-1. Apparently, a 12 % improvement of the succinate 
titer was achieved, compared to the parent strain B. succiniciproducens DD1. 
An overview of the most relevant native and recombinant microbial succinate 
production hosts is given in Table 2.1. 
 
Table 2.1. Succinate production performance of native and recombinant microbial production 
hosts. 
Organism Substrate Process operation 
Max. titer 
[g L-1] 
Max. yield 
[g g-1] 
Max. STYa 
[g L-1 h-1] Reference 
Corynebacterium 
glutamicum 
∆ldhA-pCRA717 
Glucose 
Dual phase 
fed-batch 
146.0 0.92 3.17 
(Okino et al., 
2008) 
Corynebacterium 
glutamicum 
BOL-3/pAN6-gap 
Glucose 
and 
formate 
Dual phase 
fed-batch 
134.0 1.09 2.53 
(Litsanov et 
al., 2012) 
Escherichia coli 
NZN111 ∆pflB∆ldhA 
Cassava 
starch 
Dual phase 
fed-batch 
127.0 0.86 3.23 
(Chen et al., 
2014) 
Actinobacillus 
succinogenes 
130ZT 
Glucose Batch 106.0 0.80 1.34 
(Guettler et al., 
1996) 
Escherichia coli 
AFP111-pyc Glucose 
Dual phase 
batch 
99.2 1.10 1.30 
(Vemuri et al., 
2002) 
Basfia 
succiniciproducens 
∆fruA 
Sucrose Fed-batch 71.0 0.84 3.13b 
(Lange et al., 
2017) 
Mannheimia 
succiniciproducens 
∆ldh∆pfl∆pta∆ack 
Glucose Fed-batch 52.4 0.76 1.80 
(Cheng et al., 
2013) 
Basfia 
succiniciproducens 
DD1 ∆ldhA∆pflD 
Glucose Batch 31.7 0.71 1.50 
(Becker et al., 
2013; Scholten 
and Dägele, 
2008; 
Stellmacher et 
al., 2010) 
Basfia 
succiniciproducens 
CCUG 57335 
DDAPHc Batch 30.6 0.69 1.05b 
(Salvachúa et 
al., 2016) 
Basfia 
succiniciproducens 
DD1 
Glycerol Batch 8.4 1.20 0.90 
(Scholten and 
Dägele, 2008) 
a STY = Space Time Yield 
b estimated from reference 
c DDAPH is defined as high xylose-content hydrolysate from corn stover (see reference) 
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More recently, the commercialization of bio-succinate was achieved by four 
companies, namely BioAmber (Canada), Myriant (USA), Succinity (Germany) and 
Reverdia (The Netherlands) (Table 2.2). 
The Succinity process relies on B. succiniciproducens. Up to date, 10,000 tons per 
annum are produced at a production site located in Spain (Becker et al., 2015). 
Myriant uses an engineered E. coli strain. Succinate production by BioAmber and 
Reverdia, a joint venture of DSM and Roquette, is driven in large scale, using 
Candida krusei and Saccharomyces cerevisiae, respectively (Jansen and van Gulik, 
2014). The use of yeasts allows lower pH values, advantageous for economic recovery 
of succinic acid during downstream processing (Yan et al., 2014). In addition, 
evolutionary adaptation was successfully applied to enhance production and tolerance 
(Jiang et al., 2014; Kwon et al., 2011; Li et al., 2013). As example, engineered strains 
of E. coli and C. glutamicum reach high-level production of up to 127 g L-1 and 146 g L-1 
succinate, respectively (Becker and Wittmann, 2015). In addition to anaerobic 
succinate fermentation, aerobic processes are currently evaluated. This was shown by 
a proprietary Royal DSM yeast strain, producing 43 g L-1 succinate with a yield of 
0.45 g g-1 on glucose (Cheng et al., 2013). 
 
 
Table 2.2. Industrial succinate production of organic acid from biomass feedstocks. The data is 
derived from (Becker et al., 2015). 
Company 
Annual production 
capacity (plant site) 
[t a-1] 
Organism Feedstock 
Succinitya 10,000 (Spain) 
Basfia 
succiniciproducens Glycerol, sugars 
Myriantb 13,600 (USA) Escherichia coli Sorghum 
BioAmberc 
3000 (France, 
demonstration plant) 
Escherichia coli, yeast 
(possibly Candida 
krusei) 
Corn 
Reverdiad 10,000 (Italy) 
Low pH yeast 
(Saccharomyces 
cerevisiae) 
Starch 
a Joint venture between BASF SE and Corbion Purac. 
b Cooperation with ThyssenKrupp Uhde. 
c Joint venture between DNP Green Technology, ARD, and Mitsui & Co. 
d Joint venture between Royal DSM N.V. and Roquette Frères. 
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2.3 C3 chemicals – industrial chemicals of interest to be derived by Basfia 
succiniciproducens 
 
2.3.1 Pyruvate 
 
When organic carbon-three acids are mentioned, pyruvate is one of the commonly 
known products. Especially, pyruvate is not only a central key intermediate of microbial, 
plant, animal and human metabolism, but also a chemical precursor for various 
derivatives and polymers, and an ingredient of diverse commodity products 
(Wieschalka et al., 2013). As chemical production is not very cost efficient, bio-based 
production through fermentation got in focus. 
In order to achieve pyruvate production, the diverse catabolic and anabolic pathways 
as well as fermentation routes, competing with pyruvate formation, have to be 
considered. The elimination of such reactions, for example lactate dehydrogenase, 
pyruvate dehydrogenase, pyruvate-formate lyase, pyruvate oxidase and pyruvate 
decarboxylase is thus of major interest (Li et al., 2001). Since pyruvate is generated in 
the EMP pathway (or the ED pathway), the increased supply of the needed co-factors,  
such as NAD+ and ADP, is desired (Maleki and Eiteman, 2017). Bio-based production 
has been established using multi-auxotrophic yeast and E. coli (Becker et al., 2015; 
Maleki and Eiteman, 2017). By now, the highest titers have been obtained for E. coli 
(90 g L-1) (Zhu et al., 2008) and S. cerevisiae (135 g L-1) (van Maris et al., 2004), though 
other producers are being developed (Table 2.3). 
 
2.3.2 Lactate 
 
In contrast, production of lactate, a derivative of pyruvate, is an established business 
in biotechnology with NatureWorks (USA), Purac (The Netherlands), 
Galactic (Belgium) and several Chinese companies as major suppliers of around 
400,000 tons lactate annually (Choi et al., 2015). 
Metabolically, lactate is a direct product of D/L-lactate dehydrogenase, which reduces 
pyruvate to the corresponding enantiomer of lactate. Current processes are operated 
with classically optimized Lactobacilli (Becker and Wittmann, 2015) and engineered 
yeast (Table 2.3), whereby also other producers exhibit excellent performance (Xu and 
Xu, 2014; Yamane and Tanaka, 2013). As example, immobilized mycelia of 
Rhizopus oryzae even surpass 230 g L-1 lactate, the highest titer reported so far 
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(Yamane and Tanaka, 2013). In addition, metabolic engineering has generated other 
potent production strains, which are particularly useful to obtain the optically pure 
product. Highly pure L-lactate production could be realized using E. coli (138 g L-1) and 
S. cerevisiae (122 g L-1), while C. glutamicum was successfully trained for D-lactate 
production (Table 2.3). A remarkable high titer of 195 g L-1 D-lactate was achieved by 
a synergistic amplified expression of five glycolytic genes, namely glucokinase (GLK), 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), phosphofructokinase (PFK), 
triosephosphate isomerase (TPI) and bisphosphate aldolase (FBA) with PFK as one 
of the key reactions (Tsuge et al., 2015). Future improvements can be expected from 
recent research on cellular energetics, alternative substrates (Buschke et al., 2013) 
and photoautotrophic production from CO2 using cyanobacteria (Li et al., 2015). 
 
2.3.3 L-Alanine 
 
With a world market of more than four million tons per year, amino acids are among 
the most important products in industrial biotechnology (Becker and Wittmann, 2012b). 
Almost all amino acids are exclusively derived by microbial fermentation, because this 
provides the biologically active L-enantiomer. The biosynthesis of amino acids is 
hereby closely linked to central metabolism via the supply of carbon building blocks, 
nitrogen, reducing power and energy. This poses complex demands on the producing 
cell. The L-alanine depicts one of the smallest chiral compounds (Zhou et al., 2015) 
used in food and pharmaceutical applications. Compared to the market size of lysine 
(1.5 mio t a-1) (Becker and Wittmann, 2015), L-alanine production is rather small, 
estimated to be about 500 t a-1, limited by its high production costs (Zhang et al., 2007). 
This can be overcome by recently established basic producers (Becker and Wittmann, 
2015). 
As lactate, alanine can be derived from pyruvate by use of an alanine dehydrogenase 
(Zhang et al., 2007). Additionally, aspartate decarboxylases exist, producing L-alanine 
by decarboxylation of L-aspartate. Surplus, L-alanine is produced in many 
transamination reactions (Oikawa, 2007). Current processes rely on expression of 
alanine dehydrogenases from Geobacillus stearothermophilus in E. coli (Zhang et al., 
2007; Zhou et al., 2015) or Lysinibacillus sphaericus in C. glutamicum (Jojima et al., 
2010; Yamamoto et al., 2012) (Table 2.3). The highest titer reported so far, was 
reached by C. glutamicum (216 g L-1) (Yamamoto et al., 2012). Using E. coli, 121 g L-1 
with outstanding volumetric productivities (4.18 g L-1 h-1) in an oxygen-limited process 
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were obtained (Zhou et al., 2015). A new player in the field is the recently evoked 
marine organism Vibrio natriegens (Lee et al., 2016; Weinstock et al., 2016), which 
was lately engineered for alanine production. This fast-growing organism 
demonstrated a highly outstanding volumetric productivity of 0.56 g alanine L-1 min-1 
(34 g L-1 h-1) under anaerobic conditions due to its high specific glucose uptake rates 
(7.8 g g-1 h-1) (Hoffart et al., 2017).  
 
2.3.4 β-Alanine 
 
An achiral isomer of alanine, containing the amino group in β-position, is commonly 
known as β-alanine or 3-aminopropionate (Liang et al., 2008). This special amino acid 
is used for an increasing number of applications, concerning production of important 
nitrogen-containing chemicals (Song et al., 2015) and athlete nutrition (Nassis et al., 
2017). Moreover, this compound plays a somewhat essential role in synthesis of the 
vitamin pantothenate. Here, two metabolic pathways are connected by the 
pantothenate synthase which condenses pantoate with β-alanine to form pantothenate 
(Dusch et al., 1999). Commonly, β-alanine is synthesized by a pyruvoyl-dependent 
protein, panD, which is found in many organisms, e.g. E. coli and C. glutamicum 
(Dusch et al., 1999; Stuecker et al., 2012). This aspartate 1-decarboxylase is 
expressed as a pre-protein and then cleaved to yield the active pro-protein form.  
A lately published study brought evidence, that a protein family, named panP, provides 
also aspartate 1-decarboxylase activity, but is suggested to be pyridoxal-dependent 
(Pan et al., 2017). 
Commonly, biological production of β-alanine was performed using 
β-aminopropionitrile as substrate in whole-cell bioconversions of Alcaligenes sp. 
OMT-MY14, Aminobacter aminobrance ATCC 23314 (Song et al., 2015) and 
Rhodococcus sp. G20 (Liang et al., 2008). Also, panD based whole-cell or enzymatic 
L-aspartate conversion is described in literature (Konst et al., 2009; Shen et al., 2014). 
Recently, an aerobic fermentation process was presented, allowing the production of 
32 g L-1 β-alanine from glucose, using an engineered E. coli strain expressing the panD 
gene from C. glutamicum (Song et al., 2015). This depicts a valuable study of 
bio-based recombinant β-alanine synthesis from sugars (Table 2.3). 
 
 
  THEORETICAL BACKGROUND 
  15 
2.3.5 3-Hydroxypropionate (3-HP) 
 
Since biotechnological production of lactate is commonly established, bio-based 
production of its isomer 3-hydroxypropionate was focused in the last years. As one of 
the top-value chemicals from biomass, 3-HP was identified due to its huge market 
potential as chemical precursor for acrylic acid (Werpy et al., 2004). 
In brief, commercial interesting commodity and specialty chemicals like 
1,3-propanediol, acrylate, methyl acrylate and acrylamide, with significant market 
opportunities, can be derived from 3-HP (Werpy et al., 2004). 
Since then, chemical companies involving BASF (Germany), Cargill (USA), 
Dow Chemical (USA) and Novozymes (Denmark) are chasing for commercialization of 
a bio-based production process (Choi et al., 2015). Indeed, the portfolio of potential 
pathways for fermentative 3-HP production is rather broad (Valdehuesa et al., 2013), 
being chance and challenge at the same time. The most straightforward bio-based 
route relies on glycerol utilization only requiring two enzymes, namely glycerol 
dehydratase and aldehyde dehydrogenase. Consequently, this approach yielded the 
best processes so far, using E. coli and Klebsiella pneumoniae as production hosts 
(Table 2.3) with high conversion yields of up to 0.88 g g-1 for E. coli (Kim et al., 2014). 
Discrete substrate feeding of glucose and glycerol for growth and production, 
respectively, boosted product titer to 72 g L-1 (Chu et al., 2015). Glucose-based 
production has been developed through implementation of the malonyl-CoA and the 
β-alanine route toward 3-HP in E. coli (Rathnasingh et al., 2009; Song et al., 2016) 
reaching 38.7 g L-1 and 31 g L-1 3-HP, respectively. The β-alanine route was also 
implemented in S. cerevisiae, demonstrating the production of 13.7 g L-1 3-HP 
(Borodina et al., 2015). These studies relied on a discrete set of enzymatic reactions 
using acetyl-CoA (malonyl-CoA route) and oxaloacetate (β-alanine route) as 
precursors. 
Only recently, Cargill has acquired a proprietary glucose-based fermentation process 
with recombinant E. coli, capable of producing approximately 50 g L-1 3-HP with a yield 
of 0.53 g g-1, which was initially patented by the US company OPXbio (Lynch et al., 
2015). 
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Table 2.3. Production performance of recombinant microbial production hosts of organic acids. 
Product Organism Substrate Process operation 
Max. 
titer 
[g L-1] 
Max. yield 
[g g-1] 
Max. STYa 
[g L-1 h-1] Ref. 
Pyruvate 
S. cerevisiae Glucose Fed-batch 135 0.54 1.35b (van Maris et 
al., 2004) 
E. coli Glucose Fed-batch 90 0.68 2.10 
(Zhu et al., 
2008) 
C. glutamicum Glucose Fed-batch 44 0.47 0.44b (Wieschalka et 
al., 2013) 
D-/L-
Lactate 
R. oryzae Glucose 
Fed-batch, 
immobilized 
mycelia 
231 0.93b 1.83 
(Yamane and 
Tanaka, 2013) 
C. glutamicum Glucose Fed-batch 195 0.90 6.10b (Tsuge et al., 
2015) 
B. coagulans Cane 
molasses 
Fed-batch 168 0.88 2.10 
(Xu and Xu, 
2014) 
E. coli Glucose Fed-batch 138 0.99 6.30 
(Becker and 
Wittmann, 
2015) 
S. cerevisiae Glucose Batch 122 - 2.50b 
(Becker and 
Wittmann, 
2015) 
C. glutamicum Glucose Fed-batch 120 - 4.00b 
(Becker and 
Wittmann, 
2012a) 
L-Alanine 
C. glutamicum Glucose Batch 216 0.92 4.50b 
(Yamamoto et 
al., 2012) 
E. coli Glucose Fed-batch 121 0.96 4.18 
(Zhou et al., 
2015) 
E. coli Glucose Batch 114 0.95 4.04 (Zhang et al., 
2007) 
C. glutamicum Glucose Fed-batch 98 0.83 3.10 
(Jojima et al., 
2010) 
V. natriegens Glucose Batch 34b 0.81 34.00 (Hoffart et al., 
2017) 
β-Alanine 
E. coli Glucose Fed-batch 32 0.14 0.83 
(Song et al., 
2015) 
PanDcgl 
enzyme 
Aspartate 
pH-stat, 
fed-batch 
12.9 0.97 0.36b 
(Shen et al., 
2014) 
R. sp. G20 β-amino-
propionitrile 
Batch 8.9b 0.99b 6.7b 
(Liang et al., 
2008) 
3-HP 
E. coli Glucose 
Glycerol 
Fed-batch 72 - 1.80 
(Chu et al., 
2015) 
E. coli Glycerol Fed-batch 57 0.88 1.59 (Kim et al., 
2014) 
K. 
pneumoniae Glycerol Fed-batch 49 0.40
b 1.75b 
(Huang et al., 
2013) 
E. coli Glucose Fed-batch 48 0.53 - 
(Lynch et al., 
2015) 
S. cerevisiae Glucose Fed-batch 14 0.07b 0.17b (Borodina et 
al., 2015) 
a STY = Space Time Yield 
b Estimated from reference 
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3 MATERIAL AND METHODS 
 
3.1 Bacterial strains and plasmids 
 
For cloning purposes, E. coli TOP10 (Invitrogen, Darmstadt, Germany) was used. 
B. succiniciproducens ∆ldhA ∆pflD (DD3) and B. succiniciproducens ALA-1 was 
obtained from previous work (Becker et al., 2013; Fabarius, 2013). Transformation of 
B. succiniciproducens was performed, using the episomal Pasteurellaceae vector 
pJFF224-XN (Frey, 1992) and the integrative vector pClikCM, respectively (Becker et 
al., 2013). B. succiniciproducens DD3∆DD0759∆DD0810, lacking the native lacZ 
genes DD0810 and DD0759, was constructed by Nadja Barton (Institute of Systems 
Biotechnology, Saarland University) during her master thesis (Barton, 2015). 
All strains and plasmids used in this work are listed in Table 3.1. 
 
3.2 Genes used for metabolic engineering 
 
The native aspartate 1-decarboxylase from E. coli K12 MG1655 (panDeco, KEGG entry: 
b0131), C. glutamicum ATCC13032 (panDcgl, KEGG entry: Cgl0135) and Vibrio 
natriegens DSM759 (panPvna, KEGG entry: PN96_07390) were used. Furthermore, 
the β-alanine-pyruvate transaminase from P. putida KT2440 (baptappu, KEGG entry: 
PP_0596) and the malonic semialdehyde reductase from E. coli K12 MG1655 (ydfGeco, 
KEGG entry: ydfG) were codon-optimized (Table 6.2) on DNA level for stable 
expression in B. succiniciproducens (Thermo Fisher Scientific, Regensburg, 
Germany). All used genes and their specific functions are summarized in Table 3.2. 
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Table 3.1. Bacterial strains and plasmids. 
Strain Description Source and reference 
E. coli TOP10 / DH10B Cloning host 
Invitrogen, Darmstadt, 
Germany 
B. succiniciproducens DD3 ∆ldhA ∆pflD (Becker et al., 2013) 
DD3∆∆lacZ ∆lacZ-DD0759 ∆lacZ-DD0810 This study 
DD3∆∆lacZ∆DD0789-neo ∆lacZ-DD0759 ∆lacZ-DD0810 ∆DD0789::Pneoneo This study 
DD3 ALA-1 alaD_gstear::pflD (Fabarius, 2013) 
DD3 + pJFF224 pJFF224-XN This study 
DD3 + Bsuc_PL8 PpflDGFP This study 
DD3 + Bsuc_PL9 PpflAGFP This study 
DD3 + Bsuc_PL10 PldhAGFP This study 
DD3 + Bsuc_PL11 PsodCGFP This study 
DD3 + Bsuc_PL25 PpflDpanDeco This study 
DD3 + Bsuc_PL26 PpflDpanDcgl This study 
DD3 + Bsuc_PL47 PEM7*panDcgl This study 
DD3 + Bsuc_PL80 PEM7*panD+cgl This study 
DD3 + Bsuc_PL86 PpflDpanD+cgl This study 
DD3 + Bsuc_PL105 PEM7*PN96_07390vna (panPvna) This study 
DD3 + Bsuc_PL27 PpflDbaptappu+-PpflDydfGeco+ This study 
DD3 + Bsuc_PL52 PEM7*panDcgl-RBSEM7*-baptappu+-RBSEM7*-ydfGeco This study 
DD3 + Bsuc_PL98 PEM7*panDcgl+-RBSEM7*-baptappu+-RBSEM7*-ydfGeco+ This study 
DD3∆∆lacZ + Bsuc_PL18 Complementation of lacZ-DD0810 by Bsuc_PL18 This study 
DD3∆∆lacZ + Bsuc_PL19 Complementation of lacZ-DD0759 by Bsuc_PL19 This study 
Plasmids   
pJFF224-XN XN cloning site, CMR, mob oriV, RSF1010 replicon (Frey, 1992) 
pClikCM CMR, PsacB-sacB, ori-EC(pMB) (Becker et al., 2013) 
Bsuc_PL8 pJFF224 derivative, PpflDGFP This study 
Bsuc_PL9 pJFF224 derivative, PpflAGFP This study 
Bsuc_PL10 pJFF224 derivative, PldhAGFP This study 
Bsuc_PL11 pJFF224 derivative, PsodCGFP This study 
Bsuc_PL104 pJFF224 derivative, PEM7*GFP This study 
Bsuc_PL25 pJFF224 derivative, (PpflDpanDeco) This study 
Bsuc_PL26 pJFF224 derivative, (PpflDpanDcgl) This study 
Bsuc_PL47 pJFF224 derivative, (PEM7*panDcgl) This study 
Bsuc_PL80 pJFF224 derivative, (PEM7*panDcgl+) This study 
Bsuc_PL86 pJFF224 derivative, (PpflDpanDcgl+) This study 
Bsuc_PL105 pJFF224 derivative, (PEM7*PN96_07390vna) This study 
Bsuc_PL27 pJFF224 derivative, (PpflDbaptappu+-PpflDydfGeco+) This study 
Bsuc_PL52 
pJFF224 derivative, (PEM7*panDcgl-RBSEM7*- 
baptappu+-RBSEM7*-ydfGeco+ 
This study 
Bsuc_PL98 
pJFF224 derivative, (PEM7*panDcgl+-RBS EM7*-
baptappu+-RBSEM7*-ydfGeco+) 
This study 
Bsuc_PL16 
pClikCM derivative,  
∆lacZ-DD0810 This study 
Bsuc_PL17 
pClikCM derivative, 
∆lacZ-DD0759 This study 
Bsuc_PL87 
pClikCM derivative, 200 bp US-lacZ-DD0759-lacZ-
DD0759 
This study 
Bsuc_PL88 
pClikCM derivative, 200 bp US-lacY-DD0811-
RBSDD0810-lacZ-DD0810 
This study 
Bsuc_PL18 
pJFF224 derivative, 200 bp US-lacY-DD0811-
RBSDD0810-lacZ-DD0810 
This study 
Bsuc_PL19 
pJFF224 derivative, 200 bp US-lacZ-DD0759-lacZ-
DD0759 
This study 
Bsuc_PL94 Bsuc_PL87 de., ∆DD0789-sucrose PTS::Pneoneo This study 
Bsuc_PL95 Bsuc_PL88 de., ∆DD0789-sucrose PTS::Pneoneo This study 
+ Genes are codon-optimized for B. succiniciproducens 
* PEM7* mutated version of PEM7 and its ribosomal binding site (RBS) from a P. putida specific project (Rogsch, 2015) 
de. = derivative 
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Table 3.2. Genes used for metabolic engineering. 
Gene KEGG entry Enzyme Function Codon optimization 
panDeco (E. coli) b0131 Aspartate 1-decarboxylase 
β-Alanine 
synthesis 
- 
panDcgl (C. glutamicum) Cgl0135 Aspartate 1-decarboxylase - 
panDeco+ (E. coli) b0131 Aspartate 1-decarboxylase + 
panDcgl+ (C. glutamicum) Cgl0135 Aspartate 1-decarboxylase + 
panPvna (V. natriegens) PN96_07390 Aspartate 1-decarboxylase - 
baptappu+ (P. putida) PP_0596 
β-Alanine-pyruvate 
transaminase 
Malonate 
semialdehyde 
synthesis 
+ 
ydfGeco+ (E. coli) ydfG 
Malonic semialdehyde 
reductase 
3-HP 
synthesis 
+ 
 
 
3.3 Chemicals and media 
 
3.3.1 Chemicals 
 
Chemicals were of analytical grade and were derived from Sigma Aldrich (Taufkirchen, 
Germany), Roth (Karlsruhe, Germany), Merck (Darmstadt, Germany), and Becton 
Dickinson (Franklin Lakes, NJ, US), respectively, if not stated otherwise. Silylation 
reagents for gas chromatography were obtained from Macherey-Nagel (Düren, 
Germany). For qualitative labeling experiments, [13C6] glucose (99 % purity) and 
[13C315N] β-alanine (99 % purity), was obtained from Euriso-top (Saarbrücken, 
Germany) and Sigma Aldrich (Taufkirchen, Germany), respectively. 
 
3.3.2 Media for genetic engineering 
 
Strains of E. coli were maintained, using Luria Bertani broth (Becton Dickinson, 
Franklin Lakes, NJ, US) in liquid (LB Lennox) or in solid form (35 g L-1, LB Lennox 
agar). For standard strain maintenance, genetic engineering and promoter screening 
of B. succiniciproducens, brain heart infusion (BHI) medium (Becton Dickinson, 
Franklin Lakes, NJ, US) was used (37 g L-1). BHI solid medium was prepared, adding 
18 g L-1 agar (Difco, Becton Dickinson, Franklin Lakes, NJ, US) and a combination of 
9.38 g L-1 (N-morpholino)propanesulfonic acid (MOPS), 1.25 g L-1 Mg(OH)2, 5.8 g L-1 
2,2-Bis(hydroxymethyl)-2,2’,2’’nitrilotriethanol (Bis-Tris), and 1.8 g L-1 NaHCO3 as a 
buffer system. For selection of mutant strains with chloramphenicol resistance, 
10 μg mL-1 (E. coli) or 5 μg mL-1 (B. succiniciproducens) of a chloramphenicol stock 
solution (50 mg mL-1 in ethanol) was added, respectively (Table 6.1). 
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3.3.3 Cultivation media 
 
Media for aerobic or anaerobic cultivation of B. succiniciproducens were freshly 
prepared from sterile stock solutions and sterile demineralized water. An overview of 
the stock solutions is given in Table 6.1. Stock solutions containing glycine-betaine, 
trace elements (Young Lee, 1996), and vitamins (Becker et al., 2013) were stored at 
4 °C prior to use for up to two weeks. 
 
For aerobic cultivation, the first pre-culture was grown in BHI medium. The second 
pre-culture and the main-culture were carried out in triplicates in a complex medium 
described in Table 3.3. For each experiment, the medium was freshly prepared from 
the sterilized stock solutions (See appendix). 
Minimal medium (Table 3.4) pre-cultures in 10 mL scale for anaerobic cultivation were 
inoculated directly with living cells from agar plates. All main-cultures were carried out 
as well in minimal medium in triplicates. The medium was freshly prepared from the 
sterilized stock solutions for each experiment (see appendix Table 6.1). 
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Table 3.3. Composition of complex medium for aerobic cultivation. The medium was freshly 
prepared from the sterile stock solutions. For certain experiments the specified carbon source stock 
solution was added to the medium. 
 
Stock solution Volume [mL] 
Media concentration 
[g L-1] 
Glucose, 50 % 3.0 15 
or Xylose, 50 % 3.0 15 
or Sucrose, 50 % 3.0 15 
or Fructose, 50 % 3.0 15 
or Glycerol, 50 % 3.0 15 
Yeast extracta, 10 % 5.0 5 
BHIa, 10 % 5.0 5 
Ammonium sulphate, 50%, pH 7.2 2.0 10 
ACES, 500 mM, pH 7.2 40.0 200 mM 
Sodium carbonate, 25 % 0.4 1 
Phosphate, 50 % 0.6 3 
Glycine-betaine, 500 mM 0.5 0.29 
Salt solution, 14 % 1.0 1.4 % 
Vitamin stock 1, 100x, pH 7.5 1.0 1x 
Trace elements, 200x 0.5 1x 
H2O, demineralized ad 100 mL  
a Becton and Dickinson 
 
Table 3.4. Composition of minimal medium for anaerobic cultivation. The medium was freshly 
prepared from the sterile stock solutions. In the experiments, different carbon sources or 
L-aspartate/β-alanine were added to the medium as described below in detail. Chloramphenicol was 
added to maintain the episomal plasmid of B. succiniciproducens mutant strains. As an insoluble buffer 
system, MgCO3 (30 g L-1) was used, which was added right before autoclaving. 
 
Stock solution Volume [mL] 
Media concentration 
[g L-1] 
Glucose, 50 % 6.0 30.0 
or Xylose, 50 % 6.0 30.0 
or Sucrose, 50 % 6.0 30.0 
or Fructose, 50 % 6.0 30.0 
or Glycerol, 50 % 6.0 30.0 
L-Aspartate, 25 %a 2.0 5 
β-Alanine, 25 %a 2.0 5 
3-HP, 25 %a 2.0 5 
Yeast extractb,c, 10 % 0.1 0.1 
Ammonium sulphated, 50 % 0.8 / 0.4 4.0 / 2.0 
Phosphate, 50 % 0.6 3.0 
Salt solution, 14 % 1.0 1.4 
Vitamin stock 1, 100x, pH 7.5 1.0  
Chloramphenicol, 5 % 0.1 5 μg mL-1 
H2O, demineralized ad 100 mL  
a L-aspartate, β-alanine and 3-hydroxypropionate were supplied in certain experiments to support 
production of β-alanine or 3-hydroxypropionate or examine the metabolism, respectively 
b Becton and Dickinson 
c Yeast extract was added to minimal medium to support growth of B. succiniciproducens mutant strains 
d β-alanine / 3-hydroxypropionate production was realized using 4 g L-1 / 2 g L-1 of Ammonium sulphate 
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3.4 Genetic engineering 
 
Molecular methods and genetic engineering of B. succiniciproducens were based on 
standard protocols (Becker et al., 2013; Gibson et al., 2009; Mullis et al., 1986; 
Sambrook, 2001). The oligonucleotides used for plasmid construction and screening 
are listed in Table 3.5. 
 
3.4.1 Isolation of nucleic acids 
 
The isolation of purified genomic DNA was performed with the GeneEluteTM Kit (Sigma 
Aldrich, Taufkirchen, Germany) as given by the manufacturer. Elution of purified DNA 
from preparation columns was performed with sterile demineralized water. 
Subsequently, the DNA concentration was measured, using the NanoDrop® 
Spectrophotometer ND-1000 (Thermo Fisher Scientific, Waltham, MA, USA). 
Plasmid isolation from the cloning host E. coli TOP10 was conducted using the 
QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany). Plasmid DNA elution from 
columns was conducted using sterile demineralized water, pre-warmed at 65 °C. 
Purification of amplified DNA from PCR mixtures or agarose gel suspensions was 
performed using the Wizard® SV Gel and PCR Clean-Up System (Promega, Fitchburg, 
WI, USA). Again, sterile demineralized water, pre-warmed at 65 °C, was used for 
elution.  
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Table 3.5. Oligonucleotides used as primers for genetic engineering of B. succiniciproducens 
and plasmid or strain validation. Gibson’s Assembly primer overhangs are underlined. Restriction 
sites used for restriction-digestion based cloning are given bold in the sequence and defined in the table. 
Ribosome binding sites are underlined in bold and defined in the table. The specific target plasmid and 
the resulting amplicon is also given in the table. 
# 5’-Sequence-3’ Site Plasmid and amplicon 
1 GCGGTGGCGGCCGCTCTAGAAATTTAGATATGTACCATTTAGTAATTA  - Bsuc_PL8 
PpflD 2 TTCGAACTAGTTTGGACCATTTTTAATACTTCCTTCTTTTCTAGT  - 
3 GAAAAGAAGGAAGTATTAAAAATGGTCCAAACTAGTTCGAA  - Bsuc_PL8 
GFP 4 TCTACTGGGGATCCGGGCCCTTATTTGTAGAGCTCATCCAT  - 
5 GCGGTGGCGGCCGCTCTAGAACAATCAATGTAATTGAGAGTTTG  - Bsuc_PL9 
PpflA 6 TTCGAACTAGTTTGGACCATAATATGCCCTTAAATAATCAACAAA  - 
7 TGATTATTTAAGGGCATATTATGGTCCAAACTAGTTCGAA + 4 - 
Bsuc_PL9 
GFP 
8 GCGGTGGCGGCCGCTCTAGACCGAACTTGCCCGTGC  - Bsuc_PL10 
PldhA 9 TTCGAACTAGTTTGGACCATTCAACGAAATTATTTCGAGGTATCT  - 
10 CCTCGAAATAATTTCGTTGAATGGTCCAAACTAGTTCGAA + 4 - 
Bsuc_PL10 
GFP 
11 GCGGTGGCGGCCGCTCTAGACACCGAGTTCGAGGGC - Bsuc_PL11 
PsodC 12 TTCGAACTAGTTTGGACCATGCCAATTGTTGCATTTTTGTTACATA  - 
13 ACAAAAATGCAACAATTGGCATGGTCCAAACTAGTTCGAA + 4 - 
Bsuc_PL11 
GFP 
14 TTAAAGAGGAGAAATTAAGCATGGTCCAAACTAGTTCGAA - Bsuc_PL104 
PEM7* 15 TCTACTGGGGATCCGGGCCCTTATTTGTAGAGCTCATCCAT  
16 45 + TCGAACTAGTTTGGACCATGCTTAATTTCTCCTCTTTAACC - 
Bsuc_PL104 
GFP 
17 TGACGTCGGGCCCGGTACCACGCGTTATAAGCCTTTTAATCTACGCACCTTTTTT - Bsuc_PL16 
US_lacZ-
DD0810 18 AAAGAATTATTTTGTTTTTTGCGTGAATTCCTCCTGATTATGATTGAGACGATAA  - 
19 GTCTCAATCATAATCAGGAGGAATTCACGCAAAAAACAAAATAATTCTTTACTTA  - Bsuc_PL16 
DS_lacZ-
DD0810 20 AGGAAAGCGGCCTATGGAGTCTAGATGTTAAATGCCAAATACCTTCATCATTTGC  - 
21 TGACGTCGGGCCCGGTACCACGCGTTAATGTTACGGCACCTACTTATACGGTA  - Bsuc_PL17 
US_lacZ-
DD0759 22 CGCACTTTGAGTGCGATTACAATTTGAGTGTAACTCCTACAACTTAAAATATCTC  - 
23 ATTTTAAGTTGTAGGAGTTACACTCAAATTGTAATCGCACTCAAAGTGCGGTA  - Bsuc_PL17 
DS_lacZ-
DD0759 24 AGGAAAGCGGCCTATGGAGTCTAGATGGGTTTCAATTTTGCCAACTCCCAC  - 
25 CCACCGCGGTGGCGGCCGCTCTAGATTAATTTGTTAACCTTAACACTATTTTTTG - Bsuc_PL18 
PlacY 26 CTTCAAAATAACGATGGATAAACATAATTCCTCCTGATCCTTATCAAGGATTTTAATG
TGGAA 
810* 
27 CACATTAAAATCCTTGATAAGGATCAGGAGGAATTATGTTTATCCATCGTTATTTTGA
AGACCCT 
810* Bsuc_PL18 
DD0810 
28 GTAAATCTACTGGGGATCCGGGCCCCTAACGAGCCGGGTTGCTCC - 
29 CGGTGGCGGCCGCTCTAGAACTAGTTGCGGTCGGTTTTTGCCGAATTTTATAAAT - Bsuc_PL18 
PDD0759-
DD0759 30 GTAAATCTACTGGGGATCCGGGCCCTTATAAAATCTGCAATCTGAAGTCGCAATG - 
31 CGGTGGCGGCCGCTCTAGAACTAGTAATTTAGATATGTACCATTTAGTAATTAAA - Bsuc_PL25 
PpflDpanDeco 32 GTAAATCTACTGGGGATCCGGGCCCTCAAGCAACCTGTACCGG - 
33 22 + GTAAATCTACTGGGGATCCGGGCCCCTAAATGCTTCTCGACGTCA - 
Bsuc_PL26 
PpflDpanDcgl 
34 ACGGTTCATATAATTAGCCAATCTCATATGTTGTTGACAATTAATCATCGGCATA - Bsuc_PL47 
PEM7* 35 AATCTTACTTCCGAGGATGGTGCGCAGCATGCTTAATTTCTCCTCTTTAACC - 
36 AACCCCTAGGTTAAAGAGGAGAAATTAAGCATGCTGCGCACCATCCT - Bsuc_PL47 
panDcgl 37 ATCATCGGAAGTTAGAGAGCATATGCTAAATGCTTCTCGACGTCA - 
38 ACGGTTCATATAATTAGCCAATCTCATATGTTGTTGACAATTAATCATCGGCACA - Bsuc_PL80 
PEM7* 39 ATTTTGCTGCCCAAAATGGTGCGTAACATGCTTAATTTCTCCTCTTTAACC - 
* 810 = RBS810, originates directly upstream of the DD0810 gene 
MATERIAL AND METHODS 
24 
Table 3.5. Oligonucleotides used as primers for genetic engineering of B. succiniciproducens 
and plasmid or strain validation (continued). 
# 5’-Sequence-3’ Site Plasmid and amplicon 
40 ACCCCTAGGTTAAAGAGGAGAAATTAAGCATGTTACGCACCATTTTGGG - Bsuc_PL80 
panDcgl+ 41 ATCATCGGAAGTTAGAGAGCATATGTTAAATGCTACGGCTGGTTA - 
42 TCATATAATTAGCCAATCTCATATGAATTTAGATATGTACCATTTAGTAATTAAA - Bsuc_PL86 
PpflD 43 CCCAAAATGGTGCGTAACATTTTTAATACTTCCTTCTTTTCTAG - 
44 AAAAGAAGGAAGTATTAAAAATGTTACGCACCATTTTGGG + 32 - 
Bsuc_PL86 
panDcgl+ 
45 GCGGTGGCGGCCGCTCTAGATTGTTGACAATTAATCATCGGC - Bsuc_PL105 
PEM7* 46 GTTTTTTGTTCCTTAACCATGCTTAATTTCTCCTCTTTAACC - 
47 TTAAAGAGGAGAAATTAAGCATGGTTAAGGAACAAAAAACCG - Bsuc_PL105 
panPvna 48 TCTACTGGGGATCCGGGCCCTCAAGATGCCAAAATCTTAGAA - 
49 
CGGTGGCGGCCGCTCTAGAACTAGTAATTTAGATATGTACCATTTAGTAATT
AAA 
SpeI 
 
ApaI 
Bsuc_PL27 
PpflDbapta+ppu-
PpflDydfG+eco 50 GTAAATCTACTGGGGATCCGGGCCCTCATCACTACTATTATTATTATTGAC 
51 CATATGCTCTCTAACTTCCG 
- 
Bsuc_PL98 
Bsuc_PL80 52 TTAAATGCTACGGCTGGTTA 
53 
25 + 
CCGGTTTCCGGCATATTCATGCTTAATTTCTCCTCTTTCTAAATGCTTCTCGAC
GTCA 
RBSEM7* 
Bsuc_PL52 
PEM7*panDcgl 
54 TGACGTCGAGAAGCATTTAGAAAGAGGAGAAATTAAGCATGAATATGCCGGA
AACCGG 
RBSEM7* Bsuc_PL52 
RBSEM7*-
baptappu+ 55 
CCGGTCACCAACACAATCATGCTTAATTTCTCCTCTTTTTAATCAATCAAGTTT
AAGGTTTCAC 
RBSEM7* 
56 GTGAAACCTTAAACTTGATTGATTAAAAAGAGGAGAAATTAAGCATGATTGTGT
TGGTGACCGG + 41 RBSEM7* 
Bsuc_PL52 
RBSEM7*-
ydfGcgl+ 
57 TAACCAGCCGTAGCATTTAAAAAGAGGAGAAATTAAGCATGAATATG - Bsuc_PL98 
RBSEM7*-
baptappu+-
RBSEM7*-
ydfGeco+ 
58 CGGAAGTTAGAGAGCATATGTTATTGACGATGCACATTTAAAC - 
59 TTTCAGACTGGTTCAGGATGAGCTCTGCGGTCGGTTTTTGCCGAA - Bsuc_PL87 
200 bp US-
lacZ-DD0759-
lacZ-DD0759 
60 TATCAACAGGAGTCCAAGCGAGCTCTTATAAAATCTGCAATCTGAAGTCGC - 
61 TTTCAGACTGGTTCAGGATGAGCTCTTAATTTGTTAACCTTAACACTATT - Bsuc_PL88 
200 bp US-
lacY-DD0811-
RBSDD0810-
lacZ-DD0810 
62 TATCAACAGGAGTCCAAGCGAGCTCCTAACGAGCCGGGTTGCT - 
63 AGAGGCCTGACGTCGGGCCCAAGTTCTATGCTAAATCCAATTTAA - Bsuc_PL94 
Bsuc_PL95 
US_DD0789-
sucrose PTS 
64 ATCGTAATTATTGGGGACCCGCAACACTAGAAAAATCTAAAAATT - 
65 TTAGATTTTTCTAGTGTTGCGGGTCCCCAATAATTACGAT - Bsuc_PL94 
Bsuc_PL95 
Pneoneo 
66 TTTTTGACTGATTTTTTAAATTAGAAAAATTCATCCAGCATC - 
67 TGCTGGATGAATTTTTCTAATTTAAAAAATCAGTCAAAAAAGACC - 
Bsuc_PL94 
Bsuc_PL95 
DS_DD0789-
sucrose PTS 
68 TGACGCGTGGTACCGGGCCCCCAAAAGTAAATGTTAAAAATATGT - 
69 CCTTTAACTCTTCGCCATCC - pJFF224 
screening 
primer 
70 CCGCTAAGCGATAGACTGTA - 
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Table 3.5. Oligonucleotides used as primers for genetic engineering of B. succiniciproducens 
and plasmid or strain validation (continued 2). 
# 5’-Sequence-3’ Site Plasmid and amplicon 
71 GTGAACGGCAGGTATATGTG - Bsuc_PL94 
Bsuc_PL95 
screening primer 72 TGCCGAAAATAAAGTCACGG - 
73 GACCGTACATAAAAGTGCGG - B. succiniciproducens 
genome 
∆DD0789-trehalose 
PTS::Pneoneo 
5’-screening primer 
74 TTTGCGTTAAAAGTGCGGTC - 
75 CCAGAGTATTTTTGCTCTGG - B. succiniciproducens 
genome 
∆DD0789-trehalose 
PTS::Pneoneo 
3’-screening primer 
76 GCCGATATCGAACTGGATTA - 
 
 
3.4.2 Amplification, ligation and assembly of nucleic acids 
 
For plasmid construction and strain validation, the amplification of targeted DNA 
molecules was conducted by PCR (Mullis et al., 1986), using a Tgradient Thermocycler 
(Analytik Jena AG, Jena, Germany). For insert construction, a Phusion HighFidelity 
Polymerase master mix (Thermo Fisher Scientific, Waltham, MA, USA) was used. 
Strain validation was conducted using a Phire Hot Start II PCR master mix (Thermo 
Fisher Scientific, Waltham, MA, USA). DNA elution from columns was conducted using 
sterile demineralized water, pre-warmed to 65 °C. The strategy of insert amplification 
and cloning by Gibson’s Assembly (Gibson et al., 2009) for plasmid construction is 
depicted in Figure 3.1. 
DNA amplification was conducted using a standard temperature profile. The initial 
denaturation step (3 min at 98 °C) was followed by 30 cycles of 0.5 min for denaturation 
at 98 °C, 0.5 min for annealing at the specified annealing temperature of the primer 
pair, determined by Wallace’s rule (Equation 1) and a subsequent elongation step at 
72 °C with an adjusted duration. The duration of the elongation step was based on the 
elongation activity of the polymerase (30 seconds for 1000 bp, Phusion and 
15 seconds for 1000 bp, Phire) and the length of the target DNA. After a final elongation 
step for 4 min at 72 °C, the thermocycler stored the PCR mixtures at 8 °C.  
 
    ?? ? ? ? ?? ? ?? ? ? ? ?? ? ??        (1) 
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Figure 3.1. Strategy for nucleic acid amplification and subsequent cloning by Gibson’s Assembly 
(Gibson et al., 2009). Target DNA is amplified by PCR using site-specific primers containing 
homologous regions of the parts to be fused. Therefore, PCR adds about 15-20 base pairs to the specific 
amplicon at each assembly region. After purification, the target DNA’s are mixed with the appropriate 
and digested target plasmid. Finally, fusion of DNA of interest and cloning into plasmid is performed in 
one step by using Gibson’s Assembly. The method was used to assemble up to three DNA parts 
(e.g. promoters in front of genes, or ribosomal binding sites in front of genes etc.). 
 
DNA amplification for cloning efforts was carried out in 50 μL volume. For strain 
validation, amplification of DNA was conducted in a 15 μL volume. Primers were added 
to a final concentration of 200 nM. As a template, one μL of purified genomic DNA or 
plasmid DNA was used in cloning dependent reactions. Strain validations were 
performed by using at least one μL as template of a cell suspension of 20 μL, 
containing a single colony. Amplification reactions without addition of template DNA 
were used as negative controls. Positive controls were conducted with appropriate 
template DNA, if available. By addition of 5 % DMSO, DNA amplification was improved. 
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The Gibson’s Assembly master mix was prepared according to literature and frozen in 
15 μL aliquots at -20 °C (Gibson et al., 2009). After thawing an aliquot on ice, an 
appropriate vector-insert mixture (1:3 and 1:5, ad 5 μL with sterile demineralized water) 
was added. The reaction mix was incubated for 1 h at 50 °C and subsequently 5 μL 
were transformed into E. coli TOP10.  
Ligation reactions were carried out with two different vector-insert ratios (1:3 and 1:5), 
using the RapidDNA ligation Kit (Roche Applied Science, Mannheim, Germany). 
The reaction mixtures were incubated for 30 min at room temperature. Subsequently, 
an aliquot of 5 μL was used for transformation in E. coli TOP10 by heat shock. 
 
3.4.3 Gel electrophoresis 
 
Amplification products from PCR or enzymatic restriction digestion assays were 
analyzed electrophoretically by separation in an 1 % agarose gel. In short, 
1x TAE buffer (Table 3.6) was used for electrophoresis at 120 V for about 45 min 
(EasycastTM B1A or D2 gel system, Thermo Scientific, Marietta, OH, USA with 
PowerPacTM 300 BioRad Laboratories, Hercules, CA, USA). For the differentiation of 
band sizes, a 1 kb DNA ladder (O’GeneRulerTM 1 kb DNA ladder ready-to-use, 
Fermentas, St. Leon-Roth, Germany) was used. The samples were mixed in a 
1:10 ratio with OrangeG (Table 3.6) loading dye prior to gel loading. After DNA 
separation, the gels were stained in an ethidium bromide dye bath (0.5 μg mL-1 
ethidium bromide). The detection of DNA was conducted under UV light (Universell 
Hood II T2A, BioRad Laboratories, Hercules, CA, USA). 
 
Table 3.6. Buffer composition used for gel electrophoresis. 
 
Buffer Composition 
10x Orange G 
20 g Sucrose 
100 mg OrangeG 
ad 50 mL H2O 
50x TAE 
242 g Tris-base 
57.1 mL glacial acetate 
37.2 g Na2EDTA∙H2O 
pH 8 
ad 1000 mL H2O 
 
 
 
MATERIAL AND METHODS 
28 
3.4.4 Enzymatic digestion 
 
For the validation of cloning experiments, the preparation of suitable vectors for 
Gibson’s Assembly or ligation based cloning, plasmid DNA or amplified target DNA 
was digested using selected restriction enzymes (FastDigest series, Thermo Fisher 
Scientific, Waltham, MA, USA), respectively. The digestion of plasmid DNA (10 μg) or 
linear DNA (4 μg) for cloning was conducted in a total volume of 20 μL. For analytical 
digestions, 500 ng plasmid DNA was used. Digestion of plasmid DNA was performed 
at 37 °C overnight. Linear DNA or analytical digests were incubated at 37 °C for 1.5 h. 
Subsequently, linearized vectors for ligation based cloning were treated by alkaline 
phosphatase (Shrimp alkaline phosphatase (SAP), Roche Applied Science, 
Mannheim, Germany). The reaction mixture was incubated 40 min at room 
temperature to eliminate the phosphate residue, which avoided cloning dependent re-
ligation of the vector. 
 
3.4.5 Transformation 
 
The preparation of heat shock competent E. coli TOP10 cells was based on literature 
(Inoue et al., 1990). For heat shock transformation, an aliquot (50 μL) of competent 
cells was thawed on ice. Subsequently, 1 μL plasmid DNA or 5 μL ligation- or Gibson’s 
Assembly dependent cloning reaction was added. The mixture was stored for 30 min 
on ice and was subsequently heat-shocked at 45 °C for 45 seconds. Afterwards, the 
mixture was stored on ice for another 5 min. Then, 950 μL of sterile LB medium was 
added for the regeneration (37 °C, 900 rpm, 1 h) of the cells (Thermomixer comfort, 
Eppendorf, Hamburg, Germany). Finally, the cells were plated on LB agar plates, 
containing 10 μg mL-1 chloramphenicol and were incubated at 37 °C overnight. 
Obtained colonies were validated, using PCR or restriction digestion assays, as 
specified before. 
For each electroporation of plasmid DNA, competent cells of B. succiniciproducens 
were freshly obtained by aerobic cultivation in baffled shake flasks. A pre-grown 
overnight BHI culture (10 mL, 37 °C, 230 rpm) inoculated from a glycerol stock, was 
used to inoculate the main culture (50 mL, 37 °C, 230 rpm) to an initial OD600 of 0.05. 
During cultivation OD600 was measured and the cells were harvested at a final OD600 
of 0.3 by centrifugation (5000 x g, 10 min, 4 °C). Subsequently, the cells were washed 
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with 50 mL ice-cold 10 % glycerol and harvested equally. The cell pellet was 
suspended in 1 mL ice-cold 10 % glycerol. Aliquots of 100 μL cell suspension were 
then mixed with plasmid DNA (2 μg). The mixture was electroporated with a 
MicroPulser electroporator (BioRad Laboratories, Hercules, CA, USA) at 2 kV, 400 Ω 
and 25 μF. After the pulse, pre-warmed BHI was added to a final volume of 1 mL and 
the cells were regenerated for 1.5 h (37 °C, 550 rpm, Thermomixer comfort, Eppendorf, 
Hamburg, Germany). Subsequently, the cells were plated on buffered BHI agar plates, 
containing 5 μg mL-1 chloramphenicol and incubated for up to 48 h at 37 °C. 
 
3.4.6 Strain validation 
 
Colonies, obtained from the transformation were validated by PCR, regarding the 
presence of the episomal plasmid (pJFF224-XN based transformation), using the 
primer pair 69 and 70 (Table 3.5). This primer pair was designed for amplification of 
the multiple cloning site region of pJFF224-XN to detect cloning based assembly 
events or the resulting specific plasmid fingerprints in transformed strains. 
First recombination events (pClikCM based transformation) were validated with specific 
primer pairs (Table 3.5, Figure 3.2). Subsequently, second recombination events 
(pClikCM based transformation) in positive clones from the first recombination, were 
initiated by cultivation in BHI medium (25 mL, 37 °C, 230 rpm, 48 h) without selection 
pressure. Aliquots of the cultures were plated in dilutions from 10-3 to 10-6 on buffered 
BHI agar plates. After incubation overnight at 37 °C, clones were selected and 
validated by PCR, using specific primer pairs (Table 3.5). 
 
 
 
 
 
 
 
 
MATERIAL AND METHODS 
30 
 
 
Figure 3.2. Strain validation of first recombination events in B. succiniciproducens DD3∆∆lacZ. 
The deletion plasmid of the target gene DD0789 can enter the B. succiniciproducens genome via 
homologous recombination in 5’- or 3’-integration direction. The primer pairs 73 + 74 and 75 + 76 enable 
a direct analysis of integration direction by PCR. As well, the lacZ genes on Bsuc_PL94 and Bsuc_PL95 
enable a direct visible screening on buffered BHI agar plates with X-gal. The latter turns first 
recombination colonies blue. Second recombination events can be validated by using the mentioned 
primer pairs. The parent strain B. succiniciproducens DD3∆∆lacZ forms white colonies on buffered BHI 
with X-gal, when plasmid loss occurred, and consequently plasmid based lacZ activity is eliminated. 
 
 
3.4.7 Strain preservation 
 
Obtained strains during strain construction were inoculated on appropriate agar plates. 
After incubation of about 12 – 18 h at 37 °C, cells were harvested and suspended in 
1.2 mL of a buffer solution containing per Liter: 3.75 g (N-morpholino)propanesulfonic 
acid (MOPS), 0.25 g Mg(OH)2, 2.30 g 2,2-Bis(hydroxymethyl)-2,2’,2’’nitrilotriethanol 
(Bis-Tris) and 0.72 g NaHCO3. After complete resuspension of the cells, 0.4 mL of 
80 % glycerol was added and the glycerol stock was frozen and stored at -80 °C. 
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3.5 Cultivation and strain characterization 
 
3.5.1 Aerobic cultivation in shake flasks 
 
The first pre-culture was inoculated from a glycerol stock and incubated overnight at 
37 °C on an orbital shaker (230 rpm, 5 cm shaking diameter, Infors Multitron, 
Bottmingen, Switzerland) in 100 mL baffled shake-flasks, filled with 10 mL medium. 
Subsequently, cells were harvested (5 min, 5000x g, 25 °C), washed once with medium 
and then used to inoculate the second pre-culture to an initial cell concentration (OD600) 
of 0.1, which was incubated for 3 h as described above, followed again by harvesting. 
Main cultures were then inoculated to an initial cell concentration (OD600) of 0.2 and 
were grown as triplicates in 500 mL baffled shake flasks, filled with 50 mL medium 
(Table 3.3), as given above. 
Cultivation for promoter screening (BHI medium + 10 g L-1 glucose), media 
development and kanamycin resistance screening was conducted in a miniaturized 
and parallelized bioreactor system with online sensing of fluorescence (excitation 460 
nm, emission 520 nm), cell concentration as optical density (OD620) at 620 nm, 
dissolved oxygen level and pH of the culture broth (m2p-labs, Hauppauge, NY, USA). 
Here, the incubation was conducted at 37 °C and 1000 rpm. For the determination of 
promoter strength, the fluorescence signal was plotted against the cell concentration. 
The slope derived from the correlation was assigned to the specific promoter activity 
under the given conditions (Alper et al., 2005). B. succiniciproducens DD3 + pJFF224, 
harboring the empty plasmid, was used as negative control to correct for background 
fluorescence. All experiments were conducted in triplicates. 
 
3.5.2 Anaerobic cultivation in serum bottles 
 
Growth experiments were conducted in a glucose-based minimal-medium with MgCO3 
as buffer system (Table 3.4). Routine cultivations were conducted in 30 mL serum 
bottles, filled with 10 mL medium. A CO2 atmosphere with 0.8 bar overpressure was 
applied and the bottles were sealed with gas-tight butyl rubber stoppers (Becker et al., 
2013). 
The first pre-culture was seeded with an inoculation loop from an agar plate culture 
grown in a CO2 enriched atmosphere at 37 °C (Anaerocult® C mini, Merck Millipore, 
Darmstadt, Germany) and was then incubated overnight at 37 °C on an orbital shaker 
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(230 rpm, 5 cm shaking diameter, Infors Multitron, Bottmingen, Switzerland). 
Subsequently, cells from exponential growth phase were harvested (5 min, 5000 x g, 
25 °C), washed once with medium and were then used to inoculate the main culture to 
an initial cell concentration (OD600) of 0.5, grown in triplicates. 
For defined alanine production experiments, exponentially growing cells were switched 
to an atmosphere of either CO2 or N2 at 0.8 bar overpressure. Therefore, 10 mL of an 
aerobic main culture at a cell dry mass of about 0.8 g L-1 was transferred in serum 
bottles equipped with gas-tight butyl rubber stoppers and the atmosphere switch was 
applied. Experiments were conducted in triplicates. 
 
3.5.3 Cultivation in lab scale bioreactors 
 
Bioreactor cultivations were carried out in batch and in fed-batch mode, respectively, 
using lab scale bioreactors (DasGIP, Eppendorf AG, Hamburg, Germany). 
Batch processes for L-alanine production were conducted at 37 °C in parallelized 
250 mL reactors, filled with 40 mL medium (Table 3.3). The process was maintained 
at pH 7.0 by automatic addition of 25 % NH4OH and was operated either under 
anaerobic conditions (0.18 vvm N2) or under microaerobic conditions (without aeration) 
(Yamamoto et al., 2012). The stirring rate was set to 400 min-1 throughout the process. 
After 2 hours, a pulse of (NH4)2SO4 was added, supplying a concentration of 10 g L-1 
from a sterilized stock solution (500 g L-1, pH 7.2). 
The fed-batch process for L-alanine production was conducted using 1 L bioreactors, 
filled initially with 300 mL batch medium (Table 3.3) with differing concentrations of the 
carbon source, which was 15 g or 30 g xylose as given below. The process was again 
operated at 37 °C and pH 7.0. Different culture regimes were chosen: (i) initial aerobic 
phase (1.8 vvm pressurized air) and subsequent anaerobic phase (1.8 vvm N2), and 
(ii) completely anaerobic process (1.8 vvm N2). After the initially added xylose was 
depleted, the feed phase was started. The feed was added pulse-wise on basis of 
external xylose measurement, to keep the substrate level between 5 and 15 g L-1. 
The feed solution contained per liter: 450 g xylose, 200 g (NH4)2SO4, 4 mL Na2CO3 
stock solution (250 g L-1), 5 g yeast extract (Becton Dickinson), 5 g BHI 
(Becton Dickinson), 5 mL glycine-betaine stock solution (58.6 g L-1), 3 g K2HPO4, 5 mL 
200x trace element stock solution (10 g L-1 FeSO4∙7H2O, 2.0 g L-1 CaCl2∙2H2O, 0.4 g L-1 
MnSO4∙H2O, 2.2 g L-1 ZnSO4∙7H2O, 1.0 g L-1 CuSO4·5H2O, 0.02 g L-1 Na2B4O7∙10H2O, 
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0.1 g L-1 (NH4)6Mo7O24∙4H2O) and 10 mL of a 100x vitamin stock solution (10 g L-1 
Ca-pantothenate, 0.5 g L-1 biotin, 0.05 g L-1 cyanocobalamin, 3 g L-1 nicotinamide, 
1 g L-1 pyridoxal∙HCl, 0.6 g L-1 riboflavin and 3 g L-1 thiamin∙HCl) (Becker et al., 2013; 
Young Lee, 1996). All processes were conducted in duplicates. 
 
3.6 Analytical methods 
 
3.6.1 Cell and biomass concentration 
 
The cell concentration was measured as optical density (OD600) at 600 nm in duplicates 
(1600 PC, VWR, Darmstadt, Germany). The cell dry mass (CDM) was inferred from 
the optical density as previously described (Becker et al., 2013). An OD600-CDM 
correlation factor of 0.331 gCDM OD600-1 was used. 
 
3.6.2 Substrates and products 
 
Glucose, fructose, sucrose, xylose, glycerol, pyruvate, lactate, acetate, 
3-hydroxypropionate, and succinate were quantified by HPLC in 1:5 diluted samples 
(Agilent 1260 Infinity Series, Agilent Technologies, Waldbronn, Germany) on an 
HPX-87H (Bio-Rad, Hercules, CA, USA) at 55 °C with 0.5 mM H2SO4 at 0.7 mL min-1 
as mobile phase and refraction index detection (Agilent 1260, RID G1362A, Agilent 
Technologies) with external standards. Amino acids were quantified by HPLC using 
1:10 diluted samples with α-aminobutyric acid as internal standard (Agilent 1200 
Series, Agilent Technologies), involving pre-column derivatization with 
o-phthalaldehyde, separation on a Gemini C18 column (Phenomenex, Aschaffenburg, 
Germany) by gradient elution (A: 4.8 g L-1 NaH2PO4, 0.5 g L-1 NaN3, B: 45 % 
acetonitrile, 45 % methanol, 10 % deionized water, gradient: 0 - 27.5 minutes at 100 % 
A, 27.5 - 28 minutes at 72.5 % A and 27.5 % B, 28 - 32 minutes at 100 % B, 32 - 37 
minutes at 100 % A) at a flow rate of 1 mL min-1 and fluorescence detection (Krömer 
et al., 2005).  
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3.6.3 GC-MS labeling analysis 
 
The analysis and identification of secreted products except acetate was conducted by 
GC/MS (5977A MSD, 7890B GC, HP-5MS capillary column, 30 m x 250 μm, Agilent 
Technologies, Waldbronn, Germany). In short, 50 μL of a culture supernatant was 
dried under a nitrogen stream (Wittmann et al., 2002). The obtained residue was re-
dissolved in 50 μL dimethyl formamide (0.1 % pyridine), then mixed with 50 μL 
N-methyl-N-t-butyl-dimethylsilyl-trifluoroacetamide (MBDSTFA) (Macherey-Nagel, 
Düren, Germany) and converted into the t-butyl-dimethylsilyl (TBMDS) derivatives for 
30 minutes at 80 °C. 
The instrument was operated at a carrier gas flow of 1.7 mL min-1 and temperatures of 
250 °C (inlet), 230 °C (interface), and 150 °C (quadrupole). The temperature gradient 
for separation was 120 °C for 2 minutes, a ramp of 8 °C min-1 up to 200 °C, and then 
10 °C min-1 up to 325 °C. GC-MS measurement was first conducted in scan mode 
(m/z 50 – 750). The quantitative analysis of the 13C labeling pattern of TBDMS-amino 
acids glycine (246 m/z), valine (288 m/z), leucine (302 m/z), isoleucine (302 m/z), 
serine (390 m/z), threonine (404 m/z), phenylalanine (336 m/z), aspartate (418 m/z), 
lysine (431 m/z) and tyrosine (466 m/z) was carried out in selected ion monitoring (SIM) 
mode. The analyzed ion cluster at m/z 260 – 264 represents a fragment ion, which 
contains the entire carbon skeleton and the amino group of alanine (Wittmann, 2007) 
and β-alanine as well as the entire carbon skeleton of 3-HP and lactate. Succinate was 
also considered (289 m/z). Measurements concerning acetate were derivatized with 
n-pentanol and measured according to (Adler et al., 2013). 
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3.6.4 Enzyme activities 
 
Cells were disrupted (Precellys, VWR, Erlangen, Germany) using Lysing matrix B 
tubes (MP biomedicals, Eschwege, Germany) in 100 mM Tris/HCl (pH 7.8, 1 mM 
dithiothreitol). Alanine dehydrogenase was assayed after adding 50 μL cell extract to 
950 μL of a reaction mixture, containing 100 mM Tris/HCl (pH 9.0), 0.25 mM NADH, 
5 mM (NH4)2SO4, and 10 mM pyruvate (Germano and Anderson, 1968).  
Aspartate 1-decarboxylase (PanD, PanP) activity was detected via β-alanine formation 
in HPLC measurements. For measurement of PanD, 100 μL cell extract were added 
to 1.9 mL of a 100 mM potassium phosphate buffer (pH 6.8) containing 1.2 mM 
L-aspartate. To measure PanP, a buffer variation was used (100 mM potassium 
phosphate buffer (pH 7.5), 10 mM L-aspartate, 5 mM MgSO4 and 0.75 mM pyridoxal 
5-phosphate) (Pan et al., 2017). The mixture was incubated at 30 °C and 500 rpm 
(Thermomixer comfort, Eppendorf, Hamburg, Germany) and 100 μL samples were 
withdrawn in specific intervals up to 5 h. Subsequently the samples were inactivated 
at 100 °C for 5 min (Thermomixer comfort, Eppendorf, Hamburg, Germany) and diluted 
1:10 with α-aminobutyric acid as an internal standard and measured with HPLC as 
described above. 
Glucose 6-phosphate (G6P) dehydrogenase activity was determined after adding 
50 μL cell extract to 950 μL of a reaction mixture containing 100 mM Tris/HCl (pH 7.8), 
10 mM MgCl2, 1 mM NADP+, 5 mM glucose 6-phosphate (Becker et al., 2013). 
Negative controls for each assay were conducted without cell extract or substrate, 
respectively. The total protein concentration was determined using the bicinchoninic 
acid assay (Smith et al., 1985). One unit of enzyme activity was defined as the amount 
of enzyme, converting 1 μmol of NAD+ (alanine dehydrogenase) or NADP+ (G6P 
dehydrogenase), which was quantified via the absorption change at 340 nm. The latter 
was also defined for β-alanine formation activity. All assays were conducted in 
triplicates at 30 °C. 
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4 RESULTS AND DISCUSSION 
 
4.1 Growth physiology of Basfia succiniciproducens DD3 under aerobic and 
anaerobic conditions 
 
Initial studies investigated the basic properties and production characteristics of 
B. succiniciproducens. These studies were conducted with the strain 
B. succiniciproducens DD3, lacking the ldhA and the pflD gene (Becker et al., 2013). 
The elimination of the by-products lactate and formate, achieved by the double 
deletion, previously led to high succinate production. Here, it appeared also promising 
towards overproduction of carbon-three chemicals. 
To get an insight into the growth physiology, anaerobic cultivation in glucose minimal 
medium was performed (Figure 4.1). The strain grew from early on and mainly 
produced within 48 h, 33.0 ± 0.9 g L-1 succinate from 50 g L-1 glucose. Acetate 
(2.0 ± 0.0 g L-1, Yacetate/glucose = 0.05 ± 0.00 gacetate gglucose-1), pyruvate (2.6 ± 0.0 g L-1, 
Ypyruvate/glucose = 0.07 ± 0.00 gpyruvate gglucose-1) and traces of formate, lactate and ethanol 
were found as by-products. In the exponential growth phase a μmax of 0.07 ± 0.01 h-1 
was derived. The biomass yield YX/S was low (0.07 ± 0.01 gCDM gglucose-1), indicating 
only partial conversion of glucose into biomass. The specific glucose consumption rate 
(qs) was 0.99 ± 0.04 gglucose gCDM-1 h-1. The generation time was determined to be 
10.3 ± 1.4 h-1. The succinate-substrate yield (0.66 ± 0.01 gsuccinate gglucose-1) was highly 
similar to previous findings (Becker et al., 2013). 
The deletion of competing fermentative pathways is a common strategy for enhancing 
succinate production (Lee et al., 2006; Litsanov et al., 2012; Zhu et al., 2014). The 
detected pyruvate indicated an intracellular excess of pyruvate and an overflow at the 
pyruvate node (Becker et al., 2013). This suggested a good start point into metabolic 
engineering of B. succiniciproducens for pyruvate-derived products (Becker et al., 
2015). 
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Figure 4.1. Anaerobic cultivation profile of B. succiniciproducens DD3 in glucose minimal 
medium. The data represent three independent replicates with means and deviation. 
 
In comparison, the aerobic cultivation of B. succiniciproducens DD3 in complex growth 
medium revealed a rapid increase in cell concentration, associated with a μmax of 
0.81 ± 0.02 h-1 (Figure 4.2). This growth rate corresponded to a generation time of 
52 ± 1 min. The biomass yield was 0.23 ± 0.02 gCDM gglucose-1. The cells exhibited a 
rapid glucose consumption corresponding to a glucose consumption rate qs of 
3.5 ± 0.2 gglucose gCDM-1 h-1. In contrast to the anaerobic cultivation, acetate 
(6.4 ± 0.1 g L-1) was the dominating product instead of succinate (2.3 ± 0.5 g L-1). 
Only traces of other by-products were observed. 
It is assumed, that the double deletion of the ldhA and pflD gene in 
B. succiniciproducens DD3 leads to the strong acetate production. In contrast, aerobic 
cultivation of wild type Mannheimia succiniciproducens, containing functional copies of 
ldhA and pflD, showed a strong lactate production (Lee et al., 2002). 
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Figure 4.2. Aerobic growth physiology of B. succiniciproducens DD3 in shake flask. Measurement 
of organic acids, sugars and amino acids was conducted using HPLC. The data represent three 
independent replicates with means and deviation. 
 
The pronounced production of acetate indicated an increased availability of carbon at 
the pyruvate pool. This appeared promising to establish new pathways for other 
pyruvate-derived products, using B. succiniciproducens. The observed product shift to 
acetate is also prominent in aerobically growing E. coli under excess glucose (Luli and 
Strohl, 1990). It is thought to be a limitation in respiratory capacity (Andersen and von 
Meyenburg, 1980; Szenk et al., 2017) enabling the cell to gain additional ATP, using 
substrate level phosphorylation involving the pta-ackA pathway. 
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4.2 Development of genetic tools for Basfia succiniciproducens 
 
4.2.1 Development of a blue-white screening system for genomic engineering 
 
Different experiments aimed to develop a method for more convenient genome 
engineering of B. succiniciproducens (Becker et al., 2013; Lange et al., 2017). 
This appeared reasonable, because genomic modification in this microbe is not yet 
well established. So far, genomic modification is exclusively done via homologous 
recombination, using homologous non-coding genomic regions located on the 
integrative vector pClikCM (Becker et al., 2013). The lack of an efficient selection marker 
makes engineering efforts time-consuming and elaborative. To speed up existing 
protocols, the development of a suitable screening system for genomic modification of 
B. succiniciproducens was targeted in the present study. 
Since blue white screening has been established for cloning efforts (Vieira and 
Messing, 1982), many applications and variations of this technique emerged (Geng et 
al., 2016; Speltz and Regan, 2013). Basically, the technique utilizes the expression of 
a β-galactosidase (LacZ), which turns clone colonies blue, upon the cleavage of a 
D-lactose analog, i.e. 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside, yielding 
galactose and 5-bromo-4-chloro-3-hydroxyindole (Kiernan, 2007). The latter dimerizes 
to 5,5'-dibromo-4,4'-dichloro-indigo, an insoluble blue stain. After cloning of target DNA 
into the artificial open reading frame of the β-galactosidase gene (lacZ) on the cloning 
vector, β-galactosidase expression and activity diminishes (Sambrook, 2001). 
This enables a convenient and efficient identification of recombinant clones. 
This system should now be applied to B. succiniciproducens for genomic engineering.  
 
One example for blue-white selection was conducted within the rumen bacterium 
A. succinogenes in 2014 (Joshi et al., 2014) which is also a member of Pasteurellaceae 
family. Here, deletion of the native β-galactosidase lacZ gene copy from the 
A. succinogenes genome revealed a possible blue-white selection for ∆lacZ 
recombinants. However, this was only restricted to construction of the ∆pflB ∆lacZ 
strain (Joshi et al., 2014) and not for general construction approaches. 
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4.2.2 Basfia succiniciproducens contains two β-galactosidase genes 
 
The basis for blue white selection is a commonly known β-galactosidase gene lacZ, 
exclusively subcloned on common cloning vectors. Two candidate genes for native 
β-galactosidases were annotated in the genome of B. succiniciproducens. Like 
B. succiniciproducens, its relative M. succiniciproducens contains also two lacZ genes 
which seem to posess a critical role in lactose metabolism and further unknown 
functions (Lee et al., 2012). But blue-white screening technique is not described in 
literature for M. succiniciproducens. 
The genes DD0759 (lacZ1, 3042 bp) and DD0810 (lacZ2, 3027 bp) were annotated as 
β-galactosidases when BLAST was performed on the DNA and protein level (Table 
4.1). The two genes differed in similarity on the DNA (37 %) and on the protein level 
(44 %). It seemed that both genes were also paralogues (Lee et al., 2012). 
The corresponding proteins showed strong similarity when compared to the genes and 
proteins of the related bacterium M. succiniciproducens MBEL55E. The next similar 
genes were found in the family of Pasteurellaceae varying from 70 % on DNA level to 
59 % on protein level (Table 4.1). This showed the narrow relation of 
B. succiniciproducens and M. succiniciproducens as indicated by the distinct 
differences between the gene and protein sequences of other Pasteurellaceae (Table 
4.1). 
 
 
 
Table 4.1. Overview of gene properties of two native B. succiniciproducens lacZ genes and 
BLAST similarities to related strains. The native B. succiniciproducens lacZ genes were compared 
to the three most related genes by KEGG BLAST on DNA and protein level. 
Gene Length (bp) DNA similarity, gene, strain Protein similarity, protein, strain 
DD0759 3042 
99 %, MS0749, M. 
succiniciproducens MBEL55E 
70 %, PARA_19840, Haemophilus 
parainfluenzae T3T1 
70 %, X874_17500, Mannheimia 
variegena USDA-ARS-USMARC-
1312 
99 %, LacZ, M. succiniciproducens 
MBEL55E 
64 %, β-D-galactosidase, 
Haemophilus parainfluenzae T3T1 
60 %, β-galactosidase, Mannheimia 
variegena USDA-ARS-USMARC-
1312 
DD0810 3027 
99 %, MS0806, M. 
succiniciproducens MBEL55E 
69 %, Asuc_1398, A. succinogenes 
130Z 
69 %, K756_07455, Haemophilus 
parasuis ZJ0906 
99 %, LacZ, M. succiniciproducens 
MBEL55E 
61 %, glycoside hydrolase family 2 
TIM barrel, A. succinogenes 130Z 
59 %, β-galactosidase, 
Haemophilus parasuis ZJ0906 
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The β-galactosidase was active in vivo. When B. succiniciproducens DD3 was 
streaked on agar supplemented with X-gal, β-galactosidase activity was observable 
indicated by the blue color (Figure 4.3 A). To establish a suitable blue-white screening 
system, the deletion of all endogenous lacZ genes was required (Barton, 2015). 
The single deletion of neither DD0759 nor DD0810 had an effect on the X-gal cleavage 
ability. Only the double deletion of both genes DD0759 and DD0810 yielded a strain, 
which had lost the X-gal cleavage ability (Figure 4.3 B). As a further proof-of-concept, 
this could be restored with complementation plasmids (Bsuc_PL18 and Bsuc_PL19), 
containing either the DD0759 or the DD0810 gene under the native promoter control, 
respectively (Figure 4.3 C+D) (Barton, 2015). This proved that both endogenic lacZ 
genes enabled X-gal cleavage, so the corresponding mutants exhibited 
β-galactosidase activity. 
The blue-white screening strain, designated B. succiniciproducens DD3∆∆lacZ, was 
now used to establish a more convenient genomic modification method for 
B. succiniciproducens. 
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Figure 4.3. Comparison of B. succiniciproducens DD3 and DD3∆DD0759∆DD0810. The strains 
DD3 (A) and DD3∆DD0759∆DD0810 lacking the lacZ genes DD0759 and DD0810 (B), were streaked 
on buffered BHI agar containing 80 μg mL-1 X-gal. The double lacZ knockout strain showed a lack of 
β-galactosidase activity (B). This property was restored, when gene function was complemented using 
the native lacZ genes, DD0810 (C) or DD0759 (D), on the episomal vector pJFF224-XN under native 
promoter control. 
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4.2.3 Modification of the integrative pClikCM vector for blue-white screening 
 
As shown, X-gal cleavage ability was restored by the episomal plasmids Bsuc_PL18 
and Bsuc_PL19. In a next step, these findings were implemented into the integrative 
vector pClikCM, a commonly used vector for genomic modification of 
B. succiniciproducens and other microorganisms (Becker et al., 2013; Becker et al., 
2011; Lange et al., 2017). The idea was to provide one of the identified β-galactosidase 
genes on the pClikCM backbone. In case of the occurrence of homologous 
recombination, cells which then contain a genomic copy of the modified vector should 
turn blue. If the vector was excised in a second recombination event the colonies 
should again turn white, consequently. 
 
First, derivatives of pClikCM containing one of the B. succiniciproducens lacZ genes on 
the vector backbone, each with its native promoter, were cloned into the multiple 
cloning site of the linearized (SacI) pClikCM vector. This yielded the integrative plasmids 
Bsuc_PL87 and Bsuc_PL88, containing either DD0759 or DD0810, respectively. 
Remarkably is, that positive clone colonies of the cloning host E. coli TOP10 were 
highlighted by the blue color on LB agar supplemented with X-gal (Figure 4.4 A + B). 
These clones contained the version of Bsuc_PL87 and Bsuc_PL88 episomally. 
This was emphasized in comparison with clones containing episomal pClikCM, missing 
X-gal cleavage (Figure 4.4 C). Here, convenience of using blue-white screening is 
demonstrated, but validation was furthermore conducted by PCR. 
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Figure 4.4. Clones of the intermediate host E. coli TOP10 containing the plasmids Bsuc_PL087 
and Bsuc_PL088 episomally. The genes DD0759-lacZ and DD0810-lacZ with their native control 
elements (promoters) were cloned into the linearized (SacI) vector pClikCM (A + B). Selection of positive 
clones was verified by blue-white screening on LB CM agar containing 80 μg mL-1 X-gal and comparison 
to clones containing the non-modified vector pClikCM (C). 
 
The modifications of the pClikCM vector should now enable a blue-white screening for 
B. succiniciproducens (Figure 4.5). The strategy comprises the cloning of homologous 
regions of a deletion target gene (Figure 4.5 A, Case 1.) into the multiple cloning site 
(MCS) of Bsuc_PL87 or Bsuc_PL88. The modified vectors now indicated their genomic 
integration after a first recombination event by turning recombinant clone colonies blue, 
when incubated with X-gal. In addition, this should also enable the screening for 
homologous integration of DNA sequences of choice, e.g. genes or promoters (Figure 
4.5 A, Case 2.). This reduces the effort to screen for false-positive clones after the first 
recombination (Figure 4.5 B). In the second recombination, the vector excision should 
again yield white clone colonies, indicating a modified mutant strain or the wild type 
strain (Figure 4.5 C). Only the obtained white clones are validated using PCR, which 
reduces the amount of screened colonies lacking the second recombination event. The 
developed strategy was now validated in a strain engineering approach. 
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Figure 4.5. Theoretical background for blue-white screening using B. succiniciproducens 
DD3∆∆lacZ. To establish blue-white screening, the integrative vector pClikCM (Becker et al., 2013) was 
modified by cloning the lacZ-DD0759 and lacZ-DD0810 genes on the vector backbone under native 
promoter control, respectively. Furthermore, modification for heterologous recombination by using non-
coding regions of target genes enable genomic modification (A). This is the basis for genomic 
modification of B. succiniciproducens DD3∆∆lacZ. The genomic integration of the vector is highlighted 
by turning clone colonies blue through lacZ gene activity after X-gal incubation (B). Modified strains 
(or wild type) should again yield white clone colonies after excision of the vector in 2. recombination (C). 
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4.2.4 Application of blue-white screening to gene deletion 
 
The deletion of the target gene DD0789 in B. succiniciproducens DD3∆∆lacZ, which is 
similar to the M. succiniciproducens sucrose PTS transporter MS0784 (Lee et al., 
2010), should demonstrate the potential of the blue-white screening strategy. 
The design included the replacement of DD0789 by the kanamycin resistance gene 
neo, with its native promoter Pneo. 
 
According, the two plasmids Bsuc_PL87 and Bsuc_PL88 were equipped with 1500 bp 
long sequences from the 5’ upstream and the 3’ downstream non-coding region of 
DD0789, which both flanked the 943 bp long Pneoneo DNA sequence, obtained from a 
pSEVA vector via PCR. The construct was cloned into the linearized (ApaI) vectors 
Bsuc_PL87 and Bsuc_PL88, which yielded the vectors Bsuc_PL94 and Bsuc_PL95, 
respectively. After plasmid validation and purification, strain engineering was 
conducted. The transformation yielded many clones, but only one blue colony was 
obtained for Bsuc_PL94 (Figure 4.6 A) and for Bsuc_PL95 (Figure 4.6 B), 
respectively, out of about 558 total clones. 
The small percentage (0.4 %) of positive clones demonstrates the benefit of the 
screening for strain engineering in B. succiniciproducens. The two blue clones, 
apparently positive, were streaked. Subsequently, three individual blue colonies were 
tested using 5’-3’-PCR with the primer pairs P73+74 and P75+76 (Figure 4.6 C). It was 
shown that all individual colonies contained a 5’ integration (P73+74) of the Pneoneo 
DNA sequence, which was indicated by an observed PCR amplicon at around 2500 bp 
(Figure 4.6 Lane A-F). When wild type colonies were screened, an amplicon of about 
3000 bp was detected, which comprised the native DD0789 gene (Figure 4.6 Lanes G-
I). Compared to the 3’ integration screening (P75+76), no significant differences 
between the clones (Figure 4.6 Lanes K-P) and the wild type (Figure 4.6 Lanes Q-S) 
were observed. The negative controls (Figure 4.6 Lane J and T), containing water 
instead of DNA template, showed no contamination of the reaction. 
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Figure 4.6. Results of B. succiniciproducens DD3∆∆lacZ transformation with Bsuc_PL94 and 
Bsuc_PL95. During the transformation procedure, electroporated cells were plated on buffered BHI 
agar, containing chloramphenicol (5 μg mL-1) and X-gal (80 μg mL-1). Transformation with Bsuc_PL94 
yielded one blue colony which indicated vector integration into the genome (A). Also transformation with 
Bsuc_PL95 created one blue colony (B), out of about 558 clones. The blue colonies were streaked and 
three individual clones were screened via PCR (C) comprising Bsuc_PL94 and Bsuc_PL95 
recombinants and the wild type. First recombination in 5’ (Lanes A-J) and 3’ (Lanes K-T) direction was 
tested by PCR using the primer pairs P73+74 and P75+76, respectively. Negative controls (Lane J+T) 
were conducted using demineralized water instead of DNA template. The gel comprised 1 % agarose 
using a 1 kb DNA ladder for determination of product size. Original gel is added to the appendix (Figure 
6.1). 
 
It can be concluded that the integration of the used vectors was proven successfully 
by use of the blue-white screening. The obtained blue clones exhibited the desired 
recombination, which was confirmed by PCR screening. As shown, the blue-white 
screening method was functional in B. succiniciproducens DD3∆∆lacZ to facilitate and 
support the identification of recombinants. 
 
Further strain engineering aimed at the vector excision in a second recombination 
event. Again, the blue-white screening should highlight recombinants. Therefore, two 
positive clones containing the first recombination round were cultivated for 48 h in BHI 
medium without selection pressure to initiate the second recombination event. 
They were then plated in a dilution series on buffered BHI agar plates without 
chloramphenicol, but with 80 μg mL-1 X-gal (Figure 4.7). In sum, 18 white clones were 
obtained. These colonies were patched on buffered BHI, without chloramphenicol, 
containing X-gal for further examination using PCR (Figure 4.8 A). As control, blue 
colonies were patched additionally. 
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Figure 4.7. Second recombinant clone screening of B. succiniciproducens DD3∆∆lacZ∆DD0789-
neo using blue-white technique. Two positive clones of each recombinant strain 
B. succiniciproducens DD3∆∆lacZ containing the vectors were cultivated for 48 h in BHI without 
chloramphenicol. Subsequently, each culture broth was diluted serially 1:100000 and plated on buffered 
BHI agar plates containing 80 μg mL-1 X-gal. The Bsuc_PL94 strain (A), yielded 8 white clones, depicting 
potentially the strain B. succiniciproducens DD3∆∆lacZ∆DD0789-neo or the wild type. Using the 
Bsuc_PL95 strain (B), 10 white clones were found. All 18 white clones were transferred on buffered BHI 
containing 80 μg mL-1 X-gal. Blue clones were also transferred as control. Further examination was 
conducted using PCR. 
 
The PCR 5’ screening with the primer pair P73+74 underlined the functionality of the 
blue-white screening. The 18 white clones comprised 5 clones which contained the 
desired ∆DD0789::Pneoneo genotype, designated as the B. succiniciproducens 
DD3∆∆lacZ∆DD0789-neo strain (Figure 4.8 Lanes 1, 13, 15, 16 and 18). 
The remaining 13 clones exhibited the wild type PCR amplicon at about 3000 bp. 
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Figure 4.8. Validation of second recombinant clones of B. succiniciproducens 
DD3∆∆lacZ∆DD0789-neo using blue-white technique and PCR screening. The obtained clones (A) 
were screened by PCR with the 5’ screening primer pair P73+74 (B). Screening revealed the success 
of the vector excision from the genome. At least, five out of 18 clones showed the deletion of DD0789, 
namely clone #1, #13, #15, #16 and #18. The new strain was designated as B. succiniciproducens 
DD3∆∆lacZ∆DD0789-neo. The results are emphasized by comparison to the control clones #4, #10 and 
#21, which turn blue and contain the plasmid and consequently the deletion of DD0789. 
Detection of amplicons were obtained by agarose gel electrophoresis. The gel comprised 1 % agarose 
using a 1 kb DNA ladder for determination of product size. Original gel is added to the appendix (Figure 
6.2). 
 
Additionally, it was tested if the B. succiniciproducens DD3∆∆lacZ∆DD0789-neo 
clones, containing the Pneoneo modification, were viable on buffered BHI agar plates 
containing 10 μg mL-1 kanamycin (Figure 4.9 A). As control, a B. succiniciproducens 
DD3∆∆lacZ clone and a blue clone, containing the Bsuc_PL94 or Bsuc_PL95 plasmid, 
were tested each. To prove clone viability, the same clones were patched on a non-
selection agar plate (Figure 4.9 B). Obviously, all clones of B. succiniciproducens 
DD3∆∆lacZ∆DD0789-neo grew well on kanamycin, proving functionality of the 
genomic copy of the neo gene. In contrast, the non-modified B. succiniciproducens 
DD3∆∆lacZ cells showed impaired growth. Surplus, the blue B. succiniciproducens 
DD3∆∆lacZ clones containing the plasmid and though the kanamycin resistance gene, 
grew as well as the B. succiniciproducens DD3∆∆lacZ∆DD0789-neo clones, but 
showed the blue color. To sum it up, the blue-white selection screening was found 
suitable for genetic engineering of B. succiniciproducens. 
RESULTS AND DISCUSSION 
50 
 
 
Figure 4.9. Growth test of B. succiniciproducens DD3∆∆lacZ∆DD0789-neo on kanamycin. To test 
the functionality of the integrated kanamycin resistance gene (neo), the obtained clones were patched 
on buffered BHI agar plates containing 10 μg mL-1 kanamycin and 80 μg mL-1 X-gal (A) and buffered 
BHI agar plates containing 80 μg mL-1 X-gal (B). It was shown that all clones containing the knockout 
and the neo gene, indicated by a plus, grew on kanamycin. All wild type clones, indicated by a minus 
did not grow on kanamycin. The positive control clones, indicated by a c, which contained the plasmid 
and surplus the neo gene, grew as well and showed blue color. 
 
The applicability of the new method was demonstrated by the successful deletion of 
the DD0789 gene and the functional integration of the kanamycin resistance gene neo 
into the DD0789 gene locus. For future strain construction, this technique can reduce 
costs and time effort. 
 
4.2.5 Deletion of the gene DD0789 impairs growth on sucrose 
 
The deletion of the DD0789 gene and the subsequent inactivation of the sucrose ptsG 
protein in B. succiniciproducens was now validated. Therefore, living cells of the parent 
strain and the deletion strain were used for inoculation of minimal medium containing 
glucose, fructose and sucrose, respectively. The growth was observed by measuring 
the optical density (OD600) after 24 h of anaerobic cultivation (Figure 4.10). 
The knockout strain showed impaired growth on sucrose. Nevertheless, growth on 
glucose and fructose was still possible, in a similar manner compared to the parent 
strain. This experiment proved that the functional deletion of DD0789 and the 
inactivation of the corresponding sucrose ptsG protein was successful. 
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Figure 4.10. Growth ability of B. succiniciproducens DD3∆∆lacZ∆DD0789-neo and its parent 
strain on glucose, fructose and sucrose. Optical density (OD600) of the culture broth was measured 
after 24 h of anaerobic (CO2) cultivation in minimal medium. The measured value is corrected for the 
inoculation optical density. The data represent means and deviation of duplicates. 
 
 
4.2.6 Validation of functionality of neo gene integration into the genome 
 
In order to prove the expression of the integrated neo gene and the functionality of the 
translated Neo protein, a screening experiment, using varied kanamycin 
concentrations was conducted. Therefore, a miniaturized and parallelized bioreactor 
system was used. The parent strain B. succiniciproducens DD3∆∆lacZ and the 
constructed strain B. succiniciproducens DD3∆∆lacZ∆DD0789-neo were grown in BHI 
medium supplemented with 10 g L-1 glucose and additionally, 0, 2, 5, 10, 15, 20, 35 
and 50 μg mL-1 of kanamycin (Figure 4.11). 
In comparison, a significant difference in the growth behavior was observable. 
The parent strain was significantly affected, already at low kanamycin concentration 
(Figure 4.11 A). When 20 μg mL-1 of kanamycin was supplemented, only 17 % 
(0.14 h-1) of the native growth rate (0.82 h-1) was preserved. The addition of 35 μg mL-1 
kanamycin stopped the growth almost completely. This concentration is defined as the 
minimal inhibitory concentration (MIC) for B. succiniciproducens on kanamycin. 
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In contrast, the mutant strain showed an enhanced resistance against the antibiotic 
(Figure 4.11 B). Here, 76 % (0.61 h-1) of the maximum growth rate (0.81 h-1) was still 
preserved at 20 μg mL-1 kanamycin. 
A similar behavior was observed for B. succiniciproducens DD3∆∆lacZ∆DD0789-neo 
when the optical density was considered (Figure 4.11 C). Again, 78 % of the reference 
value was reached, when 20 μg mL-1 of kanamycin was supplemented. This was 
significantly higher than the parent strain, which reached only 10 % of the unaffected 
OD620 under these conditions. Interestingly, almost 50 % of the maximum growth was 
preserved at 35 μg mL-1, a level that affected the parent strain strongly. This provides 
evidence that the expression of the heterologous neo gene is possible in 
B. succiniciproducens and that the Neo protein is functional. This expands the toolbox 
for strain engineering, enabling counter selection on kanamycin, beside the commonly 
used chloramphenicol. When literature is considered, an almost similar selection 
concentration (25 μg mL-1) was used recently in the relative bacterium 
M. succiniciproducens (Lee et al., 2006). 
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Figure 4.11. Growth impairment of B. succiniciproducens DD3∆∆lacZ∆DD0789-neo and its parent 
strain induced by kanamycin. The cells were grown aerobically in BHI medium supplemented with 
10 g L-1 of glucose. Additionally, 2, 5, 10, 15, 20, 35 and 50 μg mL-1 of kanamycin were added to the 
medium. Cultivation was conducted in a miniaturized and parallelized bioreactor system. Optical density 
at 620 nm (OD620) was measured. The data represent three biological replicates with means and 
standard deviation. 
RESULTS AND DISCUSSION 
54 
As shown, the knockout of the sucrose ptsG was achieved successfully. The strain 
engineering was shown to be fast and efficient. Screening steps, normally conducted 
using PCR, can be reduced. Additionally, the successful deletion was shown by growth 
impairment of the mutant strain on sucrose. Surplus, the functionality of the integrated 
neo gene was successful demonstrated, which increased the resistance of 
B. succiniciproducens against kanamycin. This engineered technique was now 
available for metabolic engineering of B. succiniciproducens. 
 
 
4.2.7 Evaluation of native promoter strength to support heterologous gene 
expression in Basfia succiniciproducens 
 
Beside successful implementation of engineering strategies for B. succiniciproducens, 
we know very little about the expression of heterologous proteins in this bacterium. 
In particular, we lack knowledge on suitable promoters that can be exploited to achieve 
high expression level. As shown for various microorganisms, the strength of the 
promoter is one of the most important elements to control expression level (De Mey et 
al., 2007; Keasling, 2010; Rytter et al., 2014). So far, most studies with rumen bacteria 
describe their natural ability to produce succinic acid and the construction of superior 
mutants mainly involved the deletion of genes, rather than the integration of novel ones 
(Becker et al., 2013; Choi et al., 2016; Pateraki et al., 2016). Accordingly, our 
knowledge on suitable promoters for high-level expression of heterologous genes in 
rumen bacteria is rather limited, whereas it is even missing for B. succiniciproducens 
(Jang et al., 2007). 
For this purpose, a GFP-coupled screening system was established to determine the 
strength of native promoters of B. succiniciproducens. The aerobic test conditions 
allowed to directly use common GFP as a reporter, which requires oxygen for 
maturation (Cormack et al., 1996). In a first screening campaign, promoters which 
regulate apparently active pathways to prominent by-products, i.e. formate (pflA, pflD) 
and lactate (ldhA), were selected as potential candidates. In addition, the 
housekeeping promoter of the superoxide dismutase gene (sodC) was chosen, due to 
its beneficial properties for high-level expression in other bacteria (Becker et al., 2007).  
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Each promoter was amplified from the genome sequence of B. succiniciproducens, 
and was then cloned in front of the GFP reporter gene on the episomal plasmid 
pJFF224. The derived plasmids were namely Bsuc_PL8 (PpflDGFP), Bsuc_PL9 
(PpflAGFP), Bsuc_PL10 (PldhAGFP) and Bsuc_PL11 (PsodCGFP). The associated strains 
of B. succiniciproducens DD3 were used for expression analysis. For each promoter, 
fluorescence was proportional to the cell concentration over time, indicating a steady 
expression level during the cultivation of the reporter strains (Figure 4.12 A - D). 
This allowed quantification of the specific promoter activity from the slope of the 
obtained correlation (Figure 4.12 E). In direct comparison, the pflD promoter showed 
the highest expression, followed by PpflA, which exhibited about 60 % of PpflD activity. 
Only relatively weak expression was observed for PsodC and PldhA. The promoters of 
pyruvate formate lyase (PpflA, PpflD) enabled strongest expression within the tested set 
of homologous candidates. The promoter is efficiently induced by pyruvate (Sawers 
and Böck, 1988; Yang et al., 2001). This is promising, because pyruvate and pyruvate-
based by-products were observed in aerobic metabolism in B. succiniciproducens, as 
shown previously (Figure 4.2). The latter can help to stimulate gene expression in 
engineered hosts regarding pyruvate-based production pathways under control of the 
pflD promoter. 
Surprisingly, the sodC promoter, previously found highly active in gram-positive 
C. glutamicum (Becker et al., 2011), was not that active, as one might have expected. 
Obviously, B. succiniciproducens requires specifically selected promoters, similar to 
what is known for other microorganisms (Jang et al., 2007; Rytter et al., 2014).  
So far, nothing is known about the activity of heterologous promoters in 
B. succiniciproducens. Thus, a derivative (PEM7*) of the commonly known strong and 
constitutive PEM7 promoter (Drocourt et al., 2007) was tested randomly. This derivative 
was derived by random mutagenesis and found highly active in P. putida (Rogsch, 
2015). Surprisingly, this modified promoter was also active in B. succiniciproducens. 
A distinct experiment revealed, that PEM7* enabled an almost 290 % increase in GFP 
expression by use of the established screening system (Figure 4.13). This is a 
valuable proof, that also heterologous promoters can be used in B. succiniciproducens 
to engage heterologous gene expression. The latter broadens furthermore the 
molecular toolbox for strain engineering of B. succiniciproducens. 
It can be concluded that the identified set of promoters is a basis for directed strain 
engineering regarding heterologous gene expression. Especially the PpflD and PEM7* 
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promoters seemed to support efficient expression. The PpflD promoter is supposed to 
be efficiently used for further strain engineering of B. succiniciproducens for the 
production of the pyruvate-based product L-alanine. Without doubt, the set of newly 
identified promoters might also be useful for application in other rumen bacteria. 
 
 
Figure 4.12. Expression strength of B. succiniciproducens promoters, using green fluorescent 
protein (GFP) as reporter. Correlation between on-line recorded fluorescence at 520 nm and cell 
concentration at OD620 during growth of B. succiniciproducens DD3 reporter strains, used for estimation 
of specific promoter strength: DD3 + Bsuc_PL8 containing PpflDGFP (A), DD3 + Bsuc_PL9 containing 
PpflAGFP (B), DD3 + Bsuc_PL10 containing PsodCGFP (C), DD3 + Bsuc_PL11 containing PldhAGFP (D). 
Specific promoter activity, normalized to the strongest promoter, which was set to 100 % (E). Mean 
values and standard deviations reflect three biological replicates. The data are corrected for basal 
fluorescence of B. succiniciproducens DD3, carrying the empty plasmid pJFF224. 
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Figure 4.13. Expression strength of the heterologous EM7* promoter, using green fluorescent 
protein (GFP) as reporter. On-line recorded fluorescence at 520 nm and cell concentration at OD620 
was correlated during exponential growth of B. succiniciproducens DD3 reporter strains, used for 
estimation of specific promoter strength: DD3 + Bsuc_PL8 containing PpflDGFP (A), DD3 + Bsuc_PL104 
containing PEM7*GFP (B). Specific promoter activity, normalized to the known strong PpflD promoter, 
which was set to 100 % (C). Mean values and standard deviations reflect three biological replicates. 
The data are corrected for basal fluorescence of B. succiniciproducens DD3, carrying the empty plasmid 
pJFF224. 
RESULTS AND DISCUSSION 
58 
4.3 Application of Basfia succiniciproducens for L-alanine production 
 
In a recent study, the recombinant strain B. succiniciproducens ALA-1 was engineered 
for L-alanine production (Fabarius, 2013). By homologous recombination, a 
heterologous alanine dehydrogenase (alaD) from G. stearothermophilus XL65-6 under 
control of the previously identified strong pflD promoter, was introduced in the pflD 
gene locus. This gene was codon-optimized for B. succiniciproducens to stabilize its 
expression. B. succiniciproducens DD3 was used as the parent strain, which contains 
the ldhA and pflD gene knockout. These knockouts eliminate the production of lactate 
and formate. The latter enhanced the production of the alanine precursor pyruvate and 
derived by-products (Becker et al., 2013). This novel alanine producer strain was now 
examined in a complex medium on glucose to assess its physiology. 
 
4.3.1 Aerobic physiology of a novel alanine overproducer 
 
Taken to the shake flask, the strain grew from early on and consumed the glucose 
rapidly within 12 h. The recombinant strain produced, after a short lag phase, 
0.7 ± 0.2 g L-1 L-alanine (Figure 4.14) within 12 h, whereas the parent strain 
B. succiniciproducens DD3 did not accumulate the desired product in significant 
amounts (Figure 4.2). The overall product yield of 43.3 ± 10 mgalanine g-1glucose was 
comparably low. Most of the carbon was channeled into acetate (5.2 ± 0.2 g L-1) owing 
to the examined conditions. Additionally, 2.1 ± 0.8 g L-1 succinate were produced. 
Subsequent measurements of enzyme activities in both strains (Figure 4.15) revealed 
that B. succiniciproducens ALA-1 exhibited a specific alanine dehydrogenase activity 
of 280 ± 76 mU mg-1 during amination of pyruvate. As assumed, alanine 
dehydrogenase reaction was obviously reversible, as indicated by the deamination 
reaction of alanine combined with NAD+ during enzyme assay tests. Here, an enzyme 
activity of 43 ± 4 mU mg-1 was determined. The control strain did not exhibit activity 
(< 0.1 mU mg-1) in both reaction directions, as expected, due to lack of a native alanine 
dehydrogenase in the genome. Furthermore, both strains revealed similar activity for 
G6P dehydrogenase, analyzed as positive control (250 ± 43 mU mg-1 for DD3 and 
193 ± 25 mU mg-1 for ALA-1). 
To exclude the origin of the produced alanine from the complex fraction of the medium, 
a labelling experiment was designed. Therefore, naturally labelled glucose was 
replaced by [13C6] glucose, followed by GC/MS analysis of L-alanine, harvested from 
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the culture broth at the end of the cultivation. The fully labeled [13C3] L-alanine mass 
isotopomer was the dominating fraction, verifying its De-novo synthesis from glucose 
(Figure 4.16). 
Taken together, the results emphasize that a novel alanine producer was established. 
The next steps should examine its production capacities through process engineering. 
 
 
 
Figure 4.14. Aerobic cultivation physiology of B. succiniciproducens DD3 ALA-1 in shake flask. 
The newly constructed alanine overproducer formed 0.70 ± 0.2 g L-1 of alanine in 12 h. Measurement of 
organic acids, sugars and amino acids was conducted using HPLC. The data represent three 
independent replicates with means and deviation. 
 
 
Figure 4.15. Detection of alanine dehydrogenase activity in B. succiniciproducens DD3 and DD3 
ALA-1. To prove the expression of alanine dehydrogenase in the novel engineered strain DD3 ALA-1, 
enzyme assays were conducted. Activity of AlaD protein was shown in the modified strain DD3 ALA-1, 
whereas no activity was measured in the parent strain DD3. As positive control, glucose 6-phosphate 
dehydrogenase was assayed, which showed comparable activities for both strains. All data represent 
three independent replicates with means and deviation. 
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Figure 4.16. GC-MS analysis of TBDMS derivatized alanine from the culture supernatant of 
B. succiniciproducens ALA-1 grown on naturally labelled glucose (white bars) and on [13C6] 
glucose (grey bars). M+0, M+1, M+2, M+3 reflect the monoisotopic, the single labelled, the double 
labelled, and the triple labelled mass isotopomer, respectively. The measurement was conducted on the 
ion cluster m/z 260-263, which represents a fragment ion of the analyte that contains the entire carbon 
skeleton of alanine. 
 
4.3.2 Metabolic overflow at the pyruvate-node impairs efficient alanine 
production 
 
Taken to an aerobic fed-batch environment in lab scale bioreactors, alanine production 
from glucose using B. succiniciproducens ALA-1 could be increased to 7.2 ± 1.0 g L-1 
within 36 h (Figure 4.17). This was accompanied by strong formation of acetate and 
pyruvate, which impaired overall production performance significantly. The process 
was operated as a fed-batch with an initial batch phase and pulse-wise feeding, 
coupled to the level of dissolved oxygen via the on-line signal of the oxygen probe. 
The cells grew from early on and reached a cell concentration of about 11 ± 0.1 g L-1 
after 5 hours, accompanied by a μmax of 0.74 ± 0.01 h-1. A single feed pulse after 
3 hours, triggered by a sudden rise in the dissolved oxygen signal, led to a transiently 
increased glucose level, but did not negatively impact growth. About 2.5 g L-1 of 
L-alanine was produced during the initial batch phase. Up to this point of the 
fermentation, acetate was the dominating by-product and reached about 
17.6 ± 0.4 g L-1.  
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With depletion of glucose after 5 hours, cell growth stopped and the automated feed 
addition was initiated. The entry into glucose limitation caused an interesting switch in 
the growth mode. For a short period of about 2 hours, excreted pyruvate and  acetate, 
together with L-alanine, were taken up by the cells again, likely to maintain high carbon 
influx. Subsequently, L-alanine production was re-activated and continued on a high 
level until the end of the process, when the final titer was reached. Interestingly, acetate 
accumulation ceased shortly after cell growth had stopped and the acetate level 
remained constant further on. Pyruvate was secreted for a longer time up to 
12.0 ± 0.5 g L-1, but finally also stopped, leading to a purely L-alanine producing 
process. 
 
 
Figure 4.17. Aerobic fed-batch production of L-alanine by B. succiniciproducens ALA-1 from 
glucose. An initial batch phase was followed by a carbon limiting feed phase via dissolved oxygen 
based feeding. A pure alanine production process (A) was observed, yielding 7.2 ± 1.0 g L-1 alanine. 
Predominantly, acetate and pyruvate were produced (B). The data shown represent biological 
duplicates with mean values and deviations. 
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4.3.3 Screening of industrial relevant substrates under different process 
conditions 
 
To determine the alanine production capabilities of the strain, a set of experiments now 
investigated the impact of the carbon source under different production conditions. In 
addition to glucose, fructose, sucrose, xylose and glycerol were tested (Figure 4.18). 
B. succiniciproducens ALA1 was grown aerobically on the different substrates (Figure 
4.18 A). Interestingly, the final titer for L-alanine was highest on xylose. The achieved 
amount (1.7 ± 0.1 g L-1) exceeded that observed for glucose by more than 140 %. In 
comparison, fructose and sucrose led to only weak formation of L-alanine, whereas the 
performance on glycerol was similar to glucose-grown cells. Acetate formation was 
rather unaffected by the carbon source. 
Subsequently, the different carbon sources were also tested under anaerobic 
conditions. Since several studies revealed superior performances under oxygen 
deprivation (Jojima et al., 2010; Yamamoto et al., 2012; Zhang et al., 2007; Zhou et 
al., 2015), a N2 atmosphere was applied (Figure 4.18 B). Generally, L-alanine 
production was significantly higher as compared to aerobic conditions whereas 
biomass yield decreased substantially. Coherently, acetate formation was strongly 
lowered, indicating a carbon re-direction from acetate to the product, and also a 
connection between growth and acetate production, as observed before. Again, xylose 
enabled the highest product titer (7.9 ± 0.1 g L-1), which was more than 30 % higher 
than that on glucose (5.8 ± 0.1 g L-1). Fructose and sucrose also led to high levels of 
L-alanine, but the production was slightly lower than that achieved on the pentose. 
Glycerol was found rather non suitable under these conditions, due to missing growth 
of the cultures under the applied conditions. On this carbon source, the mutant 
produced below 1.0 ± 0.0 g L-1 L-alanine. 
Apparently, xylose appeared to be a superior carbon source for alanine production, as 
indicated by the results. Additionally, the strong influence of the anaerobic environment 
led furthermore to an improved alanine titer of 370 %, when aerobic and anaerobic 
conditions on xylose were compared directly. The excellent performance on xylose is 
highly promising, as the pentose can be obtained from lignocellulosic biomass 
(Takisawa et al., 2017). Xylose is regarded as the second abundant sugar in 
lignocellulose after glucose, and is the major component accounting for more than 
30 % and 90 % in cellulosic and hemicellulosic hydrolysates, respectively (Van Dyk 
and Pletschke, 2012). 
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Figure 4.18. Impact of the carbon source on L-alanine production in engineered 
B. succiniciproducens ALA-1. The data shown represent final values, obtained after 24 h of cultivation 
under aerobic conditions (A) and after 48 h under anaerobic conditions (N2 atmosphere) (B). In all cases, 
the initially added substrate (15 g L-1 glucose (glc), fructose (frc), sucrose (sucr), xylose (xyl) and glycerol 
(glyc)) was completely consumed (except anaerobic glycerol test due to lacking growth) at the time point 
of sampling. The data represent biological duplicates with mean values and deviations. 
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4.3.4 Optimization of xylose-based L-alanine production using different gas 
atmospheres 
 
Xylose was studied in more detail, due to its superior efficiency for L-alanine 
production. Different culture conditions were compared to identify the most promising 
set-up. Grown aerobically, B. succiniciproducens ALA-1 completely consumed xylose 
in about 24 h and accumulated L-alanine to a final concentration of 1.7 ± 0.1 g L-1 
(Figure 4.19 A). Acetate was still the main product (6.4 ± 0.2 g L-1). In addition, small 
amounts of succinate were formed (1.3 ± 0.2 g L-1). Biomass was formed, particularly 
during the initial phase of the cultivation. The production was next operated as a two-
stage process in order to combine the good growth performance of the aerobic cultures 
during the first hours (Figure 4.19 A) with the good L-alanine production performance 
under anaerobic conditions (Figure 4.18 B).  
In two alternative settings, the initial aerobic growth phase was coupled to a second 
production phase under pure CO2 and under pure N2 as gas phase (Figure 4.19 B 
+ C). The initial growth phase indeed allowed fast biomass formation and xylose 
consumption. Acetate was inherently formed as a side product and reached a 
concentration of about 2.5 ± 0.1 g L-1 at the end of the growth phase after 10 hours. 
Slight formation of alanine was observed during this phase as well.  
After the switch to the CO2 atmosphere, cells continued to consume xylose, but now 
exhibited a strongly changed production behavior: L-alanine accumulation increased 
significantly, whereas acetate formation stopped immediately (Figure 4.19 B). After 
36 hours, the final L-alanine titer was 3.1 ± 0.0 g L-1. Driven by the CO2 atmosphere, 
succinate formation was relatively strong and the compound reached a final level of 
9.3 ± 0.4 g L-1. Increased availability of CO2 is regarded as major driver of 
phosphoenolpyruvate carboxykinase (Kim et al., 2009) and subsequent anaplerotic 
fueling of the reductive TCA cycle leading to the observed succinate accumulation. 
In contrast, pyruvate was completely abolished as side product. The concentration of 
acetate did not change during the production phase and thus seemed to be coupled to 
the aerobic conditions of the initial growth phase. Underlined by the 80 % increased 
product titer, the overall production characteristics were improved compared to the 
aerobic process. 
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The cultures, incubated under N2 during the production phase, showed an even better 
performance (Figure 4.19 C). Under these conditions, the mutant achieved a final 
L-alanine titer of 6.4 ± 0.2 g L-1. The elevated formation of the amino acid was linked 
to a reduction in succinate formation (6.9 ± 0.8 g L-1) by 25 %. This example 
demonstrated that it is possible to shift alanine to a main product of the metabolism of 
B. succiniciproducens ALA-1. 
These results demonstrate successfully the shift of the product spectrum from acetate 
and succinate to predominantly alanine by using aerobic conditions, CO2 or N2, 
respectively. Under commonly used growth conditions, i.e. glucose and elevated levels 
of CO2, the recombinant strain B. succiniciproducens ALA-1 still produced L-alanine 
poorly, but rather showed the typically described strong accumulation of succinate 
instead. Selected rumen bacteria have been shown to secrete small traces of 
L-alanine, among other amino acids from sugars (Stevenson, 1978). Moreover, none 
of the studied strains so far exhibited significant overproduction of L-alanine or related 
carbon-three chemicals (Becker et al., 2013; Becker and Wittmann, 2012b; Choi et al., 
2013; Choi et al., 2016; Schindler et al., 2014; Xi et al., 2013). The next step regarded 
lab scale bioreactor experiments to uncork the full potential of the investigated strain. 
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Figure 4.19. L-alanine production in engineered B. succiniciproducens ALA-1 from xylose. 
Aerobic conditions (A) were compared to a two-phase process with an initial aerobic growth phase, 
followed by an anaerobic production phase under a CO2 atmosphere (B) and in a two-phase process 
with an initial aerobic growth phase, followed by an anaerobic production phase under a N2 atmosphere 
(C). Data reflect mean values and deviations from three biological replicates. 
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4.3.5 Batch production of L-alanine from xylose under N2 atmosphere 
 
The production of alanine was next studied in lab scale bioreactors, operated in batch 
mode (Figure 4.20). In order to support process efficiency, cells were inoculated to a 
comparably high initial concentration of about 7.0 ± 0.2 g L-1 cell dry mass. 
Under microaerobic conditions without gassing (Figure 4.20 A-C) 
B. succiniciproducens ALA-1 consumed xylose from early on and completely depleted 
the carbon source within only 3 hours. This was accompanied by rapid L-alanine 
production. After 3 h, a final titer of 25.2 ± 1.8 g L-1 was reached, matching a product 
yield of 0.49 ± 0.03 galanine gxylose-1. The maximum specific productivity was 
2.3 ± 0.0 g g-1 h-1. During the incubation, the cell concentration remained rather 
constant. A fraction of the substrate carbon was channeled into acetate (2.6 ± 0.3 g L-1) 
and into succinate (10.6 ± 0.6 g L-1). 
A strictly anaerobic atmosphere with N2 gassing (Figure 4.20 D-F) was even better for 
production. The product titer (27.0 ± 2.2 g L-1) and the product yield (0.60 ± 0.03 g g-1) 
were substantially higher except the maximum specific productivity (1.9 ± 0.0 g g-1 h-
1). In addition, production was much more selective. The formation of succinate (6.5 ± 
0.5 g L-1) was reduced by 40 %, while the formation of acetate (0.54 ± 0.18 g L-1) was 
diminished. Similar to the microaerobic process (Table 4.2), the conversion was 
completed within 3 h, whereby the cell concentration stayed relatively constant. 
The developed strain achieved the excellent performance of a recent recombinant 
E. coli (Zhang et al., 2007). The basic producer E. coli XZ111 also expresses alanine 
dehydrogenase from a single genomic copy and lacks competing pathways to 
pyruvate-based by-products and therefore appears most straightforward for direct 
comparison of the two microbes. In batch culture, the titer (25 g L-1) was 40 % higher 
for B. succiniciproducens ALA-1, as compared to the glucose-grown E. coli strain, and 
the overall specific productivity (2.3 g g-1 h-1) surpassed the value by the E. coli 
producer more than twentyfold. Although significantly suppressed in cells, grown on 
xylose under N2, the formation of succinate was not completely eliminated. This is one 
major reason for the suboptimal yield and remains to be addressed in future 
developments, as E. coli enables practically exclusive production of L-alanine. Low 
levels of formed lactate correspond to the methylglyoxal pathway (Grabar et al., 2006), 
because lactate dehydrogenase was deleted in the B. succiniciproducens ALA-1 
genome, suggesting straightforward strain engineering. 
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Figure 4.20. Batch production of L-alanine from xylose in lab-scale bioreactors using B. 
succiniciproducens ALA-1. Microaerobic conditions without gassing (A-C) and anaerobic conditions 
with N2 gassing (D-F) were deployed. Data reflect mean values and deviations from two biological 
replicates. 
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4.3.6 Fed-batch production of L-alanine from xylose 
 
Finally, the producing strain was evaluated in a fed-batch environment using again 
xylose as carbon source. A first setup coupled an initial aerobic batch phase for growth 
with a subsequent anaerobic feed phase (N2) for production (Figure 4.21 A-C). 
The cells consumed xylose from early. After already 2 hours, the substrate level had 
decreased to about 6.0 ± 0.2 g L-1, which then triggered the start of the feed and the 
switch in the gas supply from air to N2. During this initial batch phase, a cell dry mass 
concentration of about 2.4 ± 0.2 g L-1 was reached. In addition, about 2.0 ± 0.0 g L-1 of 
L-alanine was produced. Growth was linked to the accumulation of acetate 
(3.5 ± 0.0 g L-1) as observed previously. Immediately after the change in the cultivation 
mode, cell growth and acetate formation stopped. From the on-set of the feed addition 
until the very end of the process, the xylose level remained within the desired corridor 
between 5 and 15 g L-1. Within 48 hours, 28.2 ± 2.0 g L-1 L-alanine was formed. 
The overall product yield was 0.50 ± 0.02 g g-1 and the maximum specific productivity 
was 1.7 ± 0.1 g g-1 h-1. It was interesting to note that the different production phases 
had a strong impact on by-product formation. Succinate did not accumulate during the 
aerobic growth phase, but was formed after the switch to the anaerobic conditions. 
After about 9 hours, cells revealed a switch in their product spectrum. While succinate 
production slowed down significantly, small amounts of lactate and pyruvate were 
formed. 
A second setup was designed as fully anaerobic process with N2 supply (Figure 4.21 D-
F). Here, B. succiniciproducens ALA-1 grew during the first 24 hours up to a cell dry 
mass concentration of 2.5 g ± 0.2 L-1, which then remained constant until the end of 
the process. After 60 h, a final titer of 29.4 ± 2.4 g L-1 L-alanine was reached, 
corresponding to a product yield of 0.60 ± 0.1 g g-1. The maximum specific production 
rate was 1.7 ± 0.2 g g-1 h-1. Compared to batch processes, it was not possible to 
achieve higher titers by the fed-batch process. There seems to be a bottleneck 
hampering the alanine productivity of the cells in later process stages. 
An overview over the conducted processes with B. succiniciproducens ALA-1 is 
summarized in Table 4.2. Given that additional rounds of metabolic engineering and 
strain evolution further improve performance, as impressively demonstrated for E. coli 
(Zhang et al., 2007), B. succiniciproducens ALA-1 exhibits highly promising potential 
to be further developed towards industrial L-alanine production. 
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Figure 4.21. Fed-batch production of L-alanine from D-xylose using B. succiniciproducens ALA-1. 
One process design combined a dual-phase process with an initial aerobic batch phase, followed by an 
anaerobic production phase with N2 gassing (A-C). Additionally, a two-stage process divided in the 
aerobic biomass preparation followed by a subsequent anaerobic process with N2 gassing was used 
(D-F). The data shown represent biological duplicates with mean values and deviations. CDM, Cell dry 
mass. 
 
Table 4.2. Production of L-alanine by B. succiniciproducens ALA-1 using batch and fed-batch 
production with xylose as the carbon source. The data given comprise the final L-alanine titer, the 
specific substrate uptake rate (qS), the maximum specific L-alanine production rate (qP, max), the 
maximum volumetric productivity (QP, max), and the product yield and reflect mean values and deviations 
from duplicates. 
 
Substrate Process L-alanine 
[g L-1] 
qSa 
[g g-1 h-1] 
qp, max  
[g g-1 h-1] 
Qp, maxb  
[g L-1 h-1] 
YP/Sc 
[g g-1] 
Xylose Microaerobic 
batch 
25.20 
± 1.84 
2.41 
± 0.04 
2.27 
± 0.01 
8.40 
± 0.50 
0.48 
± 0.04 
Xylose Anaerobic 
batch (N2) 
27.00 
± 2.20 
2.19 
± 0.05 
1.87 
± 0.04 
9.00 
± 0.59 
0.60 
± 0.05 
Xylose 
Aerobic batch, 
Anaerobic 
feed phase 
(N2) 
28.16 
± 2.00 
2.1  
± 0.06 
1.67 
± 0.14 
0.59 
± 0.03 
0.50 
± 0.02 
Xylose Anaerobic fed-
batch (N2) 
29.35 
± 2.40 
1.61 
± 0.09 
1.69 
±  0.16 
0.49 
± 0.03 
0.60 
± 0.06 
a The specific substrate uptake rate refers to the batch phase of each experiment 
b The volumetric productivity refers to the mean value of the total process 
c For the fed-batch processes, the yield refers to the value obtained during the feed phase 
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4.3.7 Basfia succiniciproducens ALA-1 is a promising strain for L-alanine 
production. 
 
As shown, B. succiniciproducens ALA-1 was used as a host for L-alanine production. 
The double deletion mutant B. succiniciproducens ∆ldhA ∆pflD, previously designated 
B. succiniciproducens DD3, was selected as host, because it already exhibited the 
desired feature of lacking the pathways to major competing by-products (Becker et al., 
2013; Scholten and Dägele, 2008). Rumen bacteria belonging to the Pasteurellaceae 
group, such as M. succiniciproducens (Hong et al., 2004), A. succinogenes (Guettler 
et al., 1999), and B. succiniciproducens (Kuhnert et al., 2010), are described as 
capnophilic microbes, which naturally use fumarate as the final electron acceptor and 
secrete succinate, while efficiently fixing CO2. This results in enormous succinic acid 
yields up to 75 % even in wild types (Becker et al., 2013). Accordingly, research so far 
has focused to further explore this biosynthetic potential and breed strains for elevated 
production of succinic acid and other related carbon-four chemicals from the reductive 
TCA cycle (Becker et al., 2013; Choi et al., 2013; Choi et al., 2016; Pateraki et al., 
2016; Salvachúa et al., 2016). 
Interestingly, B. succiniciproducens excretes pyruvate-derived metabolites, when the 
pathways of the natural by-products lactate and formate are interrupted on genome 
level (Becker et al., 2013). Hence, beyond previous work, it was shown that the product 
spectrum of rumen bacteria can be significantly altered towards pyruvate-based 
products and that this relies on combined efforts of metabolic and bioprocess 
engineering. In particular, the expression of the used heterologous alaD gene had to 
be high enough to mediate sufficient enzymatic activity for alanine production. 
Here, the promoter of the pyruvate formate lyase was later found capable to enable 
the excellent performance of the created L-alanine producing strain under aerobic or 
either anaerobic conditions. The full metabolic potential of the strain was released, 
when cells were grown under N2 gassing with the lignocellulose based substrate 
xylose. Gassing resulted in low levels of CO2, as endogenously formed CO2 was 
continuously stripped out of the culture resulting in lowered succinate production. 
This enhanced the availability of carbon for alanine formation drastically. Beyond 
L-alanine, the present findings open interesting possibilities to re-engineer 
B. succiniciproducens and related rumen bacteria for other carbon-three products of 
industrial relevance such as pyruvate (Zhu et al., 2008) and lactate (Tsuge et al., 2015), 
among others. 
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4.4 Metabolic engineering for β-alanine production 
 
B. succiniciproducens is known as a strong succinate overproducer (Becker et al., 
2013; Lange et al., 2017). Thus, further engineering to use this capability for other 
products derived from succinate or related precursors seemed promising. As example, 
the related succinate-producer M. succiniciproducens was re-modified for the 
production of 4-hydroxybutyrate, a precursor of the carbon-four chemical 
γ-butyrolactone (GBL) (Choi et al., 2013). In fed-batch mode about 6 g L-1 of 
4-hydroxybutyrate were produced by an engineered strain, which indicates that rumen 
bacteria are able to produce further carbon-four products beside succinate. 
The molecule of interest in this work, β-alanine, is the precursor of 
3-hydroxypropionate, a platform chemical (Werpy et al., 2004). Aspartate, the 
precursor of β-alanine (Leonardi and Jackowski, 2007), is linked to the succinate 
pathway (Figure 4.23). 
In B. succiniciproducens oxaloacetate is converted to aspartate by an aspartate 
aminotransferase (tyrB, DD1033, 1263 bp, 421 amino acids, KEGG database), using 
glutamate as amino group donor (Fotheringham et al., 1986; Schuster et al., 1999). 
Additionally, aspartate is connected to the fumarate node by three reactions, 
comprising first the direct amination by an aspartate ammonia-lyase (aspA, DD0770, 
1398 bp, 466 amino acids, KEGG database). The other two reactions proceed via 
adenylo-succinate and L-arginino-succinate, which are part of purine metabolism and 
arginine biosynthesis, respectively (Aimi et al., 1990; Sakanyan et al., 1996; Wang et 
al., 1995). The product of interest, β-alanine, can be derived from aspartate by an 
aspartate 1-decarboxylase (panD) (Dusch et al., 1999). This enzyme or any other 
β-alanine producing or consuming enzyme, however, is not found by BLAST search in 
neither the M. succiniciproducens nor the B. succiniciproducens genome 
(KEGG database). 
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4.4.1 Wild type Basfia succiniciproducens does not form β-alanine 
 
When B. succiniciproducens DD3, harboring the empty episomal vector pJFF224-XN, 
was grown in glucose minimal medium supplemented with aspartate (Figure 4.22 A+B) 
or β-alanine (Figure 4.22 C+D), neither β-alanine formation nor substantial β-alanine 
consumption was observed. This confirmed the computationally predicted lack of β-
alanine formation and consumption in B. succiniciproducens. 
 
 
 
Figure 4.22. Anaerobic growth physiology of B. succiniciproducens DD3, harboring the empty 
vector pJFF224-XN, in serum bottles. To detect β-alanine formation or consumption, cultivation in 
minimal medium under CO2 atmosphere was conducted. The constructed strain showed a similar 
behavior compared to the parent strain. Supplementation of aspartate (A+B) enhanced succinate 
formation, due to anaplerotic fueling of the TCA cycle by conversion of aspartate to oxaloacetate and 
fumarate. Supplementation with β-alanine (C+D) did not affect the performance parameters of the strain. 
Furthermore no substantial consumption of β-alanine was detectable. Measurement of organic acids, 
sugars and amino acids was conducted using HPLC. The data represent three independent replicates 
with means and standard deviations. CDM, Cell dry mass. 
 
 
RESULTS AND DISCUSSION 
74 
4.4.2 Aspartate 1-decarboxylase depicts a possible entry point to β-alanine 
synthesis 
 
In a previous study, aspartate 1-decarboxylases from E. coli and C. glutamicum were 
shown to catalyze the decarboxylation of aspartate into β-alanine, encoded by the 
panD gene (Dusch et al., 1999). To test the suitability of the E. coli and C. glutamicum 
panD genes for β-alanine synthesis, they were expressed in B. succiniciproducens. 
The “β-alanine production module” was designed in a combinatorial way (Figure 4.23). 
Different promoter-gene combinations, cloned onto the episomal Pasteurellacea vector 
pJFF224-XN (Frey, 1992), were used to identify the most suitable combination. 
 
 
 
Figure 4.23. Reconstruction of B. succiniciproducens DD3 metabolism for β-alanine production. 
The succinate pathway, specifically aspartate from oxaloacetate and fumarate, was identified as a 
promising precursor supplier for β-alanine synthesis. A corresponding aspartate 1-decarboxylase, 
encoded by the gene panD, was identified for heterologous β-alanine production, which can be 
supported by aspartate feeding. Two alternative sources were regarded, E. coli and C. glutamicum. 
A codon-optimized version (indicated by a +) of the panDcgl gene was additionally tested. 
Abbreviations of chemicals are GLC, glucose; PEP, phosphoenolpyruvate; ATP, adenosine 
triphosphate; ADP, adenosine diphosphate; CO2, carbon dioxide; OAA, oxaloacetate; FUM, fumarate; 
NH3, ammonia; SA, succinic acid; GLU, glutamate; A-KGL, α-ketoglutarate; ASP, aspartate; β-ALA, 
β-alanine. 
 
 
 
 
 
  RESULTS AND DISCUSSION 
  75 
4.4.3 Screening for suitable heterologous enzymes for β-alanine synthesis 
 
In the beginning, the identified promoters PpflD and PEM7* were used to implement the 
β-alanine production module in the strain B. succiniciproducens DD3. Thus, cloning of 
panDeco and panDcgl was conducted, yielding the plasmids Bsuc_PL25, Bsuc_PL26 
and Bsuc_PL47, respectively (Figure 6.3). 
The lack of conversion or production of β-alanine in the basic strain 
B. succiniciproducens DD3 + pJFF224-XN, allowed direct screening for suitable panD 
genes, via the resulting β-alanine production from aspartate during anaerobic 
cultivation (Figure 4.24). The cells consumed glucose and aspartate right from the 
beginning (Figure 6.4). The control strain and the strain containing the panD gene from 
E. coli did not show substantial β-alanine formation (Figure 4.24). In contrast, the use 
of the panDcgl gene from C. glutamicum enabled the formation of 39 ± 1 mg L-1 and 
90 ± 3 mg L-1 β-alanine when PpflD or PEM7* were used as promoters, respectively. 
The supplied aspartate was not quantitatively converted to β-alanine. The main fraction 
of the 5 g L-1 of aspartate was channeled into the metabolism elsewhere, most likely 
into the reductive branch of the TCA cycle, and thus consequently into succinate as 
shown by the succinic acid titer (Figure 6.4). 
The use of the obviously stronger EM7* promoter enabled a 130 % higher β-alanine 
formation. This PEM7* mediated expression was stronger as compared to that under 
control of the pflD promoter. Still, the β-alanine formed was rather low. To enhance the 
production, the (NH4)2SO4 supplementation was varied, to enforce the aspA driven 
reaction, and to improve the performance of the implemented β-alanine production 
module. 
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Figure 4.24. Comparison of basic β-alanine producers of B. succiniciproducens. To detect 
β-alanine formation, anaerobic cultivation in glucose minimal medium using aspartate feeding was 
conducted. After 48 h, the PpflD mediated expression of panD from E. coli did not show substantial 
β-alanine production, like the control strain. In contrast, 39 mg L-1 was produced using the panD gene 
from C. glutamicum under same promoter control. Using the PEM7* and panDcgl enhanced the β-alanine 
formation up to 89 mg L-1. Measurement of amino acids was conducted using HPLC. The data represent 
three independent replicates with means and deviation. Cultivation profiles are added to the appendix 
(Figure 6.4). 
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4.4.4 Determination of the optimal ammonium sulphate concentration 
 
The initial concentration of (NH4)2SO4 in the minimal medium was varied, to determine 
the optimal concentration for β-alanine production. This appeared important, because 
the precursor aspartate is derived mainly from fumarate, as shown for E. coli (Song et 
al., 2015). The AspA protein uses NH3 directly for fumarate amination, which is more 
controllable than the transamination reaction catalyzed by the AspC protein. As a 
consequence, the intracellular (NH4)2SO4 concentration, which is depending on 
extracellular concentration, plays a role in precursor supply.  
The minimal medium contained initial concentrations of 2, 4 and 9 g L-1 (NH4)2SO4 for 
cultivation of B. succiniciproducens DD3 PEM7*panDcgl (Figure 4.25 A-C). To study how 
the different (NH4)2SO4 concentrations support the β-alanine formation, the same 
experiment was conducted with 5 g L-1 aspartate (Figure 4.25 D-F). Samples were 
taken after 48 h and processed by HPLC analysis. This revealed that β-alanine 
formation was possible without supplementing aspartate, whereby the (NH4)2SO4 
amount had an impact on the β-alanine formation. The maximum production 
(62 ± 1 mg L-1) was detected, using 4 g L-1 of supplemented ammonium (Figure 
4.25 B). When 2 g L-1 (Figure 4.25 A) or 9 g L-1 (Figure 4.25 C) of (NH4)2SO4 were 
supplemented, 35 ± 9.0 mg L-1 and 41 ± 0 mg L-1 of β-alanine were formed, 
respectively.  
A maximum β-alanine titer of 100 ± 1 mg L-1 was reached when aspartate was 
supplemented, accompanied by use of 4 g L-1 (NH4)2SO4. When 2 g L-1 (NH4)2SO4 was 
supplied, the β-alanine titer decreased slightly. In contrast, the highest (NH4)2SO4 
concentration (9 g L-1) caused a decrease of the β-alanine titer (50.3 ± 0.9 mg L-1 
β-alanine). 
The highest ammonium supplementation decreased growth substantially, either 
without or with aspartate supplementation. This seemed one reason for the lowered 
β-alanine production under these conditions. To implement these results in further 
β-alanine production experiments, 4 g L-1 of (NH4)2SO4 were added. 
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Figure 4.25. Influence of varied (NH4)2SO4 supplementation on β-alanine formation using B. 
succiniciproducens DD3 + PEM7*panDcgl. The strain was anaerobically grown in minimal medium for 
48 h before sampling. Different concentrations of (NH4)2SO4 (2 g L-1: A+D; 4 g L-1: B+E; 9 g L-1: C+F) 
were used. For comparison, the minimal medium was used lean (A, B, C) or with supplementation of 
5 g L-1 aspartate (D, E, F). Measurement of β-alanine was conducted using HPLC. The data represent 
duplicates with means and deviation 
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4.4.5 Codon optimization of the panD gene 
 
To increase and stabilize the expression of the panD gene from C. glutamicum, and 
consequently the corresponding enzyme activity, a codon-optimized version was 
synthesized (Sequence 6.1). The codon-optimized panDcgl+ gene was cloned onto the 
pJFF224-XN vector under control of the pflD or the EM7* promoter, yielding 
Bsuc_PL80 (PEM7*panDcgl+) and Bsuc_PL86 (PpflDpanDcgl+) (Figure 6.5). 
Minimal medium cultivation of the constructed strains was conducted (Figure 4.26). 
As before, 5 g L-1 aspartate was either supplemented (Figure 4.26 A-C, G-I) or omitted 
(Figure 4.26 D-F, J-L) from the medium. The strains revealed a similar physiology as 
before. Glucose was consumed from early on. The strain DD3 PpflDpanDcgl+ produced 
42.5 ± 0.0 mg L-1 β-alanine without aspartate and 38 ± 0.0 mg L-1 with aspartate 
supplementation. Increased production of about 105.3 ± 4.9 mg L-1 β-alanine was 
observed for DD3 PEM7*panDcgl+, which was even improved further 
(187.6 ± 10.2 mg L-1), when aspartate was supplemented. The strains grew up to a 
biomass concentration of about 2 gCDM L-1 and 3.5 gCDM L-1 without and with aspartate 
supplementation, respectively. The biomass formation was clearly enhanced, when 
aspartate was supplied. Aspartate supplementation again enhanced succinate 
formation. Here, an increase from 19.9 ± 0.2 g L-1 (Figure 4.26 B+H) to 23.4 ± 0.2 g L-1 
succinate (Figure 4.26 E+K) was observable.  
Regarding β-alanine production, the EM7* promoter was found superior, as observed 
before. Coupling the strong EM7* promoter and the optimal codon usage of the panDcgl 
gene, the β-alanine production was improved by 163 %, as compared to the first 
generation producer strain DD3 PpflDpanDcgl. When the direct precursor aspartate was 
supplied, the production was even enhanced by 369 %. 
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Figure 4.26. Comparison of anaerobic growth physiology of second generation β-alanine 
producer strains of B. succiniciproducens DD3. The strains B. succiniciproducens DD3 + 
PpflDpanDcgl+ (A-C, D-F) and DD3 PEM7*panDcgl+ (G-I, J-L) contain a codon-optimized version (indicated 
by the +) of the panDcgl gene. A subsequent cultivation under anaerobic (CO2) conditions in glucose 
minimal medium was conducted. For comparison, medium was used lean (A, G) or supplemented with 
5 g L-1 aspartate (D, J). Native succinate production (B, H) was found to be improved by aspartate 
supplementation (E, K) confirming a drain of aspartate carbon into succinate. Although, no substantial 
increase in β-alanine production was detected (42.5 mg L-1 in 42 h), when pflD promoter was used, 
either with aspartate. An improvement to 105 mg L-1 of β-alanine was reached, when the EM7* promoter 
was deployed in combination with the codon-optimized panDcgl+ gene. A further improvement of about 
78 % (187 mg L-1) was achieved, when the latter was supplied with aspartate. Measurement of organic 
acids, sugars and amino acids was conducted using HPLC. The data represent three independent 
replicates with means and standard deviations. CDM, Cell dry mass. 
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4.4.6 Harnessing the panP gene from Vibrio natriegens for β-alanine production 
 
Due to the low titers, the used panD genes appeared non-optimal for β-alanine 
production in B. succiniciproducens. Commonly, β-alanine is synthesized by similar 
pyruvoyl-dependent PanD proteins, which are found in many organisms, e.g. E. coli 
and C. glutamicum (Dusch et al., 1999; Stuecker et al., 2012). This enzyme is 
expressed as an inactive pro-protein and is then cleaved to yield the active protein 
(Stuecker et al., 2012). This mechanism, however, might have been not properly 
functioning in B. succiniciproducens. 
Recent work (Pan et al., 2017) uncovered, that another protein family, namely PanP, 
provides also aspartate 1-decarboxylase activity, but is suggested to be pyridoxal-
dependent. The PanP proteins are commonly found in a number of marine bacteria, 
including Vibrio fischeri (Pan et al., 2017). The lately evoked interest in the marine 
bacterium V. natriegens (Fernández-Llamosas et al., 2017; Hoffart et al., 2017; Lee et 
al., 2016; Long et al., 2017; Maida et al., 2013; Weinstock et al., 2016) was a trigger 
to search for such a panP gene in this microbe. 
A BLAST search on the protein level, using the V. fischeri PanP protein (glutamate 
decarboxylase, EC 4.1.1.15, KEGG entry: VF0892) against the V. natriegens genome 
was conducted. This identified a homologous protein (86 %), annotated as a glutamate 
decarboxylase (glutamate decarboxylase, EC 4.1.1.15, KEGG entry: PN96_07390). 
On DNA level, 72 % similarity was found. This protein (548 amino acids) is longer than 
the PanD protein (136 amino acids). This implicates different properties or even 
reaction mechanisms, which could be more suitable for β-alanine synthesis in 
B. succiniciproducens than the examined PanD proteins. No evidence of such a PanP 
related protein in B. succiniciproducens was found by BLAST search. 
It was not known if this protein produces β-alanine from aspartate. The gene 
PN96_07390 was cloned onto pJFF224-XN under PEM7* control, yielding Bsuc_PL105 
(Figure 6.6). Subsequent cultivation of the cloning host E. coli DH10B in minimal 
medium, revealed substantial De-novo production of β-alanine, as compared to the 
control strain, containing only the empty vector pJFF224-XN (Figure 6.7). 
After subsequent construction of the corresponding B. succiniproducens strain (Figure 
6.6), a minimal medium cultivation either without or with 5 g L-1 aspartate 
supplementation was conducted (Figure 4.27). Deploying the panP gene enabled 
significant β-alanine formation in B. succiniciproducens. The titer increased to 
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161 ± 11 mg L-1 without aspartate supplementation (Figure 4.27 A+B). 
When aspartate was added, even 446 ± 31 mg L-1 β-alanine was formed, but cell 
growth was somehow impaired (Figure 4.27 C+D). Additionally, the depletion of the 
supplied aspartate, was accompanied by a decreased β-alanine production rate. 
While aspartate was available, a volumetric productivity of 26.7 mg β-alanine L-1 h-1 
was observed. After the aspartate was consumed, this value decreased to 2.8 mg L-1 
h-1, almost similar compared to the cultivation without aspartate (6.5 mg L-1 h-1). 
This indicated that aspartate supply is a bottleneck in the synthesis of β-alanine in 
B. succiniciproducens, independently of the used aspartate 1-decarboxylase. 
Taken together, use of the novel panP gene enabled highest β-alanine production 
performance compared to the best second generation strain, which contained the 
panDcgl+ gene. Future codon optimization of the V. natriegens panP might further 
improve the performance. 
 
 
Figure 4.27. Growth physiology of a B. succiniciproducens DD3 strain containing the panPvna 
gene from V. natriegens under PEM7* control. Glucose minimal medium was used either lean or with 
5 g L-1 of aspartate supplementation. An increased β-alanine production was observed in lean medium 
(160 mg L-1). The latter was improved by aspartate supplementation to about 450 mg L-1. 
Organic acids, sugars and amino acids were measured using HPLC. The data represent three 
independent replicates with means and deviation. CDM, Cell dry mass. 
  RESULTS AND DISCUSSION 
  83 
Next, enzyme assays for the implemented PanD aspartate 1-decarboxylases were 
conducted (Table 6.3). In short, the negative control showed no formation of β-alanine 
and no aspartate consumption, respectively (Figure 4.28 A). The control strain 
revealed no β-alanine formation, but consumption of aspartate (10.8 mg L-1 h-1) (Figure 
4.28 B). The crude extract, containing the native PanDcgl enzyme, showed a β-alanine 
formation rate of 4.5 ± 0.3 mg L-1 h-1, corresponding to a specific activity of 4.6 ± 0.3 
mU mgprotein-1 (Figure 4.28 C + F). The aspartate consumption was increased (16.8 
mg L-1 h-1) compared to the control, due to the additional aspartate depletion by 
PanDcgl. An increased β-alanine formation (7.4 ± 0.6 mg L-1 h-1) (Figure 4.28 D) was 
observed, using the codon-optimized panDcgl+ gene, corresponding to a specific activity 
of 7.3 mU mg-1 (Figure 4.28 F). Obviously, the codon optimization improved gene 
expression, and consequently the specific activity of PanDcgl by 59 %. PanP showed a 
loss of activity after 1 h of incubation. A substantial lower specific activity of 
1.2 ± 0.6 mU mg-1 was derived from the data, although this enzyme was shown to yield 
better producer strains than the PanDcgl enzyme. It was assumed, that the used assay 
conditions were not suitable for this type of enzyme, due to a lack of pyridoxal 
5-phosphate. Therefore, supplementation of pyridoxal 5-phosphate and selected 
assay conditions (Pan et al., 2017) were tested in an additional PanP enzyme assay. 
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Figure 4.28. Results of the PanD aspartate 1-decarboxylase assay. Crude extracts of 
B. succiniciproducens DD3 + PEM7*panDcgl, DD3 + PEM7*panDcgl+, DD3 + PEM7*panPvna and the control 
strain, containing pJFF224-XN, were used for the aspartate 1-decarboxlase assay. The water control 
(A) showed no significant aspartate consumption or β-alanine formation. The control extract converted 
aspartate but no β-alanine formation was observable (B). Distinct β-alanine formation rates were 
obtained for the crude extracts of DD3 + PEM7*panDcgl (C), DD3 + PEM7*panDcgl+ (D) and DD3 + 
PEM7*panPvna (E). The obtained β-alanine formation rates were converted to specific enzyme activities, 
using the measured protein concentration of the crude extracts (F). Amino acids were measured using 
HPLC. The data represent three independent replicates with means and standard deviations. 
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Similarly, to the PanD assay, the negative control of the PanP assay showed neither 
β-alanine formation nor aspartate consumption (Figure 4.29 A). The control strain 
extract formed no β-alanine, but elevated aspartate consumption was observed in the 
first hour (up to 300 mg L-1 h-1) (Figure 4.29 B). The crude extract, which expressed 
the codon-optimized panDcgl+ showed a similar specific activity of 
10.15 ± 0.17 mU mg-1, when compared to the PanD assay. This corresponded to an 
increase in aspartate consumption (357 mg L-1) (Figure 4.29 C). Obviously, the highest 
activity showed the PanPvna enzyme (Figure 4.29 D). The specific activity 
(264 mU mg-1) was superior compared to PanDcgl. Consequently, the aspartate 
consumption was furthermore increased (665 mg L-1 h-1). In regard of the decreasing 
enzyme activity during the assay, it was decided to test PanPvna once again under 
these conditions. Samples were taken during the first hour of the assay, which allowed 
determination of the enzyme’s maximum specific activity (Figure 4.29 E). A maximum 
β-alanine formation rate of up to 445 mg L-1 h-1 was measured. The corresponding 
maximum specific activity of the enzyme was 372.66 ± 19.61 mU mg-1. 
The enzyme assay confirmed the observed advantages of PanPvna in 
B. succiniciproducens. A 37-fold improvement of the specific activity was reached, 
compared to the codon-optimized expressed PanDcgl enzyme. It is concluded that the 
PanPvna reaction mechanism, relying on pyridoxal 5-phosphate, is advantageous 
compared to the PanDcgl protein. It is assumed, that a major hurdle regarding the low 
activity of the PanDcgl enzyme, may its cleavage mechanism to yield the active protein, 
which is not fully functional in B. succiniciproducens.  
As shown for the panDcgl gene, a codon-optimization of the panPvna gene can 
additionally improve β-alanine production. Furthermore, the crude extracts of 
B. succiniciproducens showed a conversion of aspartate in vitro to, so far, unknown 
metabolites. A competition between β-alanine forming and aspartate consuming 
enzymes is the consequence. This depicts a target for future metabolic engineering to 
improve aspartate supply and diminish competitive aspartate consuming reactions. 
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Figure 4.29. Results of the PanP aspartate 1-decarboxylase assay. Crude extracts of 
B. succiniciproducens DD3 + PEM7*panDcgl+, DD3 + PEM7*panPvna and the control strain, containing 
pJFF224-XN, were used. No significant aspartate consumption or β-alanine formation was shown by 
the water control (A). The control extract converted aspartate but no β-alanine formation was observed 
(B). A similar β-alanine formation rate compared to the PanD assay was obtained using the crude extract 
of DD3 + PEM7*panDcgl (C). The crude extract of DD3 + PEM7*panPvna showed the highest β-alanine 
formation rate during this study (D, E). The obtained β-alanine formation rates were converted to specific 
enzyme activities, using the measured protein concentration of the crude extracts (F). Amino acids were 
measured using HPLC. The data represent three independent replicates with means and standard 
deviations. 
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4.5 Metabolic engineering for 3-hydroxypropionate production 
 
The achieved β-alanine production now opened the possibility to derive 3-HP via the 
β-alanine route. This pathway appeared promising, due to its negative 
∆G0 (-32.3 kJ mol-1) (Valdehuesa et al., 2013). 
 
4.5.1 Conversion of β-alanine to 3-hydroxypropionate – concept and plasmid 
construction 
 
A closer look at the pathway (Figure 4.30 A) revealed that NADP+ is supplied for 
NADPH regeneration. In addition pyruvate is needed in the β-alanine transamination 
step to malonate semialdehyde and alanine. 
It comprised two more enzymes. One enzyme: a β-alanine pyruvate transaminase, 
catalyzing the amino group transfer from β-alanine to pyruvate, yielding malonate 
semialdehyde and alanine (Ingram et al., 2007), and a malonate semialdehyde 
reductase to reduce malonate semialdehyde by use of NADPH (Fujisawa et al., 2003). 
There was no evidence of a β-alanine pyruvate transaminase present in the genome 
of B. succiniciproducens. Hence, it was decided to use a heterologous gene (baptappu) 
from P. putida KT2440 (beta-alanine--pyruvate transaminase, EC 2.6.1.18, PP_0596, 
KEGG database). Blast search of a malonate semialdehyde reductase against the 
B. succiniciproducens genome, i.e. ydfG from E. coli K12 MG1655, identified the dltE 
gene as a similar homologue on protein level (61 % identities). Due to the unknown 
function of the dltE gene, it was decided to use the heterologous ydfG (ydfGeco) gene 
from E. coli K12 MG1655. 
Both genes were synthesized, with regard to the B. succiniciproducens codon-usage 
(indicated by a +), in a polycistronic design under pflD promoter control (Figure 
4.30 B 1.)). The gene combination was designated as the “3-HP production module” 
(plasmid Bsuc_PL27). In a next step, the synthesis of 3-HP from glucose was tested. 
Therefore two operons comprising the genes panDcgl / panDcgl+, baptappu+ and 
ydfGeco+, were designed (Figure 4.30 B 2.) + 3.)). This organized panDcgl or panDcgl+, 
baptappu+, and ydfGeco+ under control of the strong EM7* promoter. For translation, the 
PEM7* ribosomal binding site (RBSEM7*, 18 bp), was implemented between panDcgl / 
panDcgl+, baptappu and ydfGeco, respectively.  
RESULTS AND DISCUSSION 
88 
The two designs were realized by cloning the individual fragments onto the episomal 
vector pJFF224-XN by use of Gibson’s Assembly (Figure 4.30 B) (Figure 6.8). 
The derived plasmids were named Bsuc_PL52, and Bsuc_PL98 (Table 2.1). 
 
 
 
 
Figure 4.30. Reconstruction of B. succiniciproducens DD3 metabolism for 3-HP production. 
The β-alanine synthesis pathway was enhanced by use of the 3-HP production module (A). 
P. putida KT2440 and E. coli K12 MG1655 were chosen as sources for the genes baptappu+ and ydfGeco+, 
respectively. Different constructs (B) for heterologous gene expression allowing 3-HP production from 
β-alanine or glucose were cloned onto pJFF224-XN. Abbreviations of chemicals are GLC, glucose; PEP, 
phosphoenolpyruvate; ATP, adenosine triphosphate; ADP, adenosine diphosphate; CO2, carbon 
dioxide; OAA, oxaloacetate; FUM, fumarate; NH3, ammonia; SA, succinic acid; GLU, glutamate; A-KGL, 
α-ketoglutarate; ASP, aspartate; β-ALA, β-alanine; PYR, pyruvate; ALA, alanine; MSA, malonate 
semialdehyde; NADPH, nicotineamide adenine dinucleotide phosphate, reduced; NADP+, 
nicotineamide adenine dinucleotide phosphate, oxidized; 3-HP, 3-hydroxypropionate. 
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4.5.2 There is no native 3-hydroxypropionate metabolism in Basfia 
succiniciproducens 
 
To test if the cells were able to consume 3-HP, a minimal medium cultivation with 
5 g L-1 supplemented 3-HP was conducted using B. succiniciproducens 
DD3 + pJFF224-XN (Figure 4.31). After a substantial lag phase (Figure 6.9), the cells 
grew up to 48 h until the initial glucose amount was consumed. The succinate yield 
was rather unaffected. Although, the dltE gene of B. succiniciproducens is potentially 
related to 3-HP conversion, 3-HP consumption was not observed (Figure 4.31, Figure 
6.10). This experiment suggested the feasibility of converting glucose to β-alanine and 
consequently to 3-HP by B. succiniciproducens, without undesired conversion of the 
final product. 
 
 
Figure 4.31. Influence of 3-HP on the anaerobic growth physiology of B. succiniciproducens DD3 
+ pJFF224-XN in serum bottles. To detect conversion of 3-HP (white bars), 5 g L-1 were supplemented 
in glucose (dark grey bars) minimal medium. Cell growth (black bars) was normally after a substantial 
lag phase of 36 h. The 0 h (open bars) and the 48 h (hatched bars) samples were processed via HPLC. 
There is no evidence of 3-HP conversion by the used strain. Succinate (light grey bars) production was 
not impaired by 3-HP supplementation. 
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4.5.3 The 3-hydroxypropionate production module is functional in Basfia 
succiniciproducens 
 
The plasmid Bsuc_PL27, containing the 3-HP production module, was successfully 
transformed into B. succiniciproducens DD3. Subsequently, a cultivation under 
anaerobic conditions (CO2) was conducted in minimal medium. To prove the 
functionality of the 3-HP production module, 5 g L-1 β-alanine was added (Figure 
4.32 A-C). In addition, a control experiment omitting β-alanine supplementation was 
conducted (Figure 4.32 D-F). 
3-HP production occurred, when β-alanine was supplemented, whereas no production 
occurred without supplementation. After 72 h, 217 ± 4 mg L-1 3-HP was produced. 
The presence of 3-HP in the supernatant was verified via GC-MS (Figure 6.11). 
Surprisingly, β-alanine was not converted in an equimolar ratio. The initial β-alanine 
concentration of 5 g L-1 was reduced by 813 ± 39 mg L-1. Thus, 596 mg L-1 of the 
consumed β-alanine were not recovered in the product: 73 % of the β-alanine carbon 
fraction was used in an unknown manner. In comparison to the parent strain, and non-
producing condition, significant alanine production was observed. This confirmed that 
the Baptappu enzyme used pyruvate as co-factor (Song et al., 2016). 
To sum it up, the 3-HP production module was found active and functional in 
B. succiniciproducens and converted β-alanine to 3-HP. Furthermore, an unknown 
conversion of β-alanine was observed. In the next step, β-alanine and 3-HP production 
modules were combined to produce 3-HP from glucose. 
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Figure 4.32. Anaerobic growth physiology of a first generation 3-HP producer strain of 
B. succiniciproducens DD3. The strain B. succiniciproducens DD3 PpflDbaptappu+-PpflDydfGeco+ contains 
a codon-optimized version (indicated by the +) of the 3-HP production module genes. A glucose minimal 
medium cultivation under anaerobic (CO2) conditions was conducted. For comparison, medium was 
supplemented with 5 g L-1 β-alanine (A) or used lean (D). Native succinate production (B, E) was found. 
When β-alanine was supplied (C), a substantial production of 3-HP (217 mg L-1) was observed. 
Without supplemented β-alanine (F), no 3-HP formation was found. Measurement of organic acids, 
sugars and amino acids was conducted using HPLC. The data represent three independent replicates 
with means and standard deviations. CDM, Cell dry mass. 
 
4.5.4 Combination of the β-alanine and 3-HP production module 
 
The cloned plasmid Bsuc_PL52 represented an operon of the genes panDcgl, baptappu+ 
and ydfGeco+ with the strong EM7* promoter as control element. After successful 
transformation into B. succiniciproducens DD3, a glucose minimal medium cultivation 
under anaerobic (CO2) conditions was conducted (Figure 4.33 A+B). To determine 
the influence of the single precursor metabolites in the pathway, aspartate (Figure 
4.33 C+D) or β-alanine (Figure 4.33 E+F) were supplemented at an initial concentration 
of 5 g L-1 each.  
The strain consumed glucose and native succinate production was observed (Figure 
4.33 A). When neither aspartate nor β-alanine were supplemented, only minor 3-HP 
amounts were detected (Figure 4.33 B), hard to distinguish from background noise of 
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the HPLC chromatogram. Aspartate supplementation (Figure 4.33 C) enhanced 
succinate production and cell growth and stimulated 3-HP production (Figure 4.33 D) 
(46 ± 1 mg L-1). Supplementation of β-alanine had no effect on succinate production 
and cell growth (Figure 4.33 E), but increased 3-HP production to 569 ± 13 mg L-1 
(Figure 4.33 F). This was an improvement by 160 %, as compared to the initial 
experiment. Furthermore, 3-HP overproduction was accompanied by alanine formation 
(up to 2.2 ± 0.0 g L-1). 
Obviously, the PanDcgl enzyme displayed a bottleneck in the synthetic pathway. 
This indicated that the PanDcgl protein was not sufficiently expressed or active. A lack 
of the panDcgl gene expression is unlikely, due to the polycistronic expression design, 
which enabled significant β-alanine consumption and 3-HP production by the Baptappu 
and the YdfGeco enzyme. Unknown issues, regarding maturing and folding impair the 
enzyme activity of the PanDcgl protein in the B. succiniciproducens cytosol, which 
results in a slow conversion of aspartate to β-alanine. 
 
 
Figure 4.33. Anaerobic growth physiology of a second generation 3-HP producer strain of 
B. succiniciproducens DD3. The strain B. succiniciproducens DD3 PEM7*panDcgl-RBSEM7*-baptappu+-
RBSEM7*-ydfGeco+ contains all 3-HP production genes under EM7* promoter control. A glucose minimal 
medium cultivation under anaerobic (CO2) conditions was conducted. When the medium was used lean, 
the native succinate production (A) was found and only minor 3-HP traces were produced (B). 
When aspartate was supplied, succinate production was raised as observed before (C). Additionally, a 
small but significant 3-HP production (46 mg L-1) was observed (D). Supplementation of β-alanine had 
no significant influence on succinate production (E), but enabled a substantial 3-HP formation (569 
mg L-1) (F). Measurement of organic acids, sugars and amino acids was conducted using HPLC. The 
data represent three independent replicates with means and standard deviations. CDM, Cell dry mass. 
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The 3-HP operon was proven to be functional, upon regulation by a single promoter. 
The synthetic, non-natural transcription unit indicated, that transcription and translation 
was promoted by the EM7* promoter and the RBSEM7* binding site, respectively. 
 
4.5.5 Characteristics of the β-alanine carbon loss in the 3-HP production strain 
 
To study the undesired loss of β-alanine carbon, labeled [13C-15N]-β-alanine was used 
in a feeding experiment with B. succiniciproducens DD3 + Bsuc_PL52. This should 
additionally verify the transamination reaction of pyruvate to alanine by the Baptappu 
enzyme. 
The strain grew as before (Figure 4.33 E+F). After glucose was consumed, biomass 
and supernatant samples were taken for measuring mass isotope distributions of 
selected organic acids and amino acids (Figure 4.34). The mass distributions were 
corrected for naturally occurring isotopes (van Winden et al., 2002). The obtained data 
are given in Table 6.4 and Table 6.5. 
The 3-HP production via the β-alanine route was shown to be accompanied by 
accumulation of alanine. This is a result of the β-alanine conversion to malonate 
semialdehyde via the transamination of pyruvate to alanine. This was shown by the 
m+1 mass shift of the detected alanine fragment (Figure 4.34 A), resulting from the 
15N incorporation of the deployed β-alanine. The formed alanine was not recovered by 
the production strain, hence a loss of carbon into alanine is the consequence. 
This phenomenon was not yet described in other studies using the β-alanine route 
(Borodina et al., 2015; Song et al., 2016). It is thought, that the lack of alanine recovery 
is a distinct property of B. succiniciproducens, which impairs the 3-HP production 
negatively. This phenomenon may not be present in other used microorganisms. 
Furthermore, it could be proven that the 3-HP carbon skeleton originated from 
β-alanine, due to the detected m+3 labeling (Figure 4.34 B). 
The fact that neither β-alanine nor 3-HP was converted by the parent strain, suggests 
that carbon from β-alanine must be re-routed at the level of malonate semialdehyde 
(Figure 4.34 C). Unknown enzyme reactions using this compound had to be 
considered. Genome analysis (KEGG database) of the related genus Mannheimia 
showed presence of a gene, which may cause methylmalonate-semialdehyde 
dehydrogenase (EC 1.2.1.18) activity. This enzyme is predicted to form acetyl-CoA 
from malonate semialdehyde, using oxidative decarboxylation (KEGG database) 
(Hayaishi et al., 1961). The enzyme is annotated in M. haemolytica and M. variegena. 
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When a protein BLAST of the corresponding proteins was conducted against the 
B. succiniciproducens proteom, a protein (PutA, DD1522) with a similarity of about 
29 %, and positive matching residues of 47 % was found. This gene and the 
corresponding enzyme activity is thought to cause the observed loss of β-alanine 
carbon. The corresponding protein showed aldehyde dehydrogenase motifs, but 
interestingly differed in a great extent when compared to another annotated aldehyde 
dehydrogenase (PutA, DD2045). 
To study the potential acetyl-CoA formation from β-alanine, labeling in the acetyl-CoA 
pool and related pools was considered. If labeled carbon from the β-alanine pool was 
converted into acetyl-CoA, subsequent 13C enrichment of acetate, glutamate and 
accordingly, proline should result. Exactly this was found (Figure 4.34 D-F). The most 
significant signature of the 13C-β-alanine carbon was found in the C2 compound 
acetate, which is derived from acetyl-CoA. Accordingly, a m+2 mass shift was 
observed here, indicating labeled carbon, originating from acetyl-CoA and thus from 
β-alanine. Additionally, the carbon backbone of glutamate and proline showed the m+2 
mass shift. These results indicated that carbon from 13C-15N-β-alanine was recovered 
here, which is then consequently channeled into biomass. But other biomass 
compounds did not show significant 13C enrichments. A few amino acids possessed a 
small m+1 labeling originating more likely from the 15N from β-alanine, distributed in 
the metabolism. 
One reasonable explanation of the missing biomass compound labeling is its 
distribution from acetyl-CoA to malonyl-CoA into fatty acids. This has to be considered 
carefully, due to the pflD knockout in the parent strain. Thus, 16 % of the flux from 
pyruvate to formate, and consequently into acetyl-CoA is withdrawn (Becker et al., 
2013). Hence, the latter may accentuate a substantial shortage of acetyl-CoA, yielding 
a lack of fatty acid precursors. Measuring the labeling in the fatty acid fraction of the 
biomass may unravel the missing labeling of the β-alanine carbon in future studies. 
It was shown, that β-alanine is converted into malonate semialdehyde, which is 
withdrawn from the synthetic 3-HP pathway into acetyl-CoA. Acetyl-CoA is then 
converted into compounds of the biomass. This carbon loss, the alanine formation in 
the pathway, and the missing alanine recovery reduces the 3-HP synthesis 
performance by 73 %. It is concluded, that a knockout of the gene putA (DD1522) and 
implementation of alanine recovering enzymes may improve the performance of the 
B. succiniciproducens 3-HP producer. 
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Figure 4.34. Assumed pathway topology of the engineered 3-HP metabolism unraveled by 
GC-MS. The strain B. succiniciproducens DD3 PEM7*panDcgl-RBSEM7*baptappu+-RBSEM7*ydfGeco+ was 
cultivated in minimal medium supplemented with 13C-15N-β-alanine. Subsequent GC-MS measurements 
revealed, that Baptappu protein catalyzes the transamination of β-alanine to alanine by use of pyruvate. 
This was shown by a mass shift in the m+1 mass isotope distribution of alanine (A), indicating a labelled 
amino group transfer. Additionally it can be directly proven that 3-HP originates from the fed β-alanine 
(B). The surplus of consumed β-alanine might relate to the activity of a malonate semialdehyde 
dehydrogenase, which converts malonate semialdehyde to acetyl-CoA (C). The latter was proven by 
m+2 labelling patterns in acetate (D), glutamate (E) and proline (F), respectively. 
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4.5.6 The codon-optimized panDcgl+ gene enables De-novo 3-HP synthesis from 
glucose 
 
Nonetheless of remaining bottlenecks in the 3-HP synthesis using 
B. succiniciproducens, a third generation producer was designed. The codon-
optimization of panDcgl improved β-alanine formation substantially, which could 
furthermore increase the 3-HP production. Therefore, the 3-HP operon was modified, 
using panDcgl+, yielding Bsuc_PL98. Subsequent strain construction resulted in 
B. succiniciproducens DD3 + Bsuc_PL98.  
The resulting strain was grown in glucose minimal medium under CO2 atmosphere 
(Figure 4.35). The cells grew from early on, consumed glucose, and showed, as 
observed before, a constant performance regarding the succinate production (Figure 
4.35 A).  
Cells formed De-novo 3-HP from glucose (Figure 4.35 B) up to 86 ± 15 mg L-1 within 
40 h, without supplementation of aspartate or β-alanine. Additionally, only low 
β-alanine levels indicated an almost complete conversion of this produced precursor 
(Figure 4.35 B). Furthermore, a reduction of the 3-HP titer was observed, when growth 
ceased. This indicated a back flux into malonate semialdehyde, which is converted as 
mentioned before. 
Taken together, De-novo synthesis of 3-HP from glucose was achieved successfully. 
Further strain engineering appears important for improving 3-HP production. Relevant 
targets include the deletion of pathways, responsible for the observed carbon loss on 
the level of malonate semialdehyde. Another drawback is the loss of carbon in the 
deamination step from β-alanine to malonate semialdehyde, while alanine is formed 
from pyruvate. Without recovery of the formed alanine, suboptimal yields are 
unavoidable. Furthermore, improvement in β-alanine synthesis and reduction of 
succinate production may enhance the 3-HP formation. Therefore, increasing 
enzymatic activity of PanD, or use of the newly identified PanP protein should be 
focused on, beside the improvement of aspartate supply. The latter can be achieved 
by overexpression of the aspA gene, as shown recently (Song et al., 2016).  
In addition, elimination of succinate formation in B. succiniciproducens appears 
challenging. A B. succiniciproducens DD3 ∆frdA derivate strain, lacking fumarate 
reductase, which transfers electrons to fumarate leading to succinate formation, is 
unable to grow anaerobically (Figure 6.12). When equipped with the 3-HP operon, it 
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was not possible to restore anaerobic growth, although the last step of the pathway 
comprises a reductive electron transfer step (Figure 6.13). This indicates that 
succinate production of B. succiniciproducens is essential for viability under anaerobic 
conditions, due to redox balancing. Moreover, literature suggests an elementary role 
of succinate in H+ efflux in regard of transport issues and energy generation (Choi et 
al., 2013). 
In respect of the investigated literature, this example is a unique demonstration of 3-HP 
production from glucose in the family of Pasteurellaceae. 
 
 
Figure 4.35. Anaerobic growth physiology of a third generation 3-HP producer strain of B. 
succiniciproducens DD3. The strain B. succiniciproducens DD3 PEM7*panDcgl+-RBSEM7*-baptappu+-
RBSEM7*-ydfGeco+ contains all 3-HP production genes under EM7* promoter control. Cultivation in 
glucose minimal medium under CO2 atmosphere was conducted. The major performance parameters 
of the strain, i.e. succinate production, were not affected (A). A low, but significant, production of 3-HP 
was observed (B). In 40h, up to 86 mg L-1 3-HP was formed. Measurement of organic acids, sugars and 
amino acids was conducted using HPLC. The data represent three independent replicates with means 
and standard deviations. CDM, Cell dry mass. 
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5 CONCLUSION AND OUTLOOK 
 
Without doubt, metabolic engineering of tailor-made producers of industrial relevant 
chemicals, offers a huge potential to shape a bio-based economy. This is relevant due 
to the challenges mankind is facing nowadays, i.e. climate change and decreasing 
supplies of fossil resources. This brings biotechnology in focus of the chemical 
industry, relying on future strategies for the production of bio-based products and daily 
goods from renewable feed stocks (Bozell and Petersen, 2010). 
B. succiniciproducens, got into the focus of research when the run for 
commercialization of bio-based succinate, a C4 organic diacid, was initiated (Becker et 
al., 2013; Choi et al., 2013; Lange et al., 2017; Werpy et al., 2004). By harnessing the 
distinct metabolism of B. succiniciproducens, providing incorporation of CO2 while 
forming succinate, a commercialized process was established by the BASF SE and 
Corbion Purac. Beside the industrial relevant C4 acid succinate, C3 products became 
relevant, namely 3-hydroxypropionate (Werpy et al., 2004). Less was known about the 
production capabilities of Pasteurellaceae, and in particular B. succiniciproducens, 
regarding C3 products, which is the focus of this work. 
By establishing an advanced genetic engineering tool, by using blue-white screening 
for genome based engineering of B. succiniciproducens, a basis for straightforward 
strain engineering efforts was laid. It was furthermore demonstrated, that strain 
selection is possible, using kanamycin. This is essential for more sophisticated 
genome engineering tools like the recently evoked CRISPR/Cas9 system, using two 
plasmid systems (Chung et al., 2017). Furthermore, promoter studies enhanced the 
genetic toolbox for B. succiniciproducens, identifying homologous and heterologous 
candidates for rational gene expression. The latter broadened the toolbox for 
B. succiniciproducens for future metabolic engineering studies using this microbe. 
Rational engineering of B. succiniciproducens for the production of the C3 amino acid 
alanine was conducted as an example project. A strain, containing the deletion of the 
ldhA and pflD gene which expresses the alanine dehydrogenase AlaD from G. 
stearothermophilus XL65-6, was assessed for alanine production. This strain formed 
0.7 g L-1 alanine under aerobic conditions. Alanine production was improved drastically 
to 29 g L-1 in a fed-batch by metabolic and process engineering efforts. Here, xylose 
was shown to be a superior feedstock, which is advantageous due to its origin from 
lignocellulosic biomass. Significant performance improvements were generated by the 
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use of anaerobic gas atmospheres, comprising N2. Application of the latter reduced 
formation of the main by-products acetate and succinate, enabling an almost exclusive 
production of alanine by engineered B. succiniciproducens ALA-1. These results 
demonstrate a valuable and unique product shift in the Pasteurellaceae family, known 
for prominent succinate producers, e.g. A. succinogenes and M. succiniciproducens. 
More sophisticated engineering strategies, regarding the decrease of specific 
productivity during the process, can yield a superior alanine producer, being highly 
competitive to established producers like E. coli (Zhou et al., 2015), C. glutamicum 
(Yamamoto et al., 2012) and, recently evoked, V. natriegens (Hoffart et al., 2017). 
A key to success is the understanding of breeding B. succiniciproducens to high cell 
densities, harnessing the outstanding specific glucose uptake rate. 
Further genetic engineering was conducted for the recombinant production of an 
alanine isomer, β-alanine. A combinatorial approach, validating suitable enzymes, 
i.e. aspartate 1-decarboxylase (PanD) from E. coli and C. glutamicum, and promoters 
and their combination was targeted. The latter enabled the De-novo β-alanine 
production of up to 100 mg L-1 from glucose, a unique example in the Pasteurellaceae 
family. Here, a heterologous promoter derivative of the commonly known EM7 
promoter was shown to be superior compared to the homologous pflD promoter. 
Furthermore, codon optimization of the panDcgl gene from C. glutamicum was the key 
to success. Additionally, a candidate of the PanP protein family from V. natriegens was 
evaluated as aspartate 1-decarboxylase enzyme and shown to be superior compared 
to the PanDcgl enzyme. It was demonstrated, that the specific enzymatic activity of the 
PanD enzyme was rather low, explaining the low production efficiency in contrast to 
PanP. Understanding of activity issues, in regard of the cleavage of the PanD protein 
to its mature and active form in B. succiniciproducens, should improve β-alanine 
production, certainly. Even the identification of stronger promoters, compared to the 
evaluated set, can improve this issue.  
The produced β-alanine was targeted for conversion to 3-HP using engineered 
B. succiniciproducens with the implemented β-alanine route (Valdehuesa et al., 2013). 
A completely codon-optimized operon, comprising panDcgl+, baptappu+ and ydfGeco+ 
under EM7* promoter control, enabled the De-novo synthesis of about 100 mg L-1 3-HP 
under anaerobic conditions. This depicts another unique example, demonstrating the 
production of C3 chemicals in the Pasteurellaceae family, in particular 
B. succiniciproducens.  
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The downstream 3-HP production enzymes Baptappu and YdfGeco, were shown to be 
sufficiently active in B. succiniciproducens. It was demonstrated, that the insufficient 
PanD enzyme activity hampers 3-HP production, and surplus, the insufficient aspartate 
supply, as demonstrated during the PanD and PanP enzyme assays. Furthermore, a 
conversion of malonate semialdehyde into the acetyl-CoA pool was unraveled by use 
of GC/MS. This is according to the finding, that β-alanine and 3-HP are not metabolized 
by B. succiniciproducens. Only activation of the 3-HP synthesis pathway enabled the 
drain of β-alanine carbon. It seems challenging to identify the corresponding pathway 
and responsible enzymes of this drain. But computational analysis suggests, that putA 
(DD1522), encoding a putative aldehyde dehydrogenase, is most likely a candidate for 
such a conversion. Thus it is concluded, that a deletion of the putA (DD1522) gene is 
promising to overcome this drain. As mentioned before, without doubt, improving 
β-alanine production performance will enhance consequently the 3-HP production. 
Anaerobic production of β-alanine and 3-HP using B. succiniciproducens is 
accompanied by its natural strong production of succinate. This demonstrates, that lot 
of carbon is still available for re-routing into the products of interest. 
However, eliminating succinate production is concluded to be highly challenging. 
On the one hand, it was shown in this study, that a derivative strain of 
B. succiniciproducens DD3, lacking fumarate reductase (∆frdA), is not able to grow 
anaerobically. This suggests a somehow distinct and essential role of fumarate 
reductase for anaerobic growth, transferring electrons on fumarate yielding succinate. 
It seems likely, that fumarate respiration evolved (Hong et al., 2004) consequently for 
the CO2 enriched atmosphere (65 % v/v) of the bovine rumen (Guettler et al., 1999). 
This is furthermore emphasized by the demonstration, that the implementation of the 
tested 3-HP synthesis pathway is not able to restore anaerobic growth of this strain. 
Although the last step, reduction of malonate semialdehyde to 3-HP, comprises an 
electron transfer. Additionally, the distinct role of succinate in H+ transport issues, for 
energy generation, seem to impair the elimination of this prominent product generally 
(Choi et al., 2013). 
As shown, the proof-of-concept of producing C3 products with B. succiniciproducens 
was successful. Future engineering using the established tools of this work might 
improve the production performance, to broaden the application field of 
B. succiniproducens.
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Table 6.1. Overview of the stock solutions for the preparation of media for cultivation of 
B. succiniciproducens. The specific mixing of the stocks for the different media is given below. 
All compounds were dissolved in demineralized water to the final volume, and subsequently sterilized 
as indicated by filtration (s) (Filtropur S 0.2 syringe filter, Sarstedt, Nümbrecht, Germany) or autoclaving 
(a) for 20 minutes at 121 °C. Vitamin stock 1 solution was prepared by resuspending riboflavin, nicotinic 
acid and biotin individually in demineralized water followed by dissolving with 6 M NaOH (about 100 μL). 
Additionally, the remaining vitamins were dissolved and pooled and the pH of the solution was adjusted 
to pH 7.5. For trace elements, 5 M HCl (Young Lee, 1996) was used as solvent instead of demineralized 
water. Chloramphenicol for strain selection was dissolved in pure ethanol. The 5-Brom-4-chlor-3-
indoxyl-β-D-galactopyranosid (X-gal) stock solution was prepared with dimethylformamid as the solvent. 
Stock solution  Compound Amount [g] 
Volume 
[mL] 
Sterilization 
method 
Glucose, 50 % Glucose∙H2O 25 50 s 
Xylose, 50 % Xylose 25 50 s 
Sucrose, 50 % Sucrose 25 50 s 
Fructose, 50 % Fructose 25 50 s 
Glycerol, 50 % Glycerol 25 50 s 
Yeast extracta, 10 % Yeast extract 25 250 a 
BHIa, 10 % BHI 25 250 a 
Bacto peptonea, 10 % Bacto peptone 25 250 a 
Ammonium sulphate, 50 %, pH 7.2b (NH4)2SO4 25 50 s 
Ammonium sulphate, 50 % (NH4)2SO4 25 50 s 
ACESc, 500 mM, pH 7.2d ACES 91.1 1000 a 
Sodium carbonate, 25 % Na2CO3 12.5 50 s 
Phosphate, 50 % K2HPO4 25 50 a 
Glycine-betaine, 500 mM Glycine-betaine 2.93 50 s 
L-Aspartate, 25 % L-Aspartate 12.5 50 s 
β-Alanine, 25 % β-Alanine 12.5 50 s 
3-HP, 25 % 3-Hydroxypropionate 2.5 10 s 
Salt solution, 14 % 
NaCl 
MgCl2∙6H2O 
CaCl2∙6H2O 
5 
1 
1 
50 s 
  [mg] [mL]  
Vitamin stock 1, 100x, pH 7.5b 
Thiamine∙HCl 
Riboflavine 
Nicotinic acid 
Calcium pantothenate 
Pyridoxal∙HCl 
Biotin 
Cyanocobalamine 
75 
15 
75 
250 
25 
12.5 
1.25 
25 s 
Trace elements, 200xe 
Fe(II)SO4∙7H2O 
Ca(II)Cl2∙2H2O 
Mn(II)SO4∙H2O 
Zn(II)SO4∙7H2O 
Cu(II)SO4∙5H2O 
Na2B4O7∙10H2O 
(NH4)6Mo7O24∙4H2O 
500 
100 
18.6 
110 
50 
1 
5 
50 a 
Chloramphenicol, 5 %f Chloramphenicol 2500 50 s 
X-Gal, 8 %g 
5-Brom-4-chlor-3-indoxyl-
β-D-galactopyranosid 
400 5 -h 
a Becton and Dickinson 
b pH adjusted with 1 M NaOH 
c N-(2-Acetamido)-2-aminoethanesulfonic acid 
d pH adjusted with 6 M NaOH 
e 5 M HCl as solvent 
f Ethanol as solvent 
g Dimethylformamid as solvent 
h sterilization not necessary 
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Table 6.2. Codon usage derived from the B. succiniciproducens DD1 genome. 
Amino acid Codon Fraction Amino acid Codon Fraction 
Alanine 
GCA 0.0862 
Leucine 
CTA 
0.0500 
GCC 0.2342 CTC 
0.0400 
GCG 0.2653 CTG 
0.1400 
GCT 0.1734 CTT 
0.1400 
Cysteine 
TGC 0.0106 TTA 
0.4200 
TGT 0.5105 TTG 
0.2100 
Aspartate 
GAC 
0,2984 Lysine 
AAA 
0,8802 
GAT 
0,7016 
AAG 
0,1198 
Arginine 
AGA 
0.0800 
Methionine ATG 1.0000 
AGG 
0.0200 Phenylalanine 
TTC 
0.3532 
CGA 
0.0800 
TTT 
0.6468 
CGC 
0.3000 
Proline 
CCA 
0,0921 
CGG 
0.1200 
CCC 
0,1302 
CGT 
0.4000 
CCG 
0.5200 
Asparagine 
AAC 
0,3691 
CCT 
0,2580 
AAT 
0,6309 
Serine 
AGC 
0.2100 
End 
TAA 0.0000 AGT 
0.1700 
TAG 0.0000 TCA 
0,1463 
TGA 0.0000 TCC 
0,1952 
Glutamine 
CAA 
0,6591 
TCG 
0,1399 
CAG 
0,3409 
TCT 
0,1467 
Glutamate 
GAA 
0,8369 
Threonine 
ACA 
0,1722 
GAG 
0,1631 
ACC 
0,3968 
Glycine 
GGA 
0.1300 
ACG 
0,2221 
GGC 
0.3600 
ACT 
0,2088 
GGG 
0.1000 
Tryptophan TGG 1.0000 
GGT 
0.4100 
Tyrosine 
TAC 
0,2630 
Histidine 
CAC 
0,3056 
TAT 
0,7370 
CAT 
0,6944 
Valine 
GTA 
0.2700 
Isoleucine 
ATA 
0.0800 
GTC 
0.1200 
ATC 
0.2900 
GTG 
0.3200 
ATT 
0.6300 
GTT 
0.2900 
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Figure 6.1. Original gel referring to Figure 4.6: Validation of recombinant B. succiniciproducens 
DD3∆∆lacZ clones. Three individual clones were screened comprising Bsuc_PL94 and Bsuc_PL95 
recombinants and the wild type. First recombination in 5’ (Lanes A-J) and 3’ (Lanes K-T) direction was 
tested using PCR with the primer pairs P62+63 and P64+65, respectively. Negative controls (Lane J+T) 
were conducted using demineralized water instead of DNA template. The gel comprised 1 % agarose 
using a 1 kb DNA ladder for determination of product size. 
 
 
Figure 6.2. Original gel referring to Figure 4.8: Validation of second recombinant clones using 
blue-white technique and PCR screening. The obtained clones (A) were screened by PCR with the 
5’ integration primer pair P73+74 (B). Screening revealed the success of the vector excision from the 
genome. At least, five out of 18 clones showed the deletion of DD0789, namely clone #1, #13, #15, #16 
and #18. This is emphasized by comparison to the control clones #4, #10 and #21, which turn blue and 
contain the plasmid. Detection of amplicons were obtained by agarose gel electrophoresis. The gel 
comprised 1 % agarose using a 1 kb DNA ladder for determination of product size. 
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Figure 6.3. Cloning of Bsuc_PL25, Bsuc_PL26 and Bsuc_PL47. All genes were cloned separately 
under control of the pflD or the EM7* promoter onto linearized (SpeI + ApaI or NdeI) episomal 
Pasteurellaceae vector pJFF224-XN (A), yielding Bsuc_PL25, Bsuc_PL26 and Bsuc_PL47, respectively 
(B and C). Clones of Escherichia coli TOP10 were screened for the correct amplicon of about 650 bp 
(B: Lane A-E - Bsuc_PL25, Lane G-I - Bsuc_PL26, C: Lane A and C – Bsuc_PL47). Transformation 
of the latter into Basfia succiniciproducens DD3 was furthermore successful (D: Lane A-G - Bsuc_PL25, 
E: Lane A-F – Bsuc_PL26, F: Lane A-C – Bsuc_PL47). Negative controls (B: Lane F, C: Lane D, 
F: Lane D) were conducted using demineralized water instead of DNA template. The gels comprised 
1 % agarose using a 1 kb DNA ladder for determination of product size. 
 
 
 
Figure 6.4. Cultivation profiles referring to Figure 4.24. CDW, Cell dry weight. 
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 Sequence 6.1. Sequence of the codon-optimized panDcgl+ gene from C. glutamicum for optimized 
expression in B. succiniciproducens. The gene was synthesized by Thermo Fisher Scientific 
(Regensburg, Germany) 
5’-
ATGTTACGCACCATTTTGGGCAGCAAAATTCATCGTGCGACCGTGACGCAAGCGGATTTAGATTATGTGGGTA
GCGTGACCATTGATGCCGATTTAGTGCATGCGGCAGGTTTAATTGAAGGTGAAAAAGTGGCGATTGTGGATAT
TACCAATGGTGCGCGTTTAGAAACCTATGTGATTGTGGGTGATGCAGGCACCGGTAATATTTGTATTAATGGT
GCGGCAGCGCATTTGATTAATCCGGGTGATTTAGTGATCATCATGAGCTATTTACAAGCGACCGATGCGGAAG
CGAAAGCGTATGAACCGAAAATTGTGCATGTGGATGCGGATAATCGTATTGTGGCGTTAGGTAATGATTTAGC
GGAAGCGTTACCTGGTAGCGGTTTATTAACCAGCCGTAGCATTTAA-3’ 
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Figure 6.5. Cloning of Bsuc_PL80 and Bsuc_PL86. The codon-optimized panDcgl gene was cloned 
under control of PpflD or PEM7* onto linearized (NdeI) episomal Pasteurellaceae vector pJFF224-XN (A), 
yielding Bsuc_PL80 and Bsuc_PL86 (B). Different pJFF224-XN screening primer pairs were used, 
yielding differing amplicons. Clones of Escherichia coli TOP10 were screened for the correct amplicon 
of about 750 bp (B: Lane A-E - Bsuc_PL80, Lane H-L - Bsuc_PL86). Transformation of the latter into 
Basfia succiniciproducens DD3 was furthermore successful as proven by the amplicon at about 1000 
bp (C: Lane A-I - Bsuc_PL80, Lane K-R - Bsuc_PL26). Positive controls (B: Lane F + M, C: Lane J + S) 
were conducted using Bsuc_PL80 and Bsuc_PL86 as template, respectively. Negative controls 
(B: Lane G + N, N: Lane D, F: Lane D) were conducted using demineralized water instead of DNA 
template. The gels comprised 1 % agarose using a 1 kb DNA ladder for determination of product size. 
 
 
Figure 6.6. Cloning of Bsuc_PL105. The panPvna gene was cloned under control of PEM7* onto 
linearized (XbaI + ApaI) episomal Pasteurellaceae vector pJFF224-XN (A), yielding Bsuc_PL105 (B). 
Clones of Escherichia coli TOP10 were screened for the correct amplicon of about 2400 bp (B: Lane A 
- Bsuc_PL105, Lane B depicts a clone with the empty vector pJFF224-XN). Transformation of the latter 
into Basfia succiniciproducens DD3 was furthermore successful as proven by the amplicon at about 
2400 bp (B: Lane A - Bsuc_PL105). But only one clone was obtained. Positive control (C: Lane B) was 
conducted using Bsuc_PL105 template. Negative control (B: Lane C) was conducted using 
demineralized water instead of DNA template. The gels comprised 1 % agarose using a 1 kb DNA ladder 
for determination of product size. 
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Figure 6.7. Cultivation of E. coli DH10B + Bsuc_PL105 in M9 minimal medium expressing a new 
identified aspartate 1-decarboxylase (PanPvna) from Vibrio natriegens. The producing strain formed 
up to 600 mg L-1 of β-alanine in 24 h, whereas the control strain, containing the empty vector 
pJFF224-XN, did not. Measurement of amino acids was conducted using HPLC. The data represent 
three independent replicates with means and standard deviations.  
 
Table 6.3. Determination of the protein concentration from Pan assay crude extracts. 
The individual extract was measured three times using the BCA-Assay. Dilutions were made on scale. 
Protein concentration is given in mg mL-1 with mean and standard deviations. 
 
 
 
 a Crude extract used for PanP assay in Figure 4.29 E 
Extract 
Protein 
[mg mL-1] 
diluted 
Dilution 
Factor 
Protein Ø 
[mg mL-1] 
Protein 
deviation 
[mg mL-1] 
PanD assay 
pJFF224 I 0.765 10.41 
8.060 0.305 pJFF224 II 0.772 10.12 
pJFF224 III 0.817 10.28 
Bsuc_PL47 I 0.684 10.43 
7.058 0.076 Bsuc_PL47 II 0.687 10.16 
Bsuc_PL47 III 0.683 10.34 
Bsuc_PL80 I 0.734 10.17 
7.418 0.051 Bsuc_PL80 II 0.718 10.26 
Bsuc_PL80 III 0.706 10.51 
Bsuc_PL105 I 0.683 10.39 
6.986 0.095 Bsuc_PL105 II 0.684 10.10 
Bsuc_PL105 III 0.695 10.01 
PanP assay 
pJFF224 I 0.813 10.90 
8.658 0.170 pJFF224 II 0.832 10.28 
pJFF224 III 0.841 10.18 
Bsuc_PL80 I 0.806 10.36 
8.051 0.291 Bsuc_PL80 II 0.755 10.28 
Bsuc_PL80 III 0.800 10.05 
Bsuc_PL105 I 0.891 10.25 
8.962 0.222 Bsuc_PL105 II 0.846 10.29 
Bsuc_PL105 III 0.890 10.16 
Bsuc_PL105 I 0.813 10.90 
8.928a 0.255 Bsuc_PL105 II 0.832 10.28 
Bsuc_PL105 III 0.841 10.18 
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Figure 6.8. Cloning of Bsuc_PL27, Bsuc_PL52 and Bsuc_PL98. P. putida KT2440 and E. coli K12 
MG1655 were chosen as sources for the genes baptappu+ and ydfGeco+, respectively. Different constructs 
for heterologous gene expression allowing 3-HP production from glucose were cloned into pJFF224-XN 
(A). Validation of cloning was conducted using restriction enzymes. Validation of Bsuc_PL27 (B). 
Here, the DNA was cut with the enzymes SmaI and NdeI. The cut site of SmaI is located on pJFF224-XN 
in the chloramphenicol resistance gene and in the multiple cloning site. NdeI cuts 358 bp downstream 
of ApaI. Therefore, predicted digestion patterns for Bsuc_PL27 should show a two band pattern (4358 
bp and 6164 bp), because the SmaI cut site in the multiple cloning site was eliminated due to cloning. 
The latter was confirmed in the digestion assay (Lane A-D). The negative control conducted with 
pJFF224-XN should yield a three band pattern (410 bp, 1478 bp and 6164 bp), which was observed as 
well (Lane E). Validation of Bsuc_PL52 (C). The plasmid Bsuc_PL52 was confirmed by digestion, using 
SphI. The cut site of SphI is once located in the multiple cloning site of pJFF224-XN 594 bp upstream 
of SpeI. When the panDcgl gene is fused with the PEM7*, a new SphI cut sites arises. Therefore the 
predicted two band pattern (1105 bp and 9582 bp) for Bsuc_P52 was observed (Lane A-C). The plasmid 
Bsuc_PL47 (PEM7*panDcgl) was used as negative control (1105 bp and 7452 bp) (Lane D). Validation of 
Bsuc_PL98 (D). The construct Bsuc_PL98 was confirmed in a more convenient way. Here, MunI was 
used, which cuts in baptappu and furthermore in the ydfGeco gene. The predicted two band pattern 
(1500 bp and 9187 bp), was observed and confirmed the cloning success (Lane A). All plasmids were 
constructed successfully. The gels comprised 1 % agarose using a 1 kb DNA ladder for determination 
of product size. 
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Figure 6.9. Cultivation profiles referring to Figure 4.31. CDW, Cell dry weight. 
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Figure 6.10. 3-HP conversion test. B. succiniciproducens DD3 + pJFF224-XN was grown in presence 
of 5 g L-1 3-HP. Overlay of the 0h and 48 h sample showed clearly, that 3-hydroxypropionate is not 
converted by B. succiniciproducens. 
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Figure 6.11. GC-MS measurements of B. succiniciproducens cultivation supernatants. 
The samples were measured in scan mode (50 – 400 m/z). Measurement of the 3-HP standard 
contained the main 3-HP ions at 73 m/Z, 133 m/z, 147 m/z, 189 m/z, 219 m/z, 261 m/z and 303 m/z 
covered by the 3-HP peak (retention time: 9.2 min). Presence of the 3-HP ions was shown in the 3-HP 
producing strain B. succiniciproducens DD3 + Bsuc_PL27 in the 50 h sample which converted the 
β-alanine. In contrast, when β-alanine was not supplied, the 50 h sample did not show any signs of 3-
HP in the supernatant. 
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Table 6.4. Mass isotopomer distribution (MID) for tracer experiments using 13C15N-β-alanine. 
Samples of naturally labeled (12C14N-β-alanine) supernatant (A50) and biomass (A50) and labeled 
(13C15N-β-alanine) supernatant (B50) and biomass (B50) were taken after 50h, when glucose was 
completely consumed during cultivation. A naturally labeled standard containing the examined 
compounds was additionally measured. Where indicated, data is not available (-). 
 
 
Analyte m/z Mass isotopomer 
Standard 
sample 
(S) 
Unlabeled 
supernatant 
A50 
Unlabeled 
biomass 
A50 
Labeled 
supernatant 
B50 
Labeled 
biomass 
B50 
Lactate 261.2 
M 0.75 - 0.74 - 0.74 
M+1 0.17 - 0.17 - 0.17 
M+2 0.07 - 0.07 - 0.07 
M+3 0.01 - 0.01 - 0.01 
3-HP 261.2 
M 0.75 0.75 0.74 0.04 0.15 
M+1 0.17 0.17 0.17 0.01 0.05 
M+2 0.07 0.07 0.08 0.03 0.04 
M+3 0.01 0.01 0.02 0.92 0.76 
Succinate 289.2 
M 0.74 0.74 0.74 0.73 0.73 
M+1 0.17 0.18 0.18 0.18 0.18 
M+2 0.07 0.07 0.07 0.07 0.07 
M+3 0.01 0.01 0.01 0.01 0.01 
M+4 0.00 0.00 0.00 0.00 0.00 
β-Alanine 260.2 
M 0.75 0.75 0.74 0.00 0.02 
M+1 0.17 0.17 0.17 0.00 0.01 
M+2 0.07 0.07 0.07 0.11 0.15 
M+3 0.01 0.01 0.01 0.05 0.06 
M+4 0.00 0.00 0.00 0.83 0.75 
Alanine 260.2 
M 0.74 0.74 0.74 0.17 0.35 
M+1 0.17 0.17 0.17 0.62 0.48 
M+2 0.07 0.07 0.07 0.15 0.12 
M+3 0.01 0.01 0.01 0.06 0.04 
M+4 0.00 0.00 0.00 0.01 0.01 
Glycine 246.2 
M 0.76 - 0.75 - 0.74 
M+1 0.16 - 0.17 - 0.17 
M+2 0.07 - 0.07 - 0.07 
M+3 0.01 - 0.01 - 0.01 
Valine 288.2 
M 0.73 - 0.73 - 0.72 
M+1 0.19 - 0.18 - 0.19 
M+2 0.07 - 0.07 - 0.07 
M+3 0.01 - 0.01 - 0.01 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
Leucine 302.3 
M 0.72 - 0.72 - 0.69 
M+1 0.19 - 0.19 - 0.19 
M+2 0.07 - 0.07 - 0.09 
M+3 0.01 - 0.01 - 0.02 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
M+7 0.00 - 0.00 - 0.00 
Isoleucine 302.3 
M 0.72 - 0.72 - 0.71 
M+1 0.19 - 0.19 - 0.20 
M+2 0.07 - 0.07 - 0.08 
M+3 0.01 - 0.01 - 0.01 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
M+7 0.00 - 0.00 - 0.00 
Proline 258.2 
M 0.73 - 0.73 - 0.70 
M+1 0.18 - 0.18 - 0.18 
M+2 0.07 - 0.07 - 0.09 
M+3 0.01 - 0.01 - 0.02 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
Serine 390.3 
M 0.64 - 0.64 - 0.64 
M+1 0.22 - 0.22 - 0.23 
M+2 0.10 - 0.10 - 0.10 
M+3 0.02 - 0.02 - 0.02 
M+4 0.01 - 0.01 - 0.01 
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Table 6.4. MID for tracer experiments using 13C15N-β-alanine. Continued 1. 
 
 
 
 
 
 
 
Analyte m/z Mass isotopomer 
Standard 
sample 
(S) 
Unlabeled 
supernatant 
A50 
Unlabeled 
biomass 
A50 
Labeled 
supernatant 
B50 
Labeled 
biomass 
B50 
Threonine 404.4 
M 0.64 - 0.64 - 0.63 
M+1 0.23 - 0.23 - 0.23 
M+2 0.10 - 0.10 - 0.11 
M+3 0.02 - 0.02 - 0.03 
M+4 0.01 - 0.01 - 0.01 
M+5 0.00 - 0.00 - 0.00 
Phenyl-
alanine 336.3 
M 0.70 - 0.70 - 0.68 
M+1 0.21 - 0.20 - 0.21 
M+2 0.08 - 0.08 - 0.08 
M+3 0.01 - 0.01 - 0.02 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
M+7 0.00 - 0.00 - 0.00 
M+8 0.00 - 0.00 - 0.00 
M+9 0.00 - 0.00 - 0.00 
M+10 0.00 - 0.00 - 0.00 
Aspartate 418.4 
M 0.64 - 0.63 - 0.63 
M+1 0.23 - 0.23 - 0.23 
M+2 0.11 - 0.11 - 0.11 
M+3 0.02 - 0.03 - 0.03 
M+4 0.01 - 0.01 - 0.01 
M+5 0.00 - 0.00 - 0.00 
Glutamate 432.4 
M 0.63 - 0.63 - 0.60 
M+1 0.23 - 0.23 - 0.23 
M+2 0.11 - 0.11 - 0.12 
M+3 0.03 - 0.03 - 0.03 
M+4 0.01 - 0.01 - 0.01 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
Lysine 431.4 
M 0.62 - 0.61 - 0.59 
M+1 0.24 - 0.23 - 0.24 
M+2 0.11 - 0.11 - 0.12 
M+3 0.03 - 0.03 - 0.03 
M+4 0.01 - 0.01 - 0.01 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
M+7 0.00 - 0.00 - 0.00 
M+8 0.00 - 0.00 - 0.00 
Tyrosine 466.4 
M 0.60 - 0.60 - 0.59 
M+1 0.25 - 0.25 - 0.25 
M+2 0.11 - 0.11 - 0.11 
M+3 0.03 - 0.03 - 0.03 
M+4 0.01 - 0.01 - 0.01 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
M+7 0.00 - 0.00 - 0.00 
M+8 0.00 - 0.00 - 0.00 
M+9 0.00 - 0.00 - 0.00 
M+10 0.00 - 0.00 - 0.00 
Acetate 43.1 
M 0.92 0.92 - 0.87 - 
M+1 0.03 0.03 - 0.03 - 
M+2 0.02 0.02 - 0.08 - 
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Table 6.5. Mass isotopomer distribution (MID) for tracer experiments using 13C15N-β-alanine 
corrected for natural labeling. Samples of naturally labeled (12C14N-β-alanine) supernatant (A50) and 
biomass (A50) and labeled (13C15N-β-alanine) supernatant (B50) and biomass (B50) were taken after 
50h, when glucose was completely consumed during cultivation. A naturally labeled standard containing 
the examined compounds was additionally measured. Where indicated, data is not available (-). 
 
 
Analyte m/z Mass isotopomer 
Standard 
sample 
(S) 
Unlabeled 
supernatant 
A50 
Unlabeled 
biomass 
A50 
Labeled 
supernatant 
B50 
Labeled 
biomass 
B50 
Lactate 261.2 
M 0.97 - 0.96 - 0.96 
M+1 0.03 - 0.03 - 0.04 
M+2 0.00 - 0.00 - 0.00 
M+3 0.00 - 0.00 - 0.00 
3-HP 261.2 
M 0.97 0.97 0.95 0.04 0.16 
M+1 0.03 0.03 0.03 0.01 0.02 
M+2 0.00 0.00 0.01 0.03 0.03 
M+3 0.00 0.00 0.00 0.93 0.79 
Succinate 289.2 
M 0.96 0.95 0.95 0.95 0.95 
M+1 0.04 0.04 0.04 0.05 0.05 
M+2 0.00 0.00 0.00 0.00 0.00 
M+3 0.00 0.00 0.00 0.00 0.00 
M+4 0.00 0.00 0.00 0.00 0.00 
β-Alanine 260.2 
M 0.97 0.97 0.96 0.18 0.18 
M+1 0.03 0.03 0.03 0.13 0.12 
M+2 0.00 0.00 0.00 0.32 0.36 
M+3 0.00 0.00 0.00 0.38 0.34 
M+4 - - - - - 
Alanine 260.2 
M 0.96 0.96 0.96 0.21 0.46 
M+1 0.03 0.03 0.04 0.76 0.53 
M+2 0.00 0.00 0.00 0.02 0.02 
M+3 0.00 0.00 0.00 0.00 0.00 
M+4 0.00 0.00 0.00 0.00 0.00 
Glycine 246.2 
M 0.98 - 0.97 - 0.96 
M+1 0.02 - 0.03 - 0.04 
M+2 0.00 - 0.00 - 0.00 
M+3 0.00 - 0.00 - 0.00 
Valine 288.2 
M 0.94 - 0.95 - 0.93 
M+1 0.06 - 0.05 - 0.06 
M+2 0.00 - 0.00 - 0.00 
M+3 0.00 - 0.00 - 0.00 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
Leucine 302.3 
M 0.97 - 0.97 - 0.94 
M+1 0.03 - 0.03 - 0.04 
M+2 0.00 - 0.00 - 0.02 
M+3 0.00 - 0.00 - 0.00 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
M+7 0.00 - 0.00 - 0.00 
Isoleucine 302.3 
M 0.97 - 0.97 - 0.96 
M+1 0.03 - 0.02 - 0.03 
M+2 0.00 - 0.00 - 0.00 
M+3 0.00 - 0.00 - 0.00 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
M+7 0.00 - 0.00 - 0.00 
Proline 258.2 
M 0.95 - 0.95 - 0.91 
M+1 0.05 - 0.05 - 0.06 
M+2 0.00 - 0.00 - 0.03 
M+3 0.00 - 0.00 - 0.00 
M+4 0.00 - 0.00 - 0.00 
M+5 - - - - - 
Serine 390.3 
M 0.97 - 0.97 - 0.96 
M+1 0.03 - 0.03 - 0.04 
M+2 0.00 - 0.00 - 0.00 
M+3 0.00 - 0.00 - 0.00 
M+4 0.00 - 0.00 - 0.00 
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Table 6.5. Mass isotopomer distribution (MID) for tracer experiments using 13C15N-β-alanine 
corrected for natural labeling. Continued 1. 
 
 
 
 
 
 
 
Analyte m/z Mass isotopomer 
Standard 
sample 
(S) 
Unlabeled 
supernatant 
A50 
Unlabeled 
biomass 
A50 
Labeled 
supernatant 
B50 
Labeled 
biomass 
B50 
Threonine 404.4 
M 0.96 - 0.96 - 0.95 
M+1 0.04 - 0.04 - 0.05 
M+2 0.00 - 0.00 - 0.00 
M+3 0.00 - 0.00 - 0.00 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
Phenyl-
alanine 
336.3 
M 0.91 - 0.91 - 0.89 
M+1 0.09 - 0.08 - 0.10 
M+2 0.00 - 0.00 - 0.01 
M+3 0.00 - 0.00 - 0.00 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
M+7 0.00 - 0.00 - 0.00 
M+8 0.00 - 0.00 - 0.00 
M+9 0.00 - 0.00 - 0.00 
M+10 0.00 - 0.00 - 0.00 
Aspartate 418.4 
M 0.96 - 0.96 - 0.95 
M+1 0.04 - 0.04 - 0.05 
M+2 0.00 - 0.00 - 0.00 
M+3 0.00 - 0.00 - 0.00 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
Glutamate 432.4 
M 0.95 - 0.95 - 0.91 
M+1 0.05 - 0.05 - 0.06 
M+2 0.00 - 0.00 - 0.02 
M+3 0.00 - 0.00 - 0.00 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
Lysine 431.4 
M 0.94 - 0.92 - 0.89 
M+1 0.06 - 0.06 - 0.08 
M+2 0.00 - 0.01 - 0.02 
M+3 0.00 - 0.00 - 0.00 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
M+6 0.00 - 0.00 - 0.00 
M+7 0.00 - 0.00 - 0.00 
M+8 - - - - - 
Tyrosine 466.4 
M 0.78 - 0.90 - 0.89 
M+1 0.07 - 0.09 - 0.10 
M+2 0.00 - 0.01 - 0.01 
M+3 0.00 - 0.00 - 0.00 
M+4 0.00 - 0.00 - 0.00 
M+5 0.00 - 0.00 - 0.00 
M+6 0.04 - 0.00 - 0.00 
M+7 0.04 - 0.00 - 0.00 
M+8 0.04 - 0.00 - 0.00 
M+9 0.04 - 0.00 - 0.00 
M+10 0.00 - 0.00 - 0.00 
Acetate 43.1 
M 0.92 0.92 - 0.87 - 
M+1 0.03 0.03 - 0.03 - 
M+2 0.02 0.02 - 0.08 - 
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Figure 6.12. Comparison of aerobic and anaerobic growth of B. succiniciproducens strains. 
The strains were streaked on buffered BHI agarplates. Incubation was conducted at 37 °C for 48 h. 
The strain B. succiniciproducens DD3 pH 5.3 ∆frdA showed impaired growth under anaerobic conditions 
(A). In contrast, normal growth was observed under aerobic conditions (B). The parent strain 
B. succiniciproducens DD3 pH 5.3, lacking the ldhA and the pflD gene showed normal growth, either 
under anaerobic (C) or aerobic conditions (D). 
 
 
 
 
 
 
 
 
 
 
 
  APPENDIX 
  117 
 
 
Figure 6.13. Comparison of B. succiniciproducens DD3 and DD3 pH5.3∆ldhA::aspA ∆frdA::asd 
containing the plasmids pJFF224 and Bsuc_PL98 under aerobic and anaerobic growth 
conditions. Cells were streaked on buffered BHI agar plates, which were incubated up to 72h under 
aerobic, or anaerobic conditions. The DD3 strain showed growth. DD3 + pJFF224 aerob (A) and 
anaerob (B). DD3 + Bsuc_PL98 aerob (E) and anaerob (F). DD3 pH5.3∆ldhA::aspA ∆frdA::asd + 
pJFF224 aerob (C) and anaerob (D). DD3 pH5.3∆ldhA::aspA ∆frdA::asd + Bsuc_PL98 aerob (G) and 
anaerob (H). 
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